
<html lang="en"     class="pb-page"  data-request-id="8727d5de-eb8e-4e61-959d-8571c92e845c"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2008.51.issue-13;article:article:10.1021/jm701397k;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="7-Aminopyrazolo[1,5-a]pyrimidines as Potent Multitargeted Receptor Tyrosine Kinase Inhibitors" /></meta><meta name="dc.Creator" content="Robin R.  Frey" /></meta><meta name="dc.Creator" content="Michael L.  Curtin" /></meta><meta name="dc.Creator" content="Daniel H.  Albert" /></meta><meta name="dc.Creator" content="Keith B.  Glaser" /></meta><meta name="dc.Creator" content="Lori J.  Pease" /></meta><meta name="dc.Creator" content="Niru B.  Soni" /></meta><meta name="dc.Creator" content="Jennifer J.  Bouska" /></meta><meta name="dc.Creator" content="David  Reuter" /></meta><meta name="dc.Creator" content="Kent D.  Stewart" /></meta><meta name="dc.Creator" content="Patrick  Marcotte" /></meta><meta name="dc.Creator" content="Gail  Bukofzer" /></meta><meta name="dc.Creator" content="Junling  Li" /></meta><meta name="dc.Creator" content="Steven K.  Davidsen" /></meta><meta name="dc.Creator" content="Michael R.  Michaelides" /></meta><meta name="dc.Description" content="7-Aminopyrazolo[1,5-a]pyrimidine urea receptor tyrosine kinase inhibitors have been discovered. Investigation of structure−activity relationships of the pyrazolo[1,5-a]pyrimidine nucleus led to a s..." /></meta><meta name="Description" content="7-Aminopyrazolo[1,5-a]pyrimidine urea receptor tyrosine kinase inhibitors have been discovered. Investigation of structure−activity relationships of the pyrazolo[1,5-a]pyrimidine nucleus led to a s..." /></meta><meta name="dc.Publisher" content=" American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 17, 2008" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm701397k" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2008 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm701397k" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm701397k" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm701397k" /></link>
        
    
    

<title>7-Aminopyrazolo[1,5-a]pyrimidines as Potent Multitargeted Receptor Tyrosine Kinase Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm701397k" /></meta><meta property="og:title" content="7-Aminopyrazolo[1,5-a]pyrimidines as Potent Multitargeted Receptor Tyrosine Kinase Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/large/jm-2007-01397k_0019.jpeg" /></meta><meta property="og:description" content=" 7-Aminopyrazolo[1,5-a]pyrimidine urea receptor tyrosine kinase inhibitors have been discovered. Investigation of structure−activity relationships of the pyrazolo[1,5-a]pyrimidine nucleus led to a series of 6-(4-N,N′-diphenyl)ureas that potently inhibited a panel of vascular endothelial growth factor receptor (VEGFR) and platelet-derived growth factor receptor (PDGFR) kinases. Several of these compounds, such as 34a, are potent inhibitors of kinase insert domain-containing receptor tyrosine kinase (KDR) both enzymatically (&lt;10 nM) and cellularly (&lt;10 nM). In addition, compound 34a possesses a favorable pharmacokinetic profile and demonstrates efficacy in the estradiol-induced murine uterine edema (UE) model (ED50 = 1.4 mg/kg)." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm701397k"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm701397k">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm701397k&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm701397k&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm701397k&amp;href=/doi/10.1021/jm701397k" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2008</span><span class="cit-fg-volume">, 51</span><span class="cit-fg-issue">, 13</span><span class="cit-fg-pageRange">, 3777-3787</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/51/13" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm7011694" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm701433b" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">7-Aminopyrazolo[1,5-<i>a</i>]pyrimidines as Potent Multitargeted Receptor Tyrosine Kinase Inhibitors</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robin+R.++Frey">Robin R. Frey</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+L.++Curtin">Michael L. Curtin</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniel+H.++Albert">Daniel H. Albert</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Keith+B.++Glaser">Keith B. Glaser</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lori+J.++Pease">Lori J. Pease</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Niru+B.++Soni">Niru B. Soni</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jennifer+J.++Bouska">Jennifer J. Bouska</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David++Reuter">David Reuter</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kent+D.++Stewart">Kent D. Stewart</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Patrick++Marcotte">Patrick Marcotte</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gail++Bukofzer">Gail Bukofzer</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Junling++Li">Junling Li</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Steven+K.++Davidsen">Steven K. Davidsen</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+R.++Michaelides">Michael R. Michaelides</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info"><span class="aff-text">Global Pharmaceutical Research and Development, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064-6100</span></div><div class="corresp-info"><strong>*</strong> To whom correspondence should be addressed. Phone: (847) 938-2517. Fax: (847) 935-5165. E-mail: <a href="/cdn-cgi/l/email-protection#f0829f92999ede82de96829589b09192929f8484de939f9d"><span class="__cf_email__" data-cfemail="42302d202b2c6c306c2430273b022320202d36366c212d2f">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm701397k&amp;href=/doi/10.1021%2Fjm701397k" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2008</span></span><span class="cit-volume">, 51</span><span class="cit-issue">, 13</span><span class="cit-pageRange">, 3777–3787</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 17, 2008</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>7 November 2007</li><li><span class="item_label"><b>Published</b> online</span>17 June 2008</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 1 July 2008</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm701397k" title="DOI URL">https://doi.org/10.1021/jm701397k</a></div><div class="article_header-article-copyright"><strong>Copyright © 2008 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3777%26pageCount%3D11%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DRobin%2BR.%2BFrey%252C%2BMichael%2BL.%2BCurtin%252C%2BDaniel%2BH.%2BAlbert%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D51%26issueNum%3D13%26contentID%3Djm701397k%26title%3D7-Aminopyrazolo%255B1%252C5-a%255Dpyrimidines%2Bas%2BPotent%2BMultitargeted%2BReceptor%2BTyrosine%2BKinase%2BInhibitors%26numPages%3D11%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3787%26publicationDate%3DJuly%2B2008">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm701397k"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2911</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">34</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm701397k" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;7-Aminopyrazolo[1,5-a]pyrimidines as Potent Multitargeted Receptor Tyrosine Kinase Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Robin&quot;,&quot;last_name&quot;:&quot;R. Frey&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;L. Curtin&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;H. Albert&quot;},{&quot;first_name&quot;:&quot;Keith&quot;,&quot;last_name&quot;:&quot;B. Glaser&quot;},{&quot;first_name&quot;:&quot;Lori&quot;,&quot;last_name&quot;:&quot;J. Pease&quot;},{&quot;first_name&quot;:&quot;Niru&quot;,&quot;last_name&quot;:&quot;B. Soni&quot;},{&quot;first_name&quot;:&quot;Jennifer&quot;,&quot;last_name&quot;:&quot;J. Bouska&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;Reuter&quot;},{&quot;first_name&quot;:&quot;Kent&quot;,&quot;last_name&quot;:&quot;D. Stewart&quot;},{&quot;first_name&quot;:&quot;Patrick&quot;,&quot;last_name&quot;:&quot;Marcotte&quot;},{&quot;first_name&quot;:&quot;Gail&quot;,&quot;last_name&quot;:&quot;Bukofzer&quot;},{&quot;first_name&quot;:&quot;Junling&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Steven&quot;,&quot;last_name&quot;:&quot;K. Davidsen&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;R. Michaelides&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2008&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;17&quot;,&quot;issue&quot;:&quot;13&quot;,&quot;volume&quot;:&quot;51&quot;,&quot;pages&quot;:&quot;3777-3787&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm701397k&quot;},&quot;abstract&quot;:&quot;7-Aminopyrazolo[1,5-a]pyrimidine urea receptor tyrosine kinase inhibitors have been discovered. Investigation of structure−activity relationships of the pyrazolo[1,5-a]pyrimidine nucleus led to a series of 6-(4-N,N′-diphenyl)ureas that potently inhibited a panel of vascular endothelial growth factor receptor (VEGFR) and platelet-derived growth factor receptor (PDGFR) kinases. Several of these compounds, such as 34a, are potent inhibitors of kinase insert domain-containing receptor tyrosine kinase (KDR) both enzymatically (&lt;10 nM) and cellularly (&lt;10 nM). In addition, compound 34a possesses a favorable pharmacokinetic profile and demonstrates efficacy in the estradiol-induced murine uterine edema (UE) model (ED50 = 1.4 mg/kg).&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm701397k&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm701397k" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm701397k&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm701397k" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm701397k&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm701397k" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm701397k&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm701397k&amp;href=/doi/10.1021/jm701397k" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm701397k" /></input><a href="/doi/pdf/10.1021/jm701397k" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (409 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm701397k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm701397k%26sid%3Dliteratum%253Aachs%26pmid%3D18557606%26genre%3Darticle%26aulast%3DFrey%26date%3D2008%26atitle%3D7-Aminopyrazolo%255B1%252C5-a%255Dpyrimidines%2Bas%2BPotent%2BMultitargeted%2BReceptor%2BTyrosine%2BKinase%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D51%26issue%3D13%26spage%3D3777%26epage%3D3787%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291917" title="Pyrimidine">Pyrimidine</a>,</li><li><a href="/action/doSearch?ConceptID=292271" title="Urea">Urea</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/51/13" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/medium/jm-2007-01397k_0019.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/large/jm-2007-01397k_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701397k&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">7-Aminopyrazolo[1,5-<i>a</i>]pyrimidine urea receptor tyrosine kinase inhibitors have been discovered. Investigation of structure−activity relationships of the pyrazolo[1,5-<i>a</i>]pyrimidine nucleus led to a series of 6-(4-<i>N</i>,<i>N</i>′-diphenyl)ureas that potently inhibited a panel of vascular endothelial growth factor receptor (VEGFR) and platelet-derived growth factor receptor (PDGFR) kinases. Several of these compounds, such as <b>34a</b>, are potent inhibitors of kinase insert domain-containing receptor tyrosine kinase (KDR) both enzymatically (<10 nM) and cellularly (<10 nM). In addition, compound <b>34a</b> possesses a favorable pharmacokinetic profile and demonstrates efficacy in the estradiol-induced murine uterine edema (UE) model (ED<sub>50</sub> = 1.4 mg/kg).</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52413" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52413" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Protein kinase signaling is a predominant means of signal transduction in eukaryotic cells and controls processes such as proliferation, migration, survival, and cell cycle progression. Misregulation of these tightly controlled processes through mutation or overexpression of kinases is implicated in a number of disease states including cancer and immunological disorders.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a></div><div class="NLM_p">Angiogenesis, the process by which new capillaries are formed from existing blood vessels, is essential for a tumor to grow beyond about 1−2 mm.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> As a tumor becomes larger, it becomes increasingly hypoxic, leading to induction of growth factors, including vascular endothelial growth factor (VEGF<a class="ref internalNav" href="#fnabbrev" aria-label="a">a</a>),<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a><div class="NLM_fn" id="fnabbrev">a<p class="last">Abbreviations: ATP, adenosine 5′ triphosphate; CSF1R, colony-stimulating factor-1; DMF-DMA, dimethylformamide dimethyl acetal; EDCI, <i>N</i>-(3-dimethylaminopropyl)-<i>N</i>′-ethylcarbodiimide hydrochloride; EGFR, endothelial growth factor receptor; Flt-1, fms-like tyrosine kinase-1; Flt-3, fms-like tyrosine kinase 3; KDR, kinase insert domain-containing receptor tyrosine kinase; PDGF, platelet-derived growth factor; PDGFR, platelet-derived growth factor receptor; RTK, receptor tyrosine kinase; SAR, structure−activity relationship; UE, estradiol-induced murine uretine edema assay; VEGF, vascular endothelial growth factor; VEGFR, vascular endothelial growth factor receptor.</p></div> which trigger angiogenesis.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4, 5)</a> Once angiogenesis has been induced, the tumor becomes highly vascularized and can grow at a much more rapid pace.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Although VEGF-stimulated angiogenesis is crucial for embryonic neovascularization,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> in adults its normal physiologic roles are largely restricted to reproductive function and wound healing,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> suggesting that inhibition of angiogenesis may present an opportunity for the selective treatment of cancer.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Approval by the U.S. Food and Drug Administration of the anti-VEGF antibody bevacizumab,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> along with the clinical efficacy shown by this agent, has further heightened interest in identifying small-molecule inhibitors of angiogenic kinases.</div><div class="NLM_p">VEGF, as well as other proangiogenic growth factors including platelet-derived growth factor (PDGF), acts through binding to receptor tyrosine kinases (RTKs), a family of transmembrane proteins. Upon binding the growth factor, RTKs dimerize and undergo autophosphorylation, triggering a series of downstream events leading to proliferation, migration, and cell survival.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> VEGF promotes angiogenesis through binding to a family of homologous VEGF receptors, including KDR (VEGFR-2), Flt-1 (VEGFR-1), and Flt-4 (VEGFR-3). Likewise, PDGF binds to the PDGFR family of receptors, Flt-3, PDGFRβ, cKit, and CSF1R (colony-stimulating factor 1 receptor). The PDGF receptors not only trigger angiogenesis but also contribute to tumor growth.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a></div><div class="NLM_p">Early work in the field of receptor tyrosine kinase inhibitors was directed toward the identification of agents with a high degree of selectivity for a particular enzyme.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13, 14)</a> This led to the discovery of first-generation RTK inhibitors, including compounds such as SU5416 ((<i>Z</i>)-3-((3,5-dimethyl-1<i>H</i>-pyrrol-2-yl)methylene)indolin-2-one),<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15, 16)</a> a small molecule that is selective for VEGFR. Later research, however, suggests that compounds targeting a broader range of RTKs may lead to a more robust antitumor response, as there are a number of redundant RTK-mediated processes that can promote angiogenesis.<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17, 18)</a> Furthermore, recent data show that tumors treated with selective agents can develop resistance through the up-regulation of alternative kinase-mediated pathways.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> This has led to the development of broader-spectrum RTK inhibitors, including two recently launched anticancer drugs, SU11248 ((<i>Z</i>)-<i>N</i>-(2-(diethylamino)ethyl)-2,4-dimethyl-5-((5-methyl-2-oxoindolin-3-ylidene)methyl)-1<i>H</i>-pyrrole-3-carboxamide),<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> an inhibitor of KDR, Flt-1, PDGFR, and c-Kit, and BAY 43-9006 (<i>N</i>-[4-chloro-3-(trifluoromethyl)phenyl]-<i>N</i>′-[4-[2-(<i>N</i>-methylcarbamoyl)-4-pyridyloxy]phenyl]urea),<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> an inhibitor of Raf kinase, as well as of the VEGFR, EGFR, and PDGFR kinases.</div><div class="NLM_p">Our laboratories have been engaged in research directed toward multitargeted RTK inhibitors, including thienopyrimidines,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> isoindolinone ureas,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> and aminoindazole ureas including <b>1</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> In light of the efficacy observed for RTK inhibitors in the clinic,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> we are continuing our efforts to identify structurally novel kinase inhibitor classes. Rational design efforts in our laboratories identified aminoquinoxaline <b>2</b>, which was a submicromolar inhibitor of KDR (IC<sub>50</sub> = 168 nM). Brief SAR study based on the quinoxaline scaffold failed to generate compounds with substantially improved potency, so we sought other templates that might exploit a binding mode similar to that proposed for compound <b>2</b>, in which the biarylurea extends into the hydrophobic pocket and the bicyclic core forms hydrogen bonds to the hinge region of the enzyme as shown in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Modification of the aminoquinoxaline lead structure led to the identification of a series of 7-aminopyrazolo[1,5-<i>a</i>]pyrimidine inhibitors of KDR such as <b>14</b>, which demonstrated improved potency. In this paper, we describe the synthesis and characterization of this novel series of 7-aminopyrazolo[1,5-<i>a</i>]pyrimidines as potent inhibitors of the VEGFR and PDGFR tyrosine kinases.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/medium/jm-2007-01397k_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/large/jm-2007-01397k_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Compound <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/large/jm-2007-01397k_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701397k&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/medium/jm-2007-01397k_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/large/jm-2007-01397k_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Lead structure <b>2</b> and pyrazolo[1,5-<i>a</i>]pyrimidine <b>14</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/large/jm-2007-01397k_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701397k&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec1_1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43845" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43845" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Our initial synthetic route, shown in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>, began with the cyclocondensation of 3-amino-4-bromopyrazole with 3-oxo-2-phenylpropanenitrile under acidic conditions to give the fused bicyclic aromatic heterocycle <b>3</b>.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> This compound was then subjected to electrophilic aromatic nitration yielding a mixture of nitration products favoring the para isomer, followed by reduction of the nitro group to give aniline 5, which was treated with <i>m</i>-tolyl isocyanate to give the urea <b>6</b>. Similar conditions were used to prepare urea derivatives <b>6a</b>−<b>c</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>); amide <b>7</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) was prepared by an amide coupling of <b>5</b> with benzoic acid. The 7-<i>des</i>-amino analogue <b>10</b> was prepared in an analogous fashion from 2-phenylmalonaldehyde, as shown in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. Compounds <b>4</b> and <b>41</b> (Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, respectively), which bear a 4-methoxy group in place of the urea, were prepared using cyclocondensation conditions similar to those described in Schemes <a class="ref internalNav" href="#sch1" aria-label="1">1</a> and <a class="ref internalNav" href="#sch2" aria-label="2">2</a>, respectively, starting with commercially available 3-(4-methoxyphenyl)-3-oxopropanenitrile.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/medium/jm-2007-01397k_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/large/jm-2007-01397k_0005.jpeg" id="gs1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of 7-Aminopyrazolo[1,5-<i>a</i>]pyrimidines <b>6</b> and <b>7</b> via Nitration<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/large/jm-2007-01397k_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701397k&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) concentrated HCl, EtOH, reflux, 74%; (b) HNO<sub>3</sub>, H<sub>2</sub>SO<sub>4</sub>, −20 °C to room temp; (c) Fe<sup>0</sup>, NH<sub>4</sub>Cl, THF, EtOH, H<sub>2</sub>O, 80 °C, 29% (two-step yield); (d) <i>m</i>-tolyl isocyanate, DMF, −20 °C to room temp, 47%; (e) benzoic acid, EDCI, HOBt, <i>N</i>-methylmorpholine, DMF, 60%.</p></p></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. KDR Inhibitory Activity of Initial Pyrazolo[1,5-<i>a</i>]pyrimidine Analogues</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/medium/jm-2007-01397k_0011.gif" alt="" id="gr6" /></img><div class="scrollable-table-wrap"><table class="table single-image frame_topbot"><colgroup><col align="left" /></col></colgroup><tbody><tr valign="top"><td align="left"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/medium/jm-2007-01397k_0012.gif" alt="" id="_i6" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last">Each IC<sub>50</sub> determination was performed with seven concentrations, and each assay point was determined in duplicate.</p></div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Substitutions at the 2, 3, and 5 Positions of the 7-Aminopyrazolo[1,5-<i>a</i>]pyrimidines</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/medium/jm-2007-01397k_0013.gif" alt="" id="gr11" /></img><div class="scrollable-table-wrap"><table class="table single-image frame_topbot"><colgroup><col align="left" /></col></colgroup><tbody><tr valign="top"><td align="left"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/medium/jm-2007-01397k_0014.gif" alt="" id="_i8" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last">Each IC<sub>50</sub> determination was performed with seven concentrations, and each assay point was determined in duplicate.</p></div><div class="footnote" id="tbl2-fn2"><sup>b</sup><p class="last">Each cellular IC<sub>50</sub> determination was performed with five concentrations, and each assay point was determined in duplicate.</p></div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Substitutions at the Terminal Benzene Ring of the of <i>N</i>,<i>N</i>′-Diarylureas</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/medium/jm-2007-01397k_0015.gif" alt="" id="gr5" /></img><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle">compd</th><th align="center" valign="middle">X</th><th align="center" valign="middle">R</th><th align="center" valign="middle">KDR (IC<sub>50</sub>, nM)<a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></th><th align="center" valign="middle" char=".">KDR (cell) (IC<sub>50</sub>, nM)<a class="ref internalNav" href="#tbl3-fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top"><td align="left"><b>6</b></td><td align="left">Br</td><td align="left">3-CH<sub>3</sub></td><td align="left">72</td><td align="char" char=".">86</td></tr><tr valign="top"><td align="left"><b>6a</b></td><td align="left">Br</td><td align="left">2-CH<sub>3</sub></td><td align="left">>12500</td><td align="char" char="."> </td></tr><tr valign="top"><td align="left"><b>6b</b></td><td align="left">Br</td><td align="left">4-CH<sub>3</sub></td><td align="left">810</td><td align="char" char="."> </td></tr><tr valign="top"><td align="left"><b>6c</b></td><td align="left">Br</td><td align="left">H</td><td align="left">1600</td><td align="char" char="."> </td></tr><tr valign="top"><td align="left"><b>14</b></td><td align="left">H</td><td align="left">3-CH<sub>3</sub></td><td align="left">47</td><td align="char" char=".">70</td></tr><tr valign="top"><td align="left"><b>14a</b></td><td align="left">H</td><td align="left">3-CF<sub>3</sub></td><td align="left">9</td><td align="char" char=".">35</td></tr><tr valign="top"><td align="left"><b>14b</b></td><td align="left">H</td><td align="left">3-Cl</td><td align="left">44</td><td align="char" char="."> </td></tr><tr valign="top"><td align="left"><b>14c</b></td><td align="left">H</td><td align="left">2-F, 5-CH<sub>3</sub></td><td align="left">74</td><td align="char" char="."> </td></tr><tr valign="top"><td align="left"><b>14d</b></td><td align="left">H</td><td align="left">2-F, 5-CF<sub>3</sub></td><td align="left">14</td><td align="char" char=".">70</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>a</sup><p class="last">Each IC<sub>50</sub> determination was performed with seven concentrations, and each assay point was determined in duplicate.</p></div><div class="footnote" id="tbl3-fn2"><sup>b</sup><p class="last">Each cellular IC<sub>50</sub> determination was performed with five concentrations, and each assay point was determined in duplicate.</p></div></div></div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/medium/jm-2007-01397k_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/large/jm-2007-01397k_0006.jpeg" id="gs2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of 7-<i>des</i>-Aminopyrazolo[1,5-<i>a</i>]pyrimidine Urea <b>10</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/large/jm-2007-01397k_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701397k&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) concentrated HCl, EtOH, reflux, 93%; (b) HNO<sub>3</sub>, H<sub>2</sub>SO<sub>4</sub>, −20 °C to room temp; (c) Fe<sup>0</sup>, NH<sub>4</sub>Cl, THF, EtOH, H<sub>2</sub>O, 80 °C, 34% (two-step yield); (d) <i>m</i>-tolyl isocyanate, DMF, −20 °C to room temp, 51%.</p></p></figure><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Comparison of the SAR of 7-Amino- and 7-<i>des</i>-Aminopyrazolo[1,5-<i>a</i>]pyrimidine KDR Inhibitors</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/medium/jm-2007-01397k_0016.gif" alt="" id="gr8" /></img><div class="scrollable-table-wrap"><table class="table single-image frame_topbot"><colgroup><col align="left" /></col></colgroup><tbody><tr valign="top"><td align="left"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/medium/jm-2007-01397k_0017.gif" alt="" id="_i12" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl4-fn1"><div class="footnote" id="tbl4-fn1"><sup>a</sup><p class="last">Each IC<sub>50</sub> determination was performed with seven concentrations, and each assay point was determined in duplicate.</p></div><div class="footnote" id="tbl4-fn2"><sup>b</sup><p class="last">Compound reported in ref <a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">34</a>.</p></div></div></div><div class="NLM_p">It was envisioned that the bromine atom in compound <b>3</b> would serve not only as a blocking group to prevent potential nitration at the 3-position of the pyrazole but also as a handle allowing for subsequent functionalization of the molecule using palladium-catalyzed coupling chemistry. In practice, however, neither the bromide <b>3</b> nor the analogous iodide would undergo Suzuki or Sonogoshira couplings. A variety of catalysts as well as high-temperature microwave reaction conditions were employed,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> but these compounds would not undergo palladium-catalyzed coupling reactions even following Boc protection of the amino functionality. Similar couplings have been reported for 3-bromo pyrazolo[1,5-<i>a</i>]pyrimidines lacking the 7-amino substituent,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> and we observed that compound <b>41</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>) underwent facile Suzuki coupling with thiophene-3-boronic acid.</div><div class="NLM_p">Upon discovering that bromide <b>3</b> could not be elaborated through palladium-catalyzed cross-coupling reactions, it became necessary to find an alternative route that would allow for the substitution of a broad range of substituents on the pyrazole and that would also incorporate a nitro group on the 6-phenyl ring prior to the cyclocondensation, thereby alleviating the need to perform a nitration on a more highly functionalized system. The optimized synthesis of 7-aminopyrazolo[1,5-<i>a</i>]pyrimidines incorporating a diphenylurea substituent in the 6-position is typified by the preparation of compound <b>14</b>, shown in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. 4-Nitrophenylacetonitrile was treated with dimethylformamide-dimethyl acetal (DMF-DMA) in refluxing toluene to give the dimethyl enamine <b>11</b>. Acid-catalyzed cyclocondensation of <b>11</b> with 3-aminopyrazole led to the formation of pyrazolo[1,5-<i>a</i>]pyrimidine <b>12</b>. Nitro reduction was followed by treatment of the resulting aniline <b>13</b> with <i>m</i>-tolyl isocyanate to complete the synthesis of urea <b>14</b>.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/medium/jm-2007-01397k_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/large/jm-2007-01397k_0007.jpeg" id="gs3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of 7-Aminopyrazolo[1,5-<i>a</i>]pyrimidine Urea <b>14</b> from 4-Nitrophenylacetonitrile<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/large/jm-2007-01397k_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701397k&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) CH(OCH<sub>3</sub>)<sub>2</sub>N(CH<sub>3</sub>)<sub>2</sub>, toluene, reflux, 95%; (b) 3-aminopyrazole, concentrated HCl, EtOH, reflux, 86%; (c) H<sub>2</sub> (1 atm), Pd/C, MeOH, 94%; (d) <i>m</i>-tolyl isocyanate, DMF, −20 °C to room temp, 75%.</p></p></figure><div class="NLM_p">Compounds bearing a substituent at the 3-position of the pyrazolo[1,5-<i>a</i>]pyrimidine nucleus were prepared via a similar route, using 4-substituted 3-aminopyrazoles in place of 3-aminopyrazole in the cyclocondensation step. 3-Aminopyrazole derivatives that were not available from commercial sources were prepared through synthetic sequences based on the route exemplified for compound <b>19</b> in Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>. <i>N</i>-Methylpyrazole was formylated according to the Vilsmaier−Haack protocol, and the resulting aldehyde <b>15</b> was reduced to the alcohol <b>16</b> using sodium borohydride. Conversion to the chloromethyl derivative by treatment with thionyl chloride was followed by displacement of the chloride with sodium cyanide to give acetonitrile derivative <b>17</b>. This compound was then formylated under basic conditions, and the resulting oxopropionitrile derivative <b>18</b> was condensed with hydrazine to give 4-substituted 3-aminopyrazole <b>19</b>. Cyclocondensation with compound <b>11</b> as previously described gave the 7-aminopyrazolo[1,5-<i>a</i>]pyrimidine bearing the <i>N</i>-methylpyrazole substituent in the 3-position. Reduction of the nitro group to the aniline <b>20</b> followed by treatment with isocyanate provided the urea <b>34</b>. Compounds <b>29</b>−<b>33</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) bearing substituents in the 3-position were prepared from commercially available acetonitrile derivatives, as shown for the conversion of <b>17</b> to <b>20</b> in Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>. Compounds <b>26</b> and <b>27</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>), which contain substituents at the 2-position, were prepared from 3-amino-5-methylpyrazole and 3-amino-5-phenylpyrazole, and these starting materials were synthesized according to published procedures.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/medium/jm-2007-01397k_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/large/jm-2007-01397k_0008.jpeg" id="gs4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of C3-Substituted 7-Aminopyrazolo[1,5-<i>a</i>]pyrimidine Urea <b>34</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/large/jm-2007-01397k_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701397k&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) POCl<sub>3</sub>, DMF, 0−70 °C, 79%; (b) NaBH<sub>4</sub>, MeOH, 92%; (c) SOCl<sub>2</sub>, CHCl<sub>3</sub>, reflux; (d) NaCN, DMSO, 43% (two-steps); (e) HCO<sub>2</sub>Et, NaH, catalytic EtOH, toluene; (f) H<sub>2</sub>NNH<sub>2</sub>·H<sub>2</sub>O, concentrated HCl, EtOH, reflux, 45% (two steps); (g) <b>11</b>, concentrated HCl, EtOH, reflux, 79%; (h) SnCl<sub>2</sub>, HCl, 0 °C to room temp, 80%; (i) <i>m</i>-tolyl isocyanate, DMF, −20 °C to room temp, 80%.</p></p></figure><div class="NLM_p">Compound <b>28</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>), which bears a methyl group at the 5-position of the bicyclic core, was prepared by substituting dimethylacetamide-dimethyl acetal for DMF-DMA when forming the cyanoenamine (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>). Compounds <b>38</b>−<b>40</b> incorporating an amide substituent in the 3-position of the pyrazolo[1,5-<i>a</i>]pyrimidine ring were prepared by saponification of ester <b>36</b> followed by EDCI-mediated coupling of the resulting acid <b>37</b> with various amines (Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>).</div><figure id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/medium/jm-2007-01397k_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/large/jm-2007-01397k_0009.jpeg" id="gs5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of C5-Substituted 7-Aminopyrazolo[1,5-<i>a</i>]pyrimidine <b>28</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/large/jm-2007-01397k_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701397k&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) CH<sub>3</sub>C(OCH<sub>3</sub>)<sub>2</sub>N(CH<sub>3</sub>)<sub>2</sub>, toluene, reflux, 76%; (b) 3-aminopyrazole, concentrated HCl, EtOH, reflux, 46%.</p></p></figure><figure id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/medium/jm-2007-01397k_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/large/jm-2007-01397k_0010.jpeg" id="gs6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Compounds <b>36</b>−<b>38</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/large/jm-2007-01397k_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701397k&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) LiOH, H<sub>2</sub>O, THF, MeOH, 70 °C 84%; (b) MeNH<sub>2</sub>·HCl, EDCI, HOBt, NMM, DMF, 56%.</p></p></figure></div><div id="sec1_2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Biology</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66818" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66818" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Compounds were assayed against a panel of receptor tyrosine kinases that included a KDR assay run in the presence of 1 mM ATP, which is reportedly a physiologically relevant concentration.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Active compounds were then further characterized using a cellular KDR assay, and compounds showing promise in that assay progressed to in vivo studies (vide infra).</div><div class="NLM_p">Compound <b>6</b> was prepared as the initial compound in the series and was found to be a nanomolar inhibitor of KDR (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Compound <b>10</b>, an analogue lacking the 7-amino group, was inactive, a finding consistent with the participation of this group in the hinge-binding motif proposed in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>. Removal of the 3-bromo substituent of <b>6</b> to give <b>14</b> provided a roughly equipotent compound and suggested that this position might be amenable to substitution.</div><div class="NLM_p">Consistent with the thienopyrimidine and isoindolinone urea series,<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22, 23)</a> the 4-diphenylurea substituent in the 6-position was essential for potency in this series, as evidenced by the loss of potency shown for non-ureas <b>3</b>−<b>5</b> when compared to urea <b>6</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Replacement of the diphenylurea of <b>6</b> with a benzamide (<b>7</b>) was also not tolerated, consistent with our model suggesting that both of the N−H moieties of the urea form hydrogen bonds to the enzyme (vide infra). Likewise, thiourea <b>24</b> demonstrated substantially diminished potency compared to the analogous urea <b>14</b>, and the meta-linked diphenylurea (<b>23</b>) also led to potency loss.</div><div class="NLM_p">Substitution about the pyrazolopyrimidine core generated a distinct SAR (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Addition of a methyl or phenyl group in the 2-position (<b>26</b>, <b>27</b>) led to a loss of potency, consistent with the hypothesis that N-1 is acting as a hinge binder. Incorporation of a methyl group in the 5-position (<b>28</b>) was tolerated, although this led to diminished potency in the KDR cellular assay in comparison with compound <b>14</b>, which lacks this substituent. A variety of substitutions at the 3-position were tolerated, and in many cases these compounds exhibited improved potency. In general, aryl, heteroaryl, and alkyl groups were favored over more polar groups. Both the 2- and 3-thiophene isomers <b>29</b> and <b>30</b> were roughly equipotent and were not significantly different from the phenyl analogue <b>25</b>. Other hydrophobic groups in the 3-position, including the smaller cyclopropyl (<b>31</b>) and larger methylenedioxyphenyl (<b>32</b>), also showed potency in the 15−25 nM range in the KDR enzyme assay. The most potent compounds in the KDR cellular assay incorporated nitrogen heterocycles in the 3-position, including 3-pyridine <b>33</b> and <i>N-</i>methylpyrazole <b>34</b>. These compounds exhibited cellular IC<sub>50</sub> values in the single-digit nanomolar range. Compounds such as nitrile <b>35</b>, acid <b>37</b>, and amides <b>38</b>−<b>40</b>, which bear polar substituents in the 3-position, were considerably weaker inhibitors, although the ester <b>36</b> retained potency similar to aryl compounds such as <b>25</b>, presumably because of its somewhat more hydrophobic character.</div><div class="NLM_p">The SAR of substitution about the terminal ring of the urea was similar to that observed for the thienopyrimidine urea, isoindolinone urea, and aminoindazole series studied previously. Substitution at the 3-position was required for optimal potency, as evidenced by the strongly enhanced potency of the 3-methyl analogue <b>6</b> when compared with the 2- and 4-methyl compounds <b>6a</b> and <b>6b</b> and the unsubstituted phenyl analogue <b>6c</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Further exploration of <i>des</i>-bromo compounds incorporating a 3-substituent on the terminal phenyl ring revealed that the trifluoromethyl group in compounds <b>14a</b> and <b>14d</b> was preferred over the methyl group in compounds <b>14</b> and <b>14c</b>. The 3-chloro analogue <b>14b</b> was equipotent with the methyl analogue <b>14</b>.</div><div class="NLM_p">A plausible model of the binding mode of <b>6</b> in the active site of KDR was prepared using a method previously reported and is shown in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> The urea portion of the inhibitor was docked as reported for another urea-based inhibitor<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> with hydrogen bonds between the inhibitor carbonyl and the Asp 1045 backbone N−H and between the inhibitor urea N−H groups and the side chain carboxylate of Glu 885. The pyrazolopyrimidine ring system fit well into the canonical adenosine-binding portion of the ATP-binding site, with hydrogen bonding interactions occurring between the 7-amino group and the backbone carbonyl of Glu 917 and between the pyrazolo ring nitrogen and the backbone N−H of Cys 919. This is supported by the observation that <i>des</i>-amino compound <b>10</b>, an analogue of <b>6</b> that lacks a 7-amino group, does not inhibit KDR at measured concentrations. Consistent with the observed SAR for compounds <b>26</b> and <b>27</b>, there does not appear to be room for substitution at C-2 of the pyrazolo ring.</div><figure id="fig3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/medium/jm-2007-01397k_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/large/jm-2007-01397k_0003.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Model of compound <b>6</b> bound to KDR kinase. Hydrogen bonds in black are shown between the urea and Glu 885 carboxylate, between the exocyclic amine and Glu 917 backbone carbonyl, and between the ring nitrogen and Cys 919 N−H. Also in thick bond are residues Asp 1046−Phe 1047 of the “DFG” motif in the “inactive” conformation (“DFG-out”).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/large/jm-2007-01397k_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701397k&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Researchers at Merck have also described a series of pyrazolo[1,5-<i>a</i>]pyrimidines as inhibitors of KDR, including compound <b>43</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>).<a onclick="showRef(event, 'ref30 ref34'); return false;" href="javascript:void(0);" class="ref ref30 ref34">(30, 34)</a> In order to establish whether these 7-amino pyrazolo[1,5-<i>a</i>]pyrimidines are binding in the same fashion as the previously reported compounds, hybrid compounds incorporating features of both the Abbott compounds reported in this paper and compounds from the Merck series were prepared. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, it appears that these two series of compounds must be binding in distinctly different fashions with the enzyme. Introduction of a 7-amino group onto compound <b>43</b> to give <b>4</b>2 results in a striking loss of potency. Conversely, removal of the 7-amino group from compound <b>6</b> to give compound <b>10</b> in the urea series results in loss of measurable potency. Furthermore, Merck researchers report that compounds in their series lacking an aryl or heteroaryl group in the 3-position are inactive, as shown by comparison of 3-thienyl compound <b>43</b> to the 3-bromo compound <b>41</b>. In the 7-amino series, however, 3-bromo compound <b>6</b> is roughly equipotent with 3-thienyl analogue <b>30</b>. These findings are consistent with the contrasting binding modes proposed for the two series based on homology modeling, as shown in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>. Although N-1 of the pyrazolo[1,5-<i>a</i>]pyrimidine is thought to form a hydrogen bond with Cys 919 of the hinge region in both binding modes, the 7-amino inhibitor <b>6</b> appears to be “flipped” in comparison with the <i>des</i>-amino compound <b>43</b> and also forms a second hydrogen bond through the 7-amino group. In the 7-amino series, it is proposed that the 6-substituent occupies the hydrophobic pocket, whereas in the <i>des</i>-amino series, the 3-substituent is thought to occupy this pocket. Modeling studies and SAR both suggest that the 7-amino series is indeed binding in a distinct binding mode from the previously reported series. This result is consistent with previous reports of kinase inhibitors exhibiting multiple binding modes.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></div><figure id="fig4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/medium/jm-2007-01397k_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/large/jm-2007-01397k_0004.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Comparison of proposed binding modes for compounds <b>43</b><a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> and <b>6</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/large/jm-2007-01397k_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701397k&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compounds showing potency of <100 nM in the KDR enzymatic and cellular assays were evaluated in the estradiol-induced murine uterine edema (UE) assay, an in vivo model of VEGF-induced vascular permeability.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Mice (six per group), which had been primed with pregnant mare’s serum 1 and 2 days prior to the assay, were given a KDR inhibitor orally and challenged with estradiol 30 min later. Edema was assessed 2 h following estradiol administration, comparing the uterine weights of the inhibitor-treated animals to those of estradiol-treated and untreated controls.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> This model requires a minimal amount of compound and provides a medium-throughput in vivo assessment of KDR inhibition following a single oral dose and was used as a screening tool to identify compounds that would progress to in vivo tumor growth inhibition assays.</div><div class="NLM_p">In the uterine edema assay, the most potent compounds in this series bear an <i>N</i>-methylpyrazole substituent in the 3-position (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). A number of compounds incorporating meta substituents on the terminal phenyl ring were single-digit nanomolar inhibitors of KDR in the enzymatic assay, although in the cellular KDR assay the methyl and trifluoromethyl compounds <b>34</b> and <b>34a</b> were found to be somewhat more potent than the chloro and fluoro compounds <b>34b</b> and <b>34e</b> or the trifluoromethyl compounds <b>34c</b>,<b>d</b> incorporating an additional fluoro substituent on the ring. Compound <b>34a</b>, with an ED<sub>50</sub> of 1.4 mg/kg in the uterine edema model, was the most potent compound evaluated in this series and had efficacy comparable to that observed for the best compounds in the thienopyrimidine series.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> This compound also exhibited a favorable pharmacokinetic profile characterized by low plasma clearance, high exposure, a half-life of 2.2 h, and oral availablility in the mouse (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). Compared to <i>m</i>-tolylurea <b>34</b>, 3-trifluoromethylphenylurea <b>34a</b> showed a 6-fold reduction in clearance following iv administration (3.7 vs 0.57), as well as a dramatic enhancement in exposure following oral dosing. This improved clearance and the corresponding enhanced exposure may correlate with the boost in potency observed for compound <b>34a</b> in the uterine edema model.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. KDR Enzymatic and Cellular Inhibitory Activity and in Vivo Oral Uterine Edema Inhibitory Activity of 4-Methylpyrazole-Substituted Pyrazolo[1,5-<i>a</i>]pyrimidine Ureas</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/medium/jm-2007-01397k_0018.gif" alt="" id="_i19" /></img><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle">compd</th><th align="center" valign="middle">R</th><th align="center" valign="middle" char=".">KDR (IC<sub>50</sub>, nM)<a class="ref internalNav" href="#tbl5-fn1" aria-label="a">a</a></th><th align="center" valign="middle" char=".">KDR (cell) (IC<sub>50</sub>, nM)<a class="ref internalNav" href="#tbl5-fn2" aria-label="b">b</a></th><th align="center" valign="middle">UE<a class="ref internalNav" href="#tbl5-fn3" aria-label="c">c</a> (mg/kg)</th></tr></thead><tbody><tr valign="top"><td align="left"><b>34</b></td><td align="left">3-CH<sub>3</sub></td><td align="char" char=".">4</td><td align="char" char=".">1</td><td align="left">49% @ 10<a class="ref internalNav" href="#tbl5-fn4" aria-label="d">d</a></td></tr><tr valign="top"><td align="left"><b>34a</b></td><td align="left">3-CF<sub>3</sub></td><td align="char" char=".">3</td><td align="char" char=".">0.7</td><td align="left">ED<sub>50</sub> = 1.4<a class="ref internalNav" href="#tbl5-fn5" aria-label="e">e</a></td></tr><tr valign="top"><td align="left"><b>34b</b></td><td align="left">3-Cl</td><td align="char" char=".">4</td><td align="char" char=".">8</td><td align="left">27% @ 10<a class="ref internalNav" href="#tbl5-fn4" aria-label="d">d</a></td></tr><tr valign="top"><td align="left"><b>34c</b></td><td align="left">2-F, 5-CF<sub>3</sub></td><td align="char" char=".">5</td><td align="char" char=".">28</td><td align="left">45% @ 10<a class="ref internalNav" href="#tbl5-fn4" aria-label="d">d</a></td></tr><tr valign="top"><td align="left"><b>34d</b></td><td align="left">3-CF<sub>3</sub>-4-F</td><td align="char" char=".">6</td><td align="char" char=".">55</td><td align="left">inactive<a class="ref internalNav" href="#tbl5-fn6" aria-label="f">f</a></td></tr><tr valign="top"><td align="left"><b>34e</b></td><td align="left">3-F</td><td align="char" char=".">10</td><td align="char" char=".">29</td><td align="left"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl5-fn1"><div class="footnote" id="tbl5-fn1"><sup>a</sup><p class="last">Each IC<sub>50</sub> determination was performed with seven concentrations, and each assay point was determined in duplicate.</p></div><div class="footnote" id="tbl5-fn2"><sup>b</sup><p class="last">Each cellular IC<sub>50</sub> determination was performed with five concentrations, and each assay point was determined in duplicate.</p></div><div class="footnote" id="tbl5-fn3"><sup>c</sup><p class="last">Estradiol-induced murine uterine edema assay.</p></div><div class="footnote" id="tbl5-fn4"><sup>d</sup><p class="last">Values are expressed as percent inhibition @ mg/kg.</p></div><div class="footnote" id="tbl5-fn5"><sup>e</sup><p class="last">ED<sub>50</sub> values in mg/kg.</p></div><div class="footnote" id="tbl5-fn6"><sup>f</sup><p class="last">“Inactive” indicates the compound provided <15% inhibition at 10 mg/kg.</p></div></div></div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Pharmacokinetic Data for Pyrazolo[1,5-<i>a</i>]pyrimidine Ureas <b>34</b> and <b>34a</b><a class="ref internalNav" href="#tbl6-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle"> </th><th colspan="4" align="center" valign="middle" char=".">iv<a class="ref internalNav" href="#tbl6-fn2" aria-label="b">b</a></th><th colspan="3" align="center" valign="middle" char=".">po<a class="ref internalNav" href="#tbl6-fn3" aria-label="c">c</a></th></tr><tr valign="top"><th align="center" valign="middle">compd</th><th align="center" valign="middle" char="."><i>t</i><sub>1/2</sub> (h)</th><th align="center" valign="middle" char=".">Cl (mL/(min·kg))</th><th align="center" valign="middle" char=".">AUC (µg·h/mL)</th><th align="center" valign="middle" char="."><i>V</i><sub>d</sub> (L/kg)</th><th align="center" valign="middle" char="."><i>C</i><sub>max</sub> (µM)</th><th align="center" valign="middle" char=".">AUC (µg·h/mL)</th><th align="center" valign="middle" char="."><i>F</i> (%)</th></tr></thead><tbody><tr valign="top"><td align="left"><b>34</b></td><td align="char" char=".">0.25</td><td align="char" char=".">3.7</td><td align="char" char=".">1.8</td><td align="char" char=".">1.4</td><td align="char" char=".">0.36</td><td align="char" char=".">0.81</td><td align="char" char=".">14</td></tr><tr valign="top"><td align="left"><b>34a</b></td><td align="char" char=".">2.2</td><td align="char" char=".">0.57</td><td align="char" char=".">10.6</td><td align="char" char=".">1.8</td><td align="char" char=".">5.7</td><td align="char" char=".">41.0</td><td align="char" char=".">∼100</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl6-fn1"><div class="footnote" id="tbl6-fn1"><sup>a</sup><p class="last">Mouse pharmacokinetics.</p></div><div class="footnote" id="tbl6-fn2"><sup>b</sup><p class="last">Dosed at 3 mg/kg in a vehicle comprising 2.5% DMSO, 2.5% Tween-80, 25% PEG400 in PBS.</p></div><div class="footnote" id="tbl6-fn3"><sup>c</sup><p class="last">Dosed at 10 mg/kg in a vehicle comprising 2.5% EtOH, 5% Tween-80, 25% PEG400 in PBS.</p></div></div></div><div class="NLM_p">The 7-aminopyrazolo[1,5-<i>a</i>]pyrimidines herein described are potent inhibitors of KDR, and they also display significant inhibition of other VEGFR and PDGFR kinase family members, as shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>. Compound <b>34a</b> is a single-digit-nanomolar inhibitor of the VEGFR kinases KDR and Flt-1 and also of the PDGFR kinases Flt-3, c-Kit, and CSF1R.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a></div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Kinase Inhibition Profile of Pyrazolo[1,5-<i>a</i>]pyrimidine Urea <b>34a</b><a class="ref internalNav" href="#tbl7-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle"> </th><th colspan="3" align="center" valign="middle" char=".">VEGFR kinases (IC<sub>50</sub>, nM)</th><th colspan="3" align="center" valign="middle" char=".">PDGFR kinases (IC<sub>50</sub>, nM)</th></tr><tr valign="top"><th align="center" valign="middle">compd</th><th align="center" valign="middle" char=".">KDR</th><th align="center" valign="middle" char=".">Flt-1</th><th align="center" valign="middle" char=".">FGFR</th><th align="center" valign="middle" char=".">Flt-3</th><th align="center" valign="middle" char=".">c-Kit</th><th align="center" valign="middle" char=".">CSF-1R</th></tr></thead><tbody><tr valign="top"><td align="left"><b>34a</b></td><td align="char" char=".">3</td><td align="char" char=".">3</td><td align="char" char=".">>12500</td><td align="char" char=".">5</td><td align="char" char=".">9</td><td align="char" char=".">4</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl7-fn1"><div class="footnote" id="tbl7-fn1"><sup>a</sup><p class="last">Each IC<sub>50</sub> determination was performed with seven concentrations, and each assay point was determined in duplicate.</p></div></div></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65050" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65050" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Novel 7-aminopyrazolo[1,5-<i>a</i>]pyrimidine inhibitors of VEGFR and PDGFR kinases have been discovered. These compounds display an SAR profile that is distinct from the pyrazolo[1,5-<i>a</i>]pyrimidine KDR inhibitors previously reported by other researchers. Modeling and SAR studies suggest that these compounds bind in the ATP pocket of the enzyme, with the 7-aminopyrazolo[1,5-<i>a</i>]pyrimidine core forming a bidentate hydrogen bonding interaction with the hinge region and the <i>N</i>,<i>N</i>′-diarylurea occupying the hydrophobic pocket. Optimal potency was obtained by incorporation of an <i>N</i>,<i>N</i>′-diarylurea moiety at the 6-position, with the substituents in a para orientation on the 6-phenyl ring and a small meta substituent on the terminal phenyl ring of the urea. Additional substitution at the 3-position of the pyrazolo[1,5-<i>a</i>]pyrimidine core led to compounds with enhanced activity in the cellular KDR assay, and the placement of an <i>N</i>-methylpyrazole linked through C-4 in this position provided compounds typified by <b>34a</b>, which exhibited single-digit nanomolar inhibition of KDR in both the enzymatic and cellular assays and was found to have oral efficacy in the estradiol-induced murine uterine edema assay, an in vivo model of VEGF-induced vascular permeability.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56858" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56858" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> <b>Chemistry</b></h3><div class="NLM_p last"><sup>1</sup>H NMR spectra were recorded on a 300 MHz spectrometer (Nicolet QE-300 or General Electric GN-300) if not otherwise indicated, and chemical shifts are reported in parts per million (ppm, δ) relative to tetramethylsilane as an internal standard. Mass spectra were obtained on a Finnigan MAT SSQ700 instrument. The above structural data were obtained through the Department of Structural Chemistry, Abbott Laboratories. Elemental analyses were performed by Robertson Microlit Laboratories, Inc., Madison, NJ, or by Quantitative Technologies Inc., Whitehouse, NJ, and the results indicated by elemental symbols are within ±0.4% of theoretical values unless otherwise indicated. Preparative column chromatography was performed using silica gel 60 (E. Merck, 230−400 mesh) or, when indicated, using an Analogix IntelliFlash 280 chromatographic purification system and Analogix prefilled silica gel cartridges as described.</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 3-Bromo-6-phenylpyrazolo[1,5-<i>a</i>]pyrimidin-7-amine (<b>3</b>)</h3><div class="NLM_p last">3-Amino-4-bromopyrazole (4.00 g, 24.7 mmol), 3-oxo-2-phenylpropanenitrile (3.60 g, 24.8 mmol), and concentrated HCl (8 mL) were combined in EtOH (150 mL). The mixture was heated to reflux for 16 h, then cooled to room temperature. The mixture was concentrated to dryness on a rotary evaporator, and the residue was dissolved in H<sub>2</sub>O (100 mL). An amount of 1 N NaOH was added until the mixture reached pH 6, and the resulting white solid was collected by filtration, rinsing with H<sub>2</sub>O, to give <b>3</b> (6.17 g, 86%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.29 (s, 1H), 8.17 (s, 1H), 7.70 (s, 2H), 7.48−7.54 (m, 4H), 7.37−7.45 (m, 1H); MS (ESI) <i>m</i>/<i>z</i> 288.8, 290.8 [M + H]<sup>+</sup>. Anal. (C<sub>12</sub>H<sub>9</sub>BrN<sub>4</sub>·0.1EtOH) C, H, N.</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 6-(4-Aminophenyl)-3-bromopyrazolo[1,5-<i>a</i>]pyrimidin-7-amine (<b>5</b>)</h3><div class="NLM_p last">Compound <b>3</b> (5.75 g, 19.9 mmol) was dissolved in concentrated H<sub>2</sub>SO<sub>4</sub> (70 mL), and the solution was chilled in a −20 °C cooling bath. A solution of concentrated HNO<sub>3</sub> (1.25 mL, 20 mmol) in concentrated H<sub>2</sub>SO<sub>4</sub> (5 mL) was added dropwise, and the mixture was allowed to warm slowly to room temperature and stirred for 2 h. The mixture was then poured carefully over ice (800 g) and adjusted to pH 6 by the addition of 5 N NaOH. A yellow precipitate formed and was collected by filtration, providing a crude nitration product. MS (ESI) <i>m</i>/<i>z</i> 334.0, 335.9 [M + H]<sup>+</sup>. This material was taken up in EtOH (200 mL), THF (80 mL), and H<sub>2</sub>O (40 mL), and the mixture was heated to 70 °C, whereupon Fe<sup>0</sup> (11.1 g, 199 mmol) and NH<sub>4</sub>Cl (1.06 g, 19.8 mmol) were added. The mixture was stirred at 70 °C overnight, then cooled to room temperature and filtered, rinsing with MeOH. The filtrate was concentrated to dryness, and the residue was partitioned between H<sub>2</sub>O (500 mL) and CH<sub>2</sub>Cl<sub>2</sub> (500 mL). The aqueous layer was further extracted with CH<sub>2</sub>Cl<sub>2</sub> (2 × 250 mL), and the combined extracts were dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated onto silica gel (50 g). The silica was placed atop a flash chromatography column and eluted with EtOAc/CH<sub>2</sub>Cl<sub>2</sub> (gradient elution 4−10% EtOAc) to give <b>5</b> as a light-orange solid (1.68 g, 28%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.23 (s, 1H), 8.08 (s, 1H), 7.45−7.41 (br s, 2H), 7.13 (d, <i>J</i> = 8.5 Hz, 2H), 6.68 (d, <i>J</i> = 8.5 Hz, 2H), 5.25−5.24 (br s, 2H); MS (ESI) <i>m</i>/<i>z</i> 303.9, 305.9 [M + H]<sup>+</sup>. Anal. (C<sub>12</sub>H<sub>10</sub>BrN<sub>5</sub>·0.2CH<sub>2</sub>Cl<sub>2</sub>) C, H, N.</div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 1-(4-(7-Amino-3-bromopyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)phenyl)-3-<i>m</i>-tolylurea (<b>6</b>)</h3><div class="NLM_p last">A solution of <b>5</b> (100 mg, 0.33 mmol) in DMF (1 mL) was chilled to −20 °C, and <i>m</i>-tolyl isocyanate (0.045 mL, 0.35 mmol) was added dropwise. The mixture was allowed to warm to room temperature and stirred overnight, and then H<sub>2</sub>O (20 mL) was added. The mixture was extracted with EtOAc (3 × 15 mL). The extracts were dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated. The residue was triturated with CH<sub>2</sub>Cl<sub>2</sub>, and the resulting solid was collected by filtration to give <b>6</b> (67 mg, 47%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.81 (s, 1H), 8.62 (s, 1H), 8.27 (s, 1H), 8.15 (s, 1H), 7.65 (s, 2H), 7.59 (d, <i>J</i> = 8.5 Hz, 2H), 7.41 (d, <i>J</i> = 8.8 Hz, 2H), 7.32 (s, 1H), 7.25 (d, <i>J</i> = 8.5 Hz, 1H), 7.17 (t, <i>J</i> = 7.8 Hz, 1H), 6.80 (d, <i>J</i> = 7.5 Hz, 1H), 2.29 (s, 3H); MS (ESI) <i>m</i>/<i>z</i> 436.9, 438.9 [M + H]<sup>+</sup>. Anal. (C<sub>20</sub>H<sub>17</sub>BrN<sub>6</sub>O·0.2H<sub>2</sub>O·0.1CH<sub>2</sub>Cl<sub>2</sub>) C, H, N.</div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 1-(4-(7-Amino-3-bromopyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)phenyl)-3-<i>o</i>-tolylurea (<b>6a</b>)</h3><div class="NLM_p last">Compound <b>6a</b> was prepared following the procedure described for <b>6</b>, substituting <i>o</i>-tolyl isocyanate for <i>m</i>-tolyl isocyanate. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.16 (s, 1H), 8.28 (s, 1H), 8.15 (s, 1H), 7.95 (s, 1H), 7.86 (dd, <i>J</i> = 8.0, 1.2 Hz, 1H), 7.65 (s, 2H), 7.60 (d, <i>J</i> = 8.8 Hz, 2H), 7.42 (d, <i>J</i> = 8.5 Hz, 2H), 7.07−7.21 (m, 2H), 6.96 (td, <i>J</i> = 7.4, 1.2 Hz, 1H), 2.26 (s, 3H); MS (ESI) <i>m</i>/<i>z</i> 437.1, 439.1 [M + H]<sup>+</sup>. Anal. (C<sub>20</sub>H<sub>17</sub>BrN<sub>6</sub>O) C, H, N.</div></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 1-(4-(7-Amino-3-bromopyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)phenyl)-3-<i>p</i>-tolylurea (<b>6b</b>)</h3><div class="NLM_p last">Compound <b>6b</b> was prepared following the procedure described for <b>6</b>, substituting <i>p</i>-tolyl isocyanate for <i>m</i>-tolyl isocyanate. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.77 (s, 1H), 8.58 (s, 1H), 8.27 (s, 1H), 8.15 (s, 1H), 7.65 (s, 2H), 7.58 (d, <i>J</i> = 8.5 Hz, 2H), 7.40 (d, <i>J</i> = 8.8 Hz, 2H), 7.35 (d, <i>J</i> = 8.1 Hz, 2H), 7.09 (d, <i>J</i> = 8.1 Hz, 2H), 2.25 (s, 3H); MS (ESI) <i>m</i>/<i>z</i> 437.1, 439.1 [M + H]<sup>+</sup>. Anal. (C<sub>20</sub>H<sub>17</sub>BrN<sub>6</sub>O) C, H, N.</div></div><div id="sec3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 1-(4-(7-Amino-3-bromopyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)phenyl)-3-phenylurea (<b>6c</b>)</h3><div class="NLM_p last">Compound <b>6c</b> was prepared following the procedure described for <b>6</b>, substituting phenyl isocyanate for <i>m</i>-tolyl isocyanate. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.82 (s, 1H), 8.69 (s, 1H), 8.27 (s, 1H), 8.15 (s, 1H), 7.65 (s, 2H), 7.59 (d, <i>J</i> = 8.8 Hz, 2H), 7.47 (d, <i>J</i> = 7.8 Hz, 2H), 7.41 (d, <i>J</i> = 8.8 Hz, 2H), 7.29 (t, <i>J</i> = 7.5 Hz, 2H), 6.98 (t, <i>J</i> = 7.3 Hz, 1H); MS (ESI) <i>m</i>/<i>z</i> 423.0, 425.0 [M + H]<sup>+</sup>. Anal. (C<sub>19</sub>H<sub>15</sub>BrN<sub>6</sub>O) C, H, N.</div></div><div id="sec3_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> <i>N</i>-(4-(7-Amino-3-bromopyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)phenyl)benzamide (<b>7</b>)</h3><div class="NLM_p last">A solution of <b>5</b> (100 mg, 0.33 mmol), benzoic acid (41 mg, 0.33 mmol), EDCI (78 mg, 0.41 mmol), HOBt (54 mg, 0.40 mmol), and <i>N</i>-methylmorpholine (0.18 mL, 1.5 mmol) in DMF (2 mL) was stirred overnight at room temperature, then diluted with H<sub>2</sub>O (50 mL). The mixture was extracted with EtOAc (3 × 25 mL), and the organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated to dryness. The residue was triturated with CH<sub>2</sub>Cl<sub>2</sub> and the resulting solid was collected by filtration, rinsing with CH<sub>2</sub>Cl<sub>2</sub>, to give <b>7</b> as an off-white solid (80 mg, 60%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.38 (s, 1H), 8.28 (s, 1H), 8.18 (s, 1H), 7.91−8.01 (m, 4H), 7.70 (br s, 2H), 7.47−7.63 (m, 5H); MS (ESI) <i>m</i>/<i>z</i> 408.0, 410.0 [M + H]<sup>+</sup>. Anal. (C<sub>19</sub>H<sub>15</sub>BrN<sub>6</sub>O·0.3H<sub>2</sub>O) C, H, N.</div></div><div id="sec3_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 3-Bromo-6-phenylpyrazolo[1,5-<i>a</i>]pyrimidine (<b>8</b>)</h3><div class="NLM_p last">A mixture 2-phenylmalonaldehyde (500 mg, 3.4 mmol), 3-amino-4-bromopyrazole (544 mg, 3.4 mmol), and concentrated HCl (1 mL, 12 mmol) in EtOH (20 mL) was heated to reflux for 2 h. The mixture was concentrated in vacuo to remove the EtOH, and the resulting residue was dissolved in H<sub>2</sub>O (100 mL). The solution was adjusted to basic pH with 1 N NaOH and the resulting solid was collected by filtration to give <b>8</b> (860 mg, 93%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.52 (d, <i>J</i> = 2.4 Hz, 1H), 9.03 (d, <i>J</i> = 2.0 Hz, 1H), 8.42 (s, 1H), 7.84−7.89 (m, 2H), 7.51−7.58 (m, 2H), 7.43−7.50 (m, 1H); MS (ESI) <i>m</i>/<i>z</i> 273.9, 275.9 [M + H]<sup>+</sup>.</div></div><div id="sec3_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 4-(3-Bromopyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)phenylamine (<b>9</b>)</h3><div class="NLM_p last">To a solution of <b>8</b> (500 mg, 1.82 mmol) in concentrated H<sub>2</sub>SO<sub>4</sub> (3 mL) at −20 °C was added dropwise concentrated HNO<sub>3</sub> (0.1 mL, 1.6 mmol). The mixture was allowed to warm to room temperature and stirred for 2 h. The mixture was poured over ice (50 g) and stirred until the ice had melted. The resulting solid was collected by filtration, then partitioned between 1 N NaOH (100 mL) and CH<sub>2</sub>Cl<sub>2</sub> (100 mL), and the aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> (2 × 100 mL). The organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated to give a mixture of nitration products in which the desired para isomer predominated. This crude solid was taken up in EtOH (40 mL), THF (16 mL), and H<sub>2</sub>O (8 mL) and the mixture was heated to 75 °C. Fe<sup>0</sup> (700 mg, 12.5 mmol) and NH<sub>4</sub>Cl (106 mg, 1.98 mmol) were added, and the mixture was kept at 75 °C for 16 h. TLC (25% EtOAc/hexanes) shows that the reaction is complete. The hot mixture was filtered through a pad of Celite, rinsing with copious amounts of MeOH, and the filtrate was concentrated in vacuo. The residue was partitioned between CH<sub>2</sub>Cl<sub>2</sub> (100 mL) and H<sub>2</sub>O (200 mL), and the aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> (2 × 100 mL). The organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated to give a crude solid, which was purified by flash chromatography (4% EtOAc in CH<sub>2</sub>Cl<sub>2</sub>) to give <b>9</b> as a pale-yellow solid (180 mg, 34%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.27 (d, <i>J</i> = 2.0 Hz, 1H), 8.93 (d, <i>J</i> = 2.0 Hz, 1H), 8.32 (s, 1H), 7.52 (d, <i>J</i> = 8.5 Hz, 2H), 6.68 (d, <i>J</i> = 8.5 Hz, 2H), 5.41 (s, 2H); MS (ESI) <i>m</i>/<i>z</i> 288.9, 290.8 [M + H]<sup>+</sup>.</div></div><div id="sec3_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 1-[4-(3-Bromopyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)phenyl]-3-<i>m</i>-tolylurea (<b>10</b>)</h3><div class="NLM_p last">Compound <b>10</b> was prepared from <b>9</b> following the procedure described for the synthesis of <b>6</b>. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.46 (d, <i>J</i> = 2.0 Hz, 1H), 9.02 (d, <i>J</i> = 2.0 Hz, 1H), 8.92 (s, 1H), 8.71 (s, 1H), 8.39 (s, 1H), 7.80 (d, <i>J</i> = 8.8 Hz, 2H), 7.62 (d, <i>J</i> = 8.8 Hz, 2H), 7.32 (s, 1H), 7.25 (d, <i>J</i> = 9.2 Hz, 1H), 7.17 (t, <i>J</i> = 7.6 Hz, 1H), 6.80 (d, <i>J</i> = 7.5 Hz, 1H), 2.29 (s, 3H); MS (ESI) <i>m</i>/<i>z</i> 422.0, 423.7 [M + H]<sup>+</sup>. Anal. (C<sub>20</sub>H<sub>16</sub>BrN<sub>5</sub>O) C, H, N.</div></div><div id="sec3_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 3-Dimethylamino-2-(4-nitrophenyl)acrylonitrile (<b>11</b>)</h3><div class="NLM_p last">To a solution of 4-nitrophenylacetonitrile (10 g, 62 mmol) in toluene (400 mL) was added dimethylformamide-dimethyl acetal (25.0 mL, 188 mmol). The mixture was heated to reflux for 16 h and then concentrated to dryness in vacuo. The residue was purified by flash chromatography, eluting with CH<sub>2</sub>Cl<sub>2</sub> to give <b>11</b> as a bright-yellow solid (12.7 g, 95%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.13 (d, <i>J</i> = 9.2 Hz, 2H), 7.87 (s, 1H), 7.53 (d, <i>J</i> = 9.2 Hz, 2H), 3.29 (s, 6H); MS (ESI) <i>m</i>/<i>z</i> 218.0 [M + H]<sup>+</sup>, 124.1 (base).</div></div><div id="sec3_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 6-(4-Nitrophenyl)pyrazolo[1,5-<i>a</i>]pyrimidin-7-ylamine (<b>12</b>)</h3><div class="NLM_p last">A solution of <b>11</b> (500 mg, 2.3 mmol) and 3-aminopyrazole (205 mg, 2.5 mmol) in EtOH (10 mL) was treated with concentrated HCl (0.5 mL, 6 mmol), and the mixture was heated to reflux for 16 h, then cooled to room temperature. A yellow precipitate formed and was collected by filtration, rinsing with EtOH, to give the title compound as its hydrochloride salt (627 mg, 86%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.24 (s, 2H), 8.44 (s, 1H), 8.37 (d, <i>J</i> = 2.4 Hz, 1H), 8.37 (d, <i>J</i> = 8.8 Hz, 2H), 7.82 (d, <i>J</i> = 8.8 Hz, 2H), 6.63 (d, <i>J</i> = 2.0 Hz, 1H); MS (ESI) <i>m</i>/<i>z</i> 256.0 [M + H]<sup>+</sup>.</div></div><div id="sec3_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 6-(4-Aminophenyl)pyrazolo[1,5-<i>a</i>]pyrimidin-7-ylamine (<b>13</b>)</h3><div class="NLM_p last">A suspension of the hydrochloride salt of <b>12</b> (0.62 g, 2.1 mmol) in MeOH (20 mL) was purged with N<sub>2</sub>, and 10% Pd/C (30 mg) was added. The mixture was placed under H<sub>2</sub> (1 atm) for 3 h. The mixture was purged with N<sub>2</sub> and filtered through a pad of Celite, rinsing with MeOH. The filtrate was concentrated to give the hydrochloride salt of <b>13</b> as a yellow solid (0.52 g, 94%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.66 (s, 2H), 8.28 (d, <i>J</i> = 2.4 Hz, 1H), 8.21 (s, 1H), 7.23 (d, <i>J</i> = 8.5 Hz, 2H), 6.83 (d, <i>J</i> = 8.1 Hz, 2H), 6.53 (d, <i>J</i> = 2.4 Hz, 1H); MS (ESI) <i>m</i>/<i>z</i> 226.0 [M + H]<sup>+</sup>.</div></div><div id="sec3_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 1-[4-(7-Aminopyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)phenyl]-3-<i>m</i>-tolylurea (<b>14</b>)</h3><div class="NLM_p last">Compounds <b>14</b> and <b>14a</b>−<b>d</b> were prepared from <b>13</b> following the procedure described for the synthesis of <b>6</b>. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.80 (s, 1H), 8.62 (s, 1H), 8.12 (d, <i>J</i> = 2.4 Hz, 1H), 8.10 (s, 1H), 7.58 (d, <i>J</i> = 8.5 Hz, 2H), 7.42 (d, <i>J</i> = 8.8 Hz, 2H), 7.37−7.41 (m, 2H), 7.32 (s, 1H), 7.25 (d, <i>J</i> = 8.5 Hz, 1H), 7.17 (t, <i>J</i> = 7.8 Hz, 1H), 6.80 (d, <i>J</i> = 7.1 Hz, 1H), 6.44 (d, <i>J</i> = 2.4 Hz, 1H), 2.29 (s, 3H); MS (ESI) <i>m</i>/<i>z</i> 359.1 [M + H]<sup>+</sup>. Anal. (C<sub>20</sub>H<sub>18</sub>N<sub>6</sub>O·0.2H<sub>2</sub>O) C, H, N.</div></div><div id="sec3_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 1-(4-(7-Aminopyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)phenyl)-3-(3-(trifluoromethyl)phenyl)urea (<b>14a</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.09 (s, 1H), 8.95 (s, 1H), 8.12 (d, <i>J</i> = 2.0 Hz, 1H), 8.10 (s, 1H), 8.02−8.04 (m, 1H), 7.58−7.63 (m, 3H), 7.52 (t, <i>J</i> = 8.0 Hz, 1H), 7.43 (d, <i>J</i> = 8.8 Hz, 2H), 7.40 (br s, 2H), 7.32 (d, <i>J</i> = 7.5 Hz, 1H), 6.45 (d, <i>J</i> = 2.4 Hz, 1H); MS (ESI) <i>m</i>/<i>z</i> 413.1 [M + H]<sup>+</sup>. Anal. (C<sub>20</sub>H<sub>15</sub>F<sub>3</sub>N<sub>6</sub>O·0.5H<sub>2</sub>O) C, H, N.</div></div><div id="sec3_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 1-(4-(7-Aminopyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)phenyl)-3-(3-chlorophenyl)urea (<b>14b</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.94 (s, 1H), 8.92 (s, 1H), 8.13 (d, <i>J</i> = 2.4 Hz, 1H), 8.10 (s, 1H), 7.72−7.74 (m, 1H), 7.59 (d, <i>J</i> = 8.8 Hz, 2H), 7.43 (d, <i>J</i> = 8.5 Hz, 2H), 7.40 (br s, 2H), 7.27−7.32 (m, 2H), 7.03 (ddd, <i>J</i> = 6.3, 2.4, 2.2 Hz, 1H), 6.45 (d, <i>J</i> = 2.4 Hz, 1H); MS (ESI) <i>m</i>/<i>z</i> 377.0 [M + H]<sup>+</sup>. Anal. (C<sub>19</sub>H<sub>15</sub>ClN<sub>6</sub>O·0.4H<sub>2</sub>O) C, H, N.</div></div><div id="sec3_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 1-(4-(7-Aminopyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)phenyl)-3-(2-fluoro-5-methylphenyl)urea (<b>14c</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.19 (s, 1H), 8.50 (d, <i>J</i> = 2.4 Hz, 1H), 8.13 (d, <i>J</i> = 2.4 Hz, 1H), 8.10 (s, 1H), 8.01 (dd, <i>J</i> = 8.0, 1.9 Hz, 1H), 7.58 (d, <i>J</i> = 8.5 Hz, 2H), 7.43 (d, <i>J</i> = 8.5 Hz, 2H), 7.40 (br s, 2H), 7.12 (dd, <i>J</i> = 11.4, 8.3 Hz, 1H), 6.78−6.84 (m, 1H), 6.45 (d, <i>J</i> = 2.4 Hz, 1H), 2.28 (s, 3H); MS (ESI) <i>m</i>/<i>z</i> 377.2 [M + H]<sup>+</sup>. Anal. (C<sub>20</sub>H<sub>17</sub>FN<sub>6</sub>O·1.0H<sub>2</sub>O) C, H, N.</div></div><div id="sec3_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 1-(4-(7-Aminopyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)phenyl)-3-(2-fluoro-5-(trifluoromethyl)phenyl)urea (<b>14d</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.31 (s, 1H), 8.93 (s, 1H), 8.64 (dd, <i>J</i> = 7.3, 2.2 Hz, 1H), 8.13 (d, <i>J</i> = 2.4 Hz, 1H), 8.10 (s, 1H), 7.60 (d, 2H), 7.51 (dd, <i>J</i> = 10.5, 8.5 Hz, 1H), 7.37−7.47 (m, 5H), 6.45 (d, <i>J</i> = 2.4 Hz, 1H); MS (ESI) <i>m</i>/<i>z</i> 431.1 [M + H]<sup>+</sup>. Anal. (C<sub>20</sub>H<sub>14</sub>F<sub>4</sub>N<sub>6</sub>O·0.1H<sub>2</sub>O) C, H, N.</div></div><div id="sec3_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 1-Methyl-1<i>H</i>-pyrazole-4-carbaldehyde (<b>15</b>)</h3><div class="NLM_p last">A 500 mL, two-necked round-bottomed flask equipped with an addition funnel, a water-cooled reflux condenser, and a magnetic stir bar was charged with DMF (35 mL). The condenser was equipped with a drying tube filled with Drierite. The flask was then cooled in an ice bath, and POCl<sub>3</sub> (17.0 mL, 186 mmol) was added dropwise over 10 min. The mixture was stirred for 30 min at 0 °C, followed by dropwise addition of a solution of <i>N</i>-methylpyrazole (5.0 g, 61 mmol) in DMF (12 mL) over 15 min. The ice bath was removed, and the mixture was stirred at room temperature for 16 h. The solution was then chilled to 0 °C, and saturated aqueous NaHCO<sub>3</sub> was added until the reaction was no longer acidic. The resulting mixture was extracted with EtOAc (3 × 200 mL), and the extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo to give <b>15</b> as a crude amber oil (5.3 g, 79%), which was judged sufficiently pure to be used in the next reaction. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.78 (s, 1 H), 8.42 (s, 1 H), 7.96 (s, 1 H), 3.90 (s, 3 H). MS (ESI) <i>m</i>/<i>z</i> 111.1 [M + H]<sup>+</sup>, 258.0.</div></div><div id="sec3_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> (1-Methyl-1<i>H</i>-pyrazol-4-yl)methanol (<b>16</b>)</h3><div class="NLM_p last">A solution of compound <b>15</b> (5.6 g, 51 mmol) in MeOH (500 mL) was chilled to 0 °C, and NaBH<sub>4</sub> (3.8 g, 100 mmol) was added portionwise over 10 min. The ice bath was removed, and the mixture was stirred for 1 h. TLC (19:1 CH<sub>2</sub>Cl<sub>2</sub>/MeOH, KMnO<sub>4</sub> stain) shows that the reaction is complete. The reaction was quenched with 2 N HCl (300 mL), and the MeOH was removed by concentrating in vacuo. The resulting aqueous solution was extracted with EtOAc (3 × 200 mL). The extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo to give <b>16</b> as an amber oil (5.2 g, 92%), which was used without further purification. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.54 (s, 1H), 7.30 (s, 1H), 4.77 (t, <i>J</i> = 5.4 Hz, 1H), 4.32 (d, <i>J</i> = 5.4 Hz, 2H), 3.78 (s, 3H); MS (ESI) <i>m</i>/<i>z</i> 113.1 [M + H]<sup>+</sup>.</div></div><div id="sec3_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> (1-Methyl-1<i>H</i>-pyrazol-4-yl)acetonitrile (<b>17</b>)</h3><div class="NLM_p last">A solution of compound <b>16</b> (614 mg, 5.5 mmol) in CHCl<sub>3</sub> (25 mL) was treated with SOCl<sub>2</sub> (0.80 mL, 11 mmol). The mixture was heated to reflux for 3 h, then cooled to room temperature and concentrated in vacuo to give an oil that solidified upon standing. This crude chloride was then dissolved in DMSO (30 mL), the solution was treated with NaCN (1.1 g, 22 mmol), and the mixture was stirred overnight at room temperature. The mixture was diluted with H<sub>2</sub>O (150 mL), and the mixture was extracted with EtOAc (3 × 75 mL). The extracts were washed with brine and dried (Na<sub>2</sub>SO<sub>4</sub>), then concentrated in vacuo. The residue was purified by flash chromatography (Analogix Intelliflash, RS-12 cartridge, flow rate 30 mL/min), eluting with a gradient of 0−10% EtOAc/CH<sub>2</sub>Cl<sub>2</sub> over 30 min to provide <b>17</b> as an oil (284 mg, 43%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.69 (s, 1H), 7.37 (s, 1H), 3.80 (s, 3H), 3.78 (s, 2H); MS (ESI) <i>m</i>/<i>z</i> 122.1 [M + H]<sup>+</sup>.</div></div><div id="sec3_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 1′-Methyl-2<i>H</i>,1′<i>H</i>-[4,4′]bipyrazolyl-3-ylamine (<b>19</b>)</h3><div class="NLM_p last">To a mixture of ethyl formate (1.60 mL, 19.8 mmol), NaH (60% dispersion in mineral oil, 1.16 g, 29 mmol), and EtOH (2 drops) in toluene (35 mL) at room temperature was added dropwise a solution of (1-methyl-1<i>H</i>-pyrazol-4-yl)acetonitrile) <b>17</b> (1.17 g, 9.7 mmol) in toluene (10 mL) over 30 min. The mixture was stirred at room temperature for 6 h, then quenched with H<sub>2</sub>O and brought to pH 4 using 1 N HCl (50 mL). The mixture was extracted with EtOAc (3 × 100 mL). The combined extracts were dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated to give <b>18</b> as a crude offwhite solid, which was carried forward without purification. MS (ESI) <i>m</i>/<i>z</i> 150.0 [M + H]<sup>+</sup>. This material was combined with EtOH (40 mL), hydrazine monohydrate (0.95 mL, 19.6 mmol), and concentrated HCl (0.9 mL). The mixture was heated to reflux for 16 h, then cooled to room temperature and concentrated to dryness. The residue was dissolved in H<sub>2</sub>O and neutralized by the addition of saturated aqueous NaHCO<sub>3</sub>. The resulting mixture was extracted with EtOAc (3 × 50 mL). The extracts were dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated in vacuo to provide <b>19</b> as a yellow wax (0.71 g, 45%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.42−11.54 (br s, 1H), 7.78 (s, 1H), 7.55 (app s, 2H), 4.36−4.51 (br s, 2H), 3.81 (s, 3H); MS (ESI) <i>m</i>/<i>z</i> 164.1 [M + H]<sup>+</sup>.</div></div><div id="sec3_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 6-(4-Aminophenyl)-3-(1-methyl-1<i>H</i>-pyrazol-4-yl)pyrazolo[1,5-<i>a</i>]pyrimidin-7-ylamine (<b>20</b>)</h3><div class="NLM_p last">3-(1-Methyl-1<i>H</i>-pyrazol-4-yl)-6-(4-nitrophenyl)pyrazolo[1,5-<i>a</i>]pyrimidin-7-amine was prepared via cyclocondensation of <b>11</b> with <b>19</b> following the procedure described for the synthesis of <b>12</b>, and the resulting nitro compound was reduced to <b>20</b> as follows: 3-(1-methyl-1<i>H</i>-pyrazol-4-yl)-6-(4-nitrophenyl)pyrazolo[1,5-<i>a</i>]pyrimidin-7-amine (408 mg, 1.2 mmol) was suspended in concentrated HCl (10 mL), and mixture was chilled to 0 °C. SnCl<sub>2</sub>·2H<sub>2</sub>O (824 mg, 3.6 mmol) was added, and the mixture was stirred at room temperature for 5 h. The precipitate was collected by filtration and rinsed with a little concentrated HCl, then dissolved in H<sub>2</sub>O (1000 mL). The solution was filtered, and the filtrate was neutralized by the addition of saturated aqueous NaHCO<sub>3</sub>. The mixture was extracted with EtOAc (3 × 50 mL). The extracts were dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated to provide <b>20</b> as a yellow solid (300 mg, 80%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.37 (s, 1H), 8.13 (s, 1H), 8.08 (s, 1H), 7.91 (s, 1H), 7.21 (s, 2H), 7.16 (d, <i>J</i> = 8.1 Hz, 2H), 6.69 (d, <i>J</i> = 8.5 Hz, 2H), 5.22 (s, 2H), 3.88 (s,3 H); MS (ESI) <i>m</i>/<i>z</i> 306.1 [M + H]<sup>+</sup>.</div></div><div id="sec3_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 1-{4-[7-Amino-3-(1-methyl-1<i>H</i>-pyrazol-4-yl)pyrazolo[1,5-<i>a</i>]pyrimidin-6-yl]phenyl}-3-<i>m</i>-tolyl-urea (<b>34</b>)</h3><div class="NLM_p last">Compounds <b>34</b> and <b>34a</b>−<b>e</b> were prepared from <b>20</b> following the procedure described for the synthesis of <b>6</b>. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.79 (s, 1H), 8.61 (s, 1H), 8.41 (s, 1H), 8.15 (s, 1H), 8.14 (s, 1H), 7.93 (d, <i>J</i> = 0.7 Hz, 1H), 7.59 (d, <i>J</i> = 8.8 Hz, 2H), 7.41−7.46 (m, 4H), 7.32 (s, 1H), 7.25 (d, <i>J</i> = 8.1 Hz, 1H), 7.17 (t, <i>J</i> = 7.8 Hz, 1H), 6.80 (d, <i>J</i> = 7.5 Hz, 1H), 3.89 (s, 3H), 2.29 (s, 3H); MS (ESI) <i>m</i>/<i>z</i> 439.1 [M + H]<sup>+</sup>. Anal. (C<sub>24</sub>H<sub>22</sub>N<sub>8</sub>O·0.2H<sub>2</sub>O) C, H, N.</div></div><div id="sec3_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 1-{4-[7-Amino-3-(1-methyl-1<i>H</i>-pyrazol-4-yl)pyrazolo[1,5-<i>a</i>]pyrimidin-6-yl]phenyl}-3-(3-trifluoromethylphenyl)urea (<b>34a</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.08 (s, 1H), 8.95 (s, 1H), 8.41 (s, 1H), 8.15 (s, 2H), 8.03 (s, 1H), 7.93 (s, 1H), 7.59−7.64 (m, 3H), 7.53 (t, <i>J</i> = 7.8 Hz, 1H), 7.43−7.48 (m, 4H), 7.32 (d, <i>J</i> = 7.5 Hz, 1H), 3.89 (s, 3H); MS (ESI) <i>m</i>/<i>z</i> 493.1 [M + H]<sup>+</sup>. Anal. (C<sub>24</sub>H<sub>19</sub>F<sub>3</sub>N<sub>8</sub>O) C, H, N.</div></div><div id="sec3_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 1-{4-[7-Amino-3-(1-methyl-1<i>H</i>-pyrazol-4-yl)pyrazolo[1,5-<i>a</i>]pyrimidin-6-yl]phenyl}-3-(3-chlorophenyl)urea (<b>34b</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.92 (s, 1H), 8.91 (s, 1H), 8.41 (s, 1H), 8.15 (app s, 2H), 7.93 (s, 1H), 7.72−7.75 (m, 1H), 7.60 (d, <i>J</i> = 8.8 Hz, 2H), 7.42−7.48 (m, 4H), 7.27−7.35 (m, 2H), 7.03 (dt, <i>J</i> = 6.1, 2.7 Hz, 1H), 3.89 (s, 3H); MS (ESI) <i>m</i>/<i>z</i> 459.1 [M + H]<sup>+</sup>. Anal. (C<sub>23</sub>H<sub>19</sub>ClN<sub>8</sub>O·0.1H<sub>2</sub>O·0.1CH<sub>2</sub>Cl<sub>2</sub>) C, H, N.</div></div><div id="sec3_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 1-{4-[7-Amino-3-(1-methyl-1<i>H</i>-pyrazol-4-yl)pyrazolo[1,5-<i>a</i>]pyrimidin-6-yl]phenyl}-3-(2-fluoro-5-trifluoromethylphenyl)urea (<b>34c</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.32 (s, 1H), 8.94 (s, 1H), 8.65 (dd, <i>J</i> = 7.1, 2.4 Hz, 1H), 8.41 (s, 1H), 8.15 (s, 2H), 7.93 (s, 1H), 7.58−7.63 (d, <i>J</i> = 8.8 Hz, 2H), 7.37−7.56 (m, 6H), 3.86−3.92 (s, 3H); MS (ESI) <i>m</i>/<i>z</i> 511.2 [M + H<sup>]+</sup>. Anal. (C<sub>24</sub>H<sub>18</sub>F<sub>4</sub>N<sub>8</sub>O) C, H, N.</div></div><div id="sec3_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 1-{4-[7-Amino-3-(1-methyl-1<i>H</i>-pyrazol-4-yl)pyrazolo[1,5-<i>a</i>]pyrimidin-6-yl]phenyl}-3-(4-fluoro-3-trifluoromethylphenyl)urea (<b>34d</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.06 (s, 1H), 8.95 (s, 1H), 8.41 (s, 1H), 8.15 (app s, 2H), 8.02 (dd, <i>J</i> = 0.6, 2.5 Hz, 1H), 7.93 (s, 1H), 7.64−7.71 (m, 1H), 7.61 (d, <i>J</i> = 8.5 Hz, 2H), 7.41−7.49 (m, 5H), 3.89 (s, 3H); MS (ESI) <i>m</i>/<i>z</i> 511.2 [M + H]<sup>+</sup>. Anal. (C<sub>24</sub>H<sub>18</sub>F<sub>4</sub>N<sub>8</sub>O·0.2H<sub>2</sub>O) C, H, N.</div></div><div id="sec3_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 1-{4-[7-Amino-3-(1-methyl-1<i>H</i>-pyrazol-4-yl)pyrazolo[1,5-<i>a</i>]pyrimidin-6-yl]phenyl}-3-(3-fluorophenyl)urea (<b>34e</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.94 (s, 1H), 8.90 (s, 1H), 8.41 (s, 1H), 8.15 (app s, 2H), 7.93 (s, 1H), 7.60 (d, <i>J</i> = 8.8 Hz, 2H), 7.51 (dt, <i>J</i> = 12.0, 2.3 Hz, 1H), 7.45 (s, 2H), 7.42−7.47 (m, <i>J</i> = 8.5 Hz, 2H), 7.32 (td, <i>J</i> = 8.2, 7.0 Hz, 1H), 7.13−7.17 (m, 1H), 6.79 (td, <i>J</i> = 8.4, 2.5 Hz, 1H), 3.89 (s, 3H); MS (ESI) <i>m</i>/<i>z</i> 443.1 [M + H]<sup>+</sup>. Anal. (C<sub>23</sub>H<sub>19</sub>FN<sub>8</sub>O·0.1CH<sub>2</sub>Cl<sub>2</sub>) C, H, N.</div></div><div id="sec3_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 1-[4-(7-Amino-5-methylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)phenyl]-3-<i>m</i>-tolylurea (<b>28</b>)</h3><div class="NLM_p last">Compound <b>28</b> was prepared from 3-aminopyrazole and dimethylacetamide-dimethyl acetal following the same sequence described for the synthesis of <b>14</b> from 3-aminopyrazole and dimethylformamide-dimethyl acetal, substituting the nitro reduction protocol described for the synthesis of compound <b>20</b>. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.79 (s, 1H), 8.62 (s, 1H), 8.04 (d, <i>J</i> = 2.4 Hz, 1H), 7.59 (d, <i>J</i> = 8.8 Hz, 2H), 7.32 (s, 1H), 7.21−7.28 (m, 3H), 7.17 (t, <i>J</i> = 7.6 Hz, 1H), 6.78−6.83 (m, 3H), 6.30 (d, <i>J</i> = 2.0 Hz, 1H), 2.29 (s, 3H), 2.14 (s, 3H); MS (ESI) <i>m</i>/<i>z</i> 373.1 [M + H]<sup>+</sup>. Anal. (C<sub>21</sub>H<sub>20</sub>N<sub>6</sub>O·0.3H<sub>2</sub>O) C, H, N.</div></div><div id="sec3_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 7-Amino-6-[4-(3-<i>m</i>-tolylureido)phenyl]pyrazolo[1,5-<i>a</i>]pyrimidine-3-carboxylic Acid Ethyl Ester (<b>36</b>)</h3><div class="NLM_p last">Compound <b>36</b> was prepared from 3-aminopyrazole-4-carboxylic acid ethyl ester following the sequence described for the synthesis of <b>14</b> from 3-aminopyrazole, substituting the nitro reduction protocol described for the synthesis of <b>5</b>. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.82 (s, 1H), 8.62 (s, 1H), 8.52 (s, 1H), 8.25 (s, 1H), 7.80 (s, 2H), 7.60 (d, <i>J</i> = 8.8 Hz, 2H), 7.42 (d, <i>J</i> = 8.5 Hz, 2H), 7.32 (s, 1H), 7.25 (d, <i>J</i> = 8.5 Hz, 1H), 7.17 (t, <i>J</i> = 7.6 Hz, 1H), 6.80 (d, <i>J</i> = 7.1 Hz, 1H), 4.27 (q, <i>J</i> = 7.1 Hz, 2H), 2.29 (s, 3H), 1.31 (t, <i>J</i> = 7.1 Hz, 3H); MS (ESI) <i>m</i>/<i>z</i> 431.2 [M + H]<sup>+</sup>. Anal. (C<sub>23</sub>H<sub>22</sub>N<sub>6</sub>O<sub>3</sub>·1.0DMF) C, H, N.</div></div><div id="sec3_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> 7-Amino-6-[4-(3-<i>m</i>-tolylureido)phenyl]pyrazolo[1,5-<i>a</i>]pyrimidine-3-carboxylic Acid (<b>37</b>)</h3><div class="NLM_p last">A mixture of compound <b>36</b> (113 mg, 0.26 mmol), 2 N aqueous LiOH (0.7 mL, 1.4 mmol), MeOH (0.5 mL), and THF (1 mL) was heated to 70 °C for 3 h, at which time TLC (19:1 CH<sub>2</sub>Cl<sub>2</sub>/MeOH) showed consumption of starting material. The mixture was concentrated to dryness, and the residue was taken up in H<sub>2</sub>O (25 mL). The solution was adjusted to pH 4 with with glacial HOAc and the resulting white solid was collected by filtration, rinsing with H<sub>2</sub>O, to give <b>37</b> (88 mg, 84%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.26 (s, 1H), 9.06 (s, 1H), 8.42 (s, 1H), 8.18 (s, 1H), 7.67−7.79 (br s, 2H), 7.63 (d, <i>J</i> = 8.5 Hz, 2H), 7.42 (d, <i>J</i> = 8.5 Hz, 2H), 7.36 (s, 1H), 7.29 (d, <i>J</i> = 8.1 Hz, 1H), 7.16 (t, <i>J</i> = 7.8 Hz, 1H), 6.79 (d, <i>J</i> = 7.5 Hz, 1H), 2.29 (s, 3H); MS (ESI) <i>m</i>/<i>z</i> 403.1 [M + H]<sup>+</sup>. Anal. (C<sub>21</sub>H<sub>18</sub>N<sub>6</sub>O<sub>3</sub>·2.7H<sub>2</sub>O) C, N. H calcd 5.23, found 4.66.</div></div><div id="sec3_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> 7-Amino-6-[4-(3-<i>m</i>-tolylureido)phenyl]pyrazolo[1,5-<i>a</i>]pyrimidine-3-carboxylic Acid Methylamide (<b>38</b>)</h3><div class="NLM_p last">A mixture of compound <b>37</b> (25 mg, 0.062 mmol), MeNH<sub>2</sub>·HCl (9 mg, 0.13 mmol), EDCI (36 mg, 0.19 mmol), HOBt (25 mg, 0.18 mmol), and <i>N</i>-methylmorpholine (0.07 mL, 0.63 mmol) in DMF (0.3 mL) was stirred for 16 h at room temperature. The mixture was diluted with H<sub>2</sub>O (10 mL) and extracted with EtOAc (3 × 10 mL). The extracts were dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated in vacuo, and the crude residue was triturated with CH<sub>2</sub>Cl<sub>2</sub>, yielding a solid that was collected by filtration to provide <b>38</b> (14 mg, 56%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.82 (s, 1H), 8.62 (s, 1H), 8.45 (s, 1H), 8.22 (s, 1H), 7.99 (q, <i>J</i> = 4.5 Hz, 1H), 7.90 (s, 2H), 7.60 (d, <i>J</i> = 8.8 Hz, 2H), 7.42 (d, <i>J</i> = 8.5 Hz, 2H), 7.31 (s, 1H), 7.25 (d, <i>J</i> = 8.5 Hz, 1H), 7.17 (t, <i>J</i> = 7.8 Hz, 1H), 6.80 (d, <i>J</i> = 7.1 Hz, 1H), 2.88 (d, <i>J</i> = 4.7 Hz, 3H), 2.29 (s, 3H); MS (ESI) <i>m</i>/<i>z</i> 416.2 [M + H]<sup>+</sup>. Anal. (C<sub>22</sub>H<sub>21</sub>N<sub>7</sub>O<sub>2</sub>·1.5H<sub>2</sub>O) C, H, N.</div></div><div id="sec3_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> Homogeneous Time-Resolved Fluorescence (HTRF) Assays of Receptor Tyrosine Kinases (KDR, CSR1R, cKIT, FLT1, FLT3)</h3><div class="NLM_p last">Assays were performed in a total of 40 µL in 96-well Costar black half-volume plates using HTRF technology.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Peptide substrate (Biotin-Ahx-AEEEYFFLFA-amide) at 4 µM, 1 mM ATP, enzyme, and inhibitors were incubated for 1 h at ambient temperature in 50 mM Hepes/NaOH, pH 7.5, 10 mM MgCl<sub>2</sub>, 2 mM MnCl<sub>2</sub>, 2.5 mM DTT, 0.1 mM orthovanadate, and 0.01% BSA. Inhibitors were added to the wells at final concentrations of 3.2 nM to 50 µM with 5% DMSO added as cosolvent. The reactions were stopped with 10 µL/well 0.5 M EDTA and then 75 µL buffer containing streptavidin−allophycocyanin (Prozyme, 1.1 µg/mL), and PT66 antibody europium cryptate (Cis-Bio, 0.1 µg/mL) was added to each well. The plates were read from 1 to 4 h after addition of the detection reagents, and the time-resolved fluorescence (665−615 ratio) was measured using a Packard Discovery instrument. The amount of each tyrosine kinase added to the wells was calibrated to give a control (no inhibitor) to background (prequenched with EDTA) ratio of 10−15 and was shown to be in the low nanomolar concentration range for each kinase. The inhibition of each well was calculated using the control and background readings for that plate. Inhibition constants are the mean of two determinations performed with seven concentrations of the test compounds.</div></div><div id="sec3_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> Enzyme-Linked Immunisorbent Assay (ELISA) of KDR Cellular Phosphorylation</h3><div class="NLM_p last">NIH3T3 cells stably transfected with full length human KDR (VEGFR2) were maintained in DMEM medium with 10% fetal bovine serum and 500 µg/mL Geneticin. KDR cells were plated at 20 000 cells/well into duplicate 96-well tissue culture plates and cultured overnight in an incubator at 37 °C with 5% CO<sub>2</sub> and 80% humidity. The growth medium was replaced with serum-free growth medium for 2 h prior to compound addition. Compounds in DMSO were diluted in serum-free growth medium (final DMSO concentration of 1%) and added to cells for 20 min prior to stimulation for 10 min with VEGF (50 ng/mL). Cells were lysed by addition of RIPA buffer (50 mM Tris-HCl (pH 7.4), 1% IGEPAL, 150 mM NaCl, 1 mM EDTA, and 0.25% sodium deoxycholate) containing protease inhibitors (Sigma cocktail), NaF (1 mM), and Na<sub>3</sub>VO<sub>4</sub> (1 mM) and placed on a microtiter plate shaker for 10 min. The lysates from duplicate wells were combined, and 170 µL of the combined lysate was added to the KDR ELISA plate. The KDR ELISA plate was prepared by adding anti-VEGFR2 antibody (1 µg/well, R&D Systems) to an unblocked plate and incubated overnight at 4 °C. The plate was then blocked for at least 1 h with 200 µL/well of 5% dry milk in PBS. The plate was washed two times with PBS containing 0.1% Tween 20 (PBST) before addition of the cell lysates. Cell lysates were incubated in the KDR ELISA plate with constant shaking on a microtiter plate shaker for 2 h at room temperature. The cell lysate was then removed and the plate washed five times with PBST. Detection of phospho-KDR was performed using a 1:2000 dilution of biotinylated 4G10 antiphosphotyrosine (UBI, Lake Placid, NY), incubated with constant shaking for 1.5 h at room temperature, and washed five times with PBST, and for detection a 1:2000 dilution of strepavidin-HRP (UBI, Lake Placid, NY) was added and incubated with constant shaking for 1 h at room temperature. The wells were then washed five times with PBST, and K-Blue HRP ELISA substrate (Neogen) was added to each well. Development time was monitored at 650 nm in a SprectrMax Plus plate reader until 0.4−0.5 absorbance units were obtained (approximately 10 min) in the VEGF only wells. Phosphoric acid (1 M) was added to stop the reaction, and the plate was read at 450 nm. Percent inhibition was calculated using the VEGF only wells as 100% controls and wells containing 5 µM pan-kinase inhibitor as 0% controls (no VEGF wells were used to monitor endogenous phosphorylation state of the cells). IC<sub>50</sub> values were calculated by nonlinear regression analysis of the concentration−response curve. Each IC<sub>50</sub> determination was performed with five concentrations and each assay point determined in duplicate.</div></div><div id="sec3_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> Estradiol-Induced Murine UE Assay</h3><div class="NLM_p last">The 12 week old balb/c female mice (Taconic, Germantown, NY) were pretreated with 10 units of pregnant mare’s serum gonadotropin (PMSG, Calbiochem) intraperitoneally (ip) administered 72 and 24 h prior to estradiol. Mice were randomized the day of the experiment. Test compounds were formulated in a variety of vehicles and administered po 30 min prior to stimulation with an ip injection of water soluble 17β-estradiol (20−25 µg/mouse). Animals were sacrificed and uteri removed 2.5 h following estradiol stimulation by cutting just proximal to the cervix and at the fallopian tubes. After the removal of fat and connective tissue, uteri were weighed, squeezed between filter paper to remove fluid, and weighed again. The difference between wet and blotted weights represented the fluid content of the uterus. Compound-treated groups were compared to vehicle-treated groups after subtracting the background water content of unstimulated uteri. Experimental group size was five or six.</div></div><div id="sec3_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> Mouse PK Analysis</h3><div class="NLM_p last">Male CD-1 mice weighing 26−30 g (Charles River Laboratories) were dosed intravenously via the tail vein or orally by gavage with a metal feeder tube. Dosing solutions were prepared in 2.5% ethanol, 2.5% DMSO, 5% Tween-80, 25% PEG 400, and pH 7.4 PBS for a dosing volume of 10 mL/kg. Blood samples were collected with a heparinized syringe by cardiac puncture following CO<sub>2</sub> asphixiation at specified times. Plasma samples were aliquoted into 96-well plates, and proteins were precipitated using acidified methanol. Supernatants were stored at −20 °C. Sample analyses were performed by LC−MS using a Shimadzu 10A-VP chromatography system with a Waters YMC-AQ 5 cm column. The mobile phase consisted of 45% acetonitrile and 0.1% acetic acid in water, and the flow rate was 0.4 mL/min. Mass detection was accomplished with an ESI equipped LCQ-Duo by ThermoFinnegan. External standards were prepared from spiked control plasma and used to generate a response factor for every study. Limits of detection were between 20 and 50 nM.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i63"><a href="/doi/suppl/10.1021/jm701397k">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52532" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52532" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Synthesis and spectral data for compounds <b>2</b>, <b>4</b>, <b>23</b>−<b>27</b>, <b>29</b>−<b>33</b>, <b>35</b>, <b>39</b>, <b>40</b>, and <b>42</b>. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm701397k/suppl_file/jm701397k-file003.pdf">jm701397k-file003.pdf (49.28 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm701397k" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72827" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72827" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robin R. Frey</span> - <span class="hlFld-Affiliation affiliation">Global Pharmaceutical Research and Development, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064-6100</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#a2d0cdc0cbcc8cd08cc4d0c7dbe2c3c0c0cdd6d68cc1cdcf"><span class="__cf_email__" data-cfemail="f68499949f98d884d89084938fb6979494998282d895999b">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael L. Curtin</span> - <span class="hlFld-Affiliation affiliation">Global Pharmaceutical Research and Development, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064-6100</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel H. Albert</span> - <span class="hlFld-Affiliation affiliation">Global Pharmaceutical Research and Development, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064-6100</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Keith B. Glaser</span> - <span class="hlFld-Affiliation affiliation">Global Pharmaceutical Research and Development, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064-6100</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lori J. Pease</span> - <span class="hlFld-Affiliation affiliation">Global Pharmaceutical Research and Development, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064-6100</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Niru B. Soni</span> - <span class="hlFld-Affiliation affiliation">Global Pharmaceutical Research and Development, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064-6100</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jennifer J. Bouska</span> - <span class="hlFld-Affiliation affiliation">Global Pharmaceutical Research and Development, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064-6100</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David Reuter</span> - <span class="hlFld-Affiliation affiliation">Global Pharmaceutical Research and Development, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064-6100</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kent D. Stewart</span> - <span class="hlFld-Affiliation affiliation">Global Pharmaceutical Research and Development, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064-6100</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Patrick Marcotte</span> - <span class="hlFld-Affiliation affiliation">Global Pharmaceutical Research and Development, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064-6100</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gail Bukofzer</span> - <span class="hlFld-Affiliation affiliation">Global Pharmaceutical Research and Development, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064-6100</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Junling Li</span> - <span class="hlFld-Affiliation affiliation">Global Pharmaceutical Research and Development, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064-6100</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steven K. Davidsen</span> - <span class="hlFld-Affiliation affiliation">Global Pharmaceutical Research and Development, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064-6100</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael R. Michaelides</span> - <span class="hlFld-Affiliation affiliation">Global Pharmaceutical Research and Development, Abbott Laboratories, 100 Abbott Park Road, Abbott Park, Illinois 60064-6100</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i62">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23375" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23375" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank the Department of Structural Chemistry, Abbott Laboratories, for recording the NMR and MS spectral data.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i64">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75257" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75257" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 39 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Manning, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whyte, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sudarsanam, S.</span><span> </span><span class="NLM_article-title">The Protein Kinase Complement of the Human Genome</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">298</span><span class="NLM_x">, </span> <span class="NLM_fpage">1912</span><span class="NLM_x">–</span> <span class="NLM_lpage">1934</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm701397k&amp;key=10.1126%2Fscience.1075762" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm701397k&amp;key=12471243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm701397k&amp;key=1%3ACAS%3A528%3ADC%252BD38Xpt1Wisb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=298&publication_year=2002&pages=1912-1934&author=G.+Manningauthor=D.+B.+Whyteauthor=R.+Martinezauthor=T.+Hunterauthor=S.+Sudarsanam&title=The+Protein+Kinase+Complement+of+the+Human+Genome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The Protein Kinase Complement of the Human Genome</span></div><div class="casAuthors">Manning, G.; Whyte, D. B.; Martinez, R.; Hunter, T.; Sudarsanam, S.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">298</span>
        (<span class="NLM_cas:issue">5600</span>),
    <span class="NLM_cas:pages">1912-1916, 1933-1934</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">We have catalogued the protein kinase complement of the human genome (the "kinome") using public and proprietary genomic, complementary DNA, and expressed sequence tag (EST) sequences.  This provides a starting point for comprehensive anal. of protein phosphorylation in normal and disease states, as well as a detailed view of the current state of human genome anal. through a focus on one large gene family.  We identify 518 putative protein kinase genes, of which 71 have not previously been reported or described as kinases, and we extend or correct the protein sequences of 56 more kinases.  New genes include members of well-studied families as well as previously unidentified families, some of which are conserved in model organisms.  Classification and comparison with model organism kinomes identified orthologous groups and highlighted expansions specific to human and other lineages.  We also identified 106 protein kinase pseudogenes.  Chromosomal mapping revealed several small clusters of kinase genes and revealed that 244 kinases map to disease loci or cancer amplicons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTj1hf_0cQcrVg90H21EOLACvtfcHk0liNneFdVsU0YA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xpt1Wisb0%253D&md5=b3def83bace52257a3252a3347b8bb92</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1126%2Fscience.1075762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1075762%26sid%3Dliteratum%253Aachs%26aulast%3DManning%26aufirst%3DG.%26aulast%3DWhyte%26aufirst%3DD.%2BB.%26aulast%3DMartinez%26aufirst%3DR.%26aulast%3DHunter%26aufirst%3DT.%26aulast%3DSudarsanam%26aufirst%3DS.%26atitle%3DThe%2520Protein%2520Kinase%2520Complement%2520of%2520the%2520Human%2520Genome%26jtitle%3DScience%26date%3D2002%26volume%3D298%26spage%3D1912%26epage%3D1934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Blume-Jensen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, T.</span><span> </span><span class="NLM_article-title">Oncogenic Kinase Signalling</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">411</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">365</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm701397k&amp;key=10.1038%2F35077225" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm701397k&amp;key=11357143" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm701397k&amp;key=1%3ACAS%3A528%3ADC%252BD3MXktVSjsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=411&publication_year=2001&pages=355-365&author=P.+Blume-Jensenauthor=T.+Hunter&title=Oncogenic+Kinase+Signalling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Oncogenic kinase signaling</span></div><div class="casAuthors">Blume-Jensen, Peter; Hunter, Tony</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">411</span>
        (<span class="NLM_cas:issue">6835</span>),
    <span class="NLM_cas:pages">355-365</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review with 93 refs.  Protein-tyrosine kinases (PTKs) are important regulators of intracellular signal-transduction pathways mediating development and multicellular communication in metazoans.  Their activity is normally tightly controlled and regulated.  Perturbation of PTK signaling by mutations and other genetic alterations results in deregulated kinase activity and malignant transformation.  The lipid kinase phosphoinositide 3-OH kinase (PI(3)K) and some of its downstream targets, such as the protein-serine/threonine kinases Akt and p70 S6 kinase (p70S6K), are crucial effectors in oncogenic PTK signaling.  This review emphasizes how oncogenic conversion of protein kinases results from perturbation of the normal autoinhibitory constraints on kinase activity and provides an update on our knowledge about the role of deregulated PI(3)K/Akt and mammalian target of rapamycin/p70S6K signaling in human malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJiBzQk4vjZbVg90H21EOLACvtfcHk0ljbm7TQXq0GzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXktVSjsr0%253D&md5=cd1bce803c2daadb98cbdba8550be43b</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2F35077225&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35077225%26sid%3Dliteratum%253Aachs%26aulast%3DBlume-Jensen%26aufirst%3DP.%26aulast%3DHunter%26aufirst%3DT.%26atitle%3DOncogenic%2520Kinase%2520Signalling%26jtitle%3DNature%26date%3D2001%26volume%3D411%26spage%3D355%26epage%3D365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Holmgren, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Reilly, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folkman, J.</span><span> </span><span class="NLM_article-title">Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">149</span><span class="NLM_x">–</span> <span class="NLM_lpage">153</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm701397k&amp;key=10.1038%2Fnm0295-149" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm701397k&amp;key=7585012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm701397k&amp;key=1%3ACAS%3A528%3ADyaK2MXksVeru78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1995&pages=149-153&author=L.+Holmgrenauthor=M.+S.+O%E2%80%99Reillyauthor=J.+Folkman&title=Dormancy+of+micrometastases%3A+Balanced+proliferation+and+apoptosis+in+the+presence+of+angiogenesis+suppression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression</span></div><div class="casAuthors">Holmgren, Lars; O'Reilly, Michael S.; Folkman, Judah</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">149-53</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Co.</span>)
        </div><div class="casAbstract">In cancer patients, dormant micrometastases are often asymptomatic and clin. undetectable, for months or years, until relapse.  We have studied dormant lung metastases under angiogenesis suppression in mice.  The metastases exhibited rapid growth when the inhibition of angiogenesis was removed.  Tumor cell proliferation, as measured by bromodeoxyuridine incorporation and immunohistochem. staining proliferating cell nuclear antigen, was not significantly different in dormant and growing metastases.  However, tumor cells of dormant metastases exhibited a more than threefold higher incidence of apoptosis.  These data show that metastases remain dormant when tumor cell proliferation is balanced by an equiv. rate of cell death and suggest that angiogenesis inhibitors control metastatic growth by indirectly increasing apoptosis in tumor cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqY4QX7Mmzn-7Vg90H21EOLACvtfcHk0ljbm7TQXq0GzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXksVeru78%253D&md5=ddda458c40fb17faf3d59781c47942fd</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnm0295-149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm0295-149%26sid%3Dliteratum%253Aachs%26aulast%3DHolmgren%26aufirst%3DL.%26aulast%3DO%25E2%2580%2599Reilly%26aufirst%3DM.%2BS.%26aulast%3DFolkman%26aufirst%3DJ.%26atitle%3DDormancy%2520of%2520micrometastases%253A%2520Balanced%2520proliferation%2520and%2520apoptosis%2520in%2520the%2520presence%2520of%2520angiogenesis%2520suppression%26jtitle%3DNat.%2520Med.%26date%3D1995%26volume%3D1%26spage%3D149%26epage%3D153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Fukumura, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gohongi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seed, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, R. K.</span><span> </span><span class="NLM_article-title">Hypoxia and Acidosis Independently Up-Regulate Vascular Endothelial Growth Factor Transcription in Brain Tumors in Vivo</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">6020</span><span class="NLM_x">–</span> <span class="NLM_lpage">6024</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=6020-6024&author=D.+Fukumuraauthor=L.+Xuauthor=Y.+Chenauthor=T.+Gohongiauthor=B.+Seedauthor=R.+K.+Jain&title=Hypoxia+and+Acidosis+Independently+Up-Regulate+Vascular+Endothelial+Growth+Factor+Transcription+in+Brain+Tumors+in+Vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFukumura%26aufirst%3DD.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DGohongi%26aufirst%3DT.%26aulast%3DSeed%26aufirst%3DB.%26aulast%3DJain%26aufirst%3DR.%2BK.%26atitle%3DHypoxia%2520and%2520Acidosis%2520Independently%2520Up-Regulate%2520Vascular%2520Endothelial%2520Growth%2520Factor%2520Transcription%2520in%2520Brain%2520Tumors%2520in%2520Vivo%26jtitle%3DCancer%2520Res.%26date%3D2001%26volume%3D61%26spage%3D6020%26epage%3D6024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Dvorak, H. F.</span><span> </span><span class="NLM_article-title">Vascular Permeability Factor/Vascular Endothelial Growth Factor: A Critical Cytokine in Tumor Angiogenesis and a Potential Target for Diagnosis and Therapy</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">4368</span><span class="NLM_x">–</span> <span class="NLM_lpage">4380</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm701397k&amp;key=10.1200%2FJCO.2002.10.088" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm701397k&amp;key=12409337" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm701397k&amp;key=1%3ACAS%3A528%3ADC%252BD38Xpt1CjtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2002&pages=4368-4380&author=H.+F.+Dvorak&title=Vascular+Permeability+Factor%2FVascular+Endothelial+Growth+Factor%3A+A+Critical+Cytokine+in+Tumor+Angiogenesis+and+a+Potential+Target+for+Diagnosis+and+Therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Vascular Permeability Factor/Vascular Endothelial Growth Factor: A Critical Cytokine in Tumor Angiogenesis and a Potential Target for Diagnosis and Therapy</span></div><div class="casAuthors">Dvorak, Harold F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">4368-4380</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review.  Vascular endothelial growth factor A (VEGF-A), the founding member of the vascular permeability factor (VPF)/VEGF family of proteins, is an important angiogenic cytokine with crit. roles in tumor angiogenesis.  This article reviews the literature with regard to VEGF-A's multiple functions, the mechanisms by which it induces angiogenesis, and its current and projected roles in clin. oncol.  VEGF-A is a multifunctional cytokine that is widely expressed by tumor cells and that acts through receptors (VEGFR-1, VEGFR-2, and neuropilin) that are expressed on vascular endothelium and on some other cells.  It increases microvascular permeability, induces endothelial cell migration and division, reprograms gene expression, promotes endothelial cell survival, prevents senescence, and induces angiogenesis.  Recently, VEGF-A has also been shown to induce lymphangiogenesis.  Measurements of circulating levels of VEGF-A may have value in estg. prognosis, and VEGF-A and its receptors are potential targets for therapy.  Recognized as the single most important angiogenic cytokine, VEGF-A has a central role in tumor biol. and will likely have an important role in future approaches designed to evaluate patient prognosis.  It may also become an important target for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7hJeymF1RYLVg90H21EOLACvtfcHk0ljbm7TQXq0GzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xpt1CjtL0%253D&md5=3f173a57f2060a949d5ae17f46191df6</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1200%2FJCO.2002.10.088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2002.10.088%26sid%3Dliteratum%253Aachs%26aulast%3DDvorak%26aufirst%3DH.%2BF.%26atitle%3DVascular%2520Permeability%2520Factor%252FVascular%2520Endothelial%2520Growth%2520Factor%253A%2520A%2520Critical%2520Cytokine%2520in%2520Tumor%2520Angiogenesis%2520and%2520a%2520Potential%2520Target%2520for%2520Diagnosis%2520and%2520Therapy%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2002%26volume%3D20%26spage%3D4368%26epage%3D4380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Carmeliet, P.</span><span> </span><span class="NLM_article-title">VEGF as a Key Mediator of Angiogenesis in Cancer</span> <span class="citation_source-journal">Oncology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 3</span><span class="NLM_x">) </span> <span class="NLM_fpage">4</span><span class="NLM_x">–</span> <span class="NLM_lpage">10</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2005&pages=4-10&issue=Suppl.+3&author=P.+Carmeliet&title=VEGF+as+a+Key+Mediator+of+Angiogenesis+in+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarmeliet%26aufirst%3DP.%26atitle%3DVEGF%2520as%2520a%2520Key%2520Mediator%2520of%2520Angiogenesis%2520in%2520Cancer%26jtitle%3DOncology%26date%3D2005%26volume%3D69%26issue%3DSuppl.%25203%26spage%3D4%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Beck, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Amore, P. A.</span><span> </span><span class="NLM_article-title">Vascular development: cellular and molecular regulation</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">365</span><span class="NLM_x">–</span> <span class="NLM_lpage">373</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1997&pages=365-373&author=L.+Beckauthor=P.+A.+D%E2%80%99Amore&title=Vascular+development%3A+cellular+and+molecular+regulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeck%26aufirst%3DL.%26aulast%3DD%25E2%2580%2599Amore%26aufirst%3DP.%2BA.%26atitle%3DVascular%2520development%253A%2520cellular%2520and%2520molecular%2520regulation%26jtitle%3DFASEB%2520J.%26date%3D1997%26volume%3D11%26spage%3D365%26epage%3D373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Reynolds, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Killilea, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redmer, D. A.</span><span> </span><span class="NLM_article-title">Angiogenesis in the female reproductive system</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">886</span><span class="NLM_x">–</span> <span class="NLM_lpage">892</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1992&pages=886-892&author=L.+P.+Reynoldsauthor=S.+D.+Killileaauthor=D.+A.+Redmer&title=Angiogenesis+in+the+female+reproductive+system"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReynolds%26aufirst%3DL.%2BP.%26aulast%3DKillilea%26aufirst%3DS.%2BD.%26aulast%3DRedmer%26aufirst%3DD.%2BA.%26atitle%3DAngiogenesis%2520in%2520the%2520female%2520reproductive%2520system%26jtitle%3DFASEB%2520J.%26date%3D1992%26volume%3D6%26spage%3D886%26epage%3D892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Augustin, H. G.</span><span> </span><span class="NLM_article-title">Antiangiogenic tumor therapy: will it work?</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">216</span><span class="NLM_x">–</span> <span class="NLM_lpage">222</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1998&pages=216-222&author=H.+G.+Augustin&title=Antiangiogenic+tumor+therapy%3A+will+it+work%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAugustin%26aufirst%3DH.%2BG.%26atitle%3DAntiangiogenic%2520tumor%2520therapy%253A%2520will%2520it%2520work%253F%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D1998%26volume%3D19%26spage%3D216%26epage%3D222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Ferrara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillan, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerber, H.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novotny, W.</span><span> </span><span class="NLM_article-title">Discovery and Development of Bevacizumab, an Anti-VEGF Antibody for Treating Cancer</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">391</span><span class="NLM_x">–</span> <span class="NLM_lpage">400</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm701397k&amp;key=10.1038%2Fnrd1381" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm701397k&amp;key=15136787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm701397k&amp;key=1%3ACAS%3A528%3ADC%252BD2cXktlCrt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=391-400&author=N.+Ferraraauthor=K.+J.+Hillanauthor=H.-P.+Gerberauthor=W.+Novotny&title=Discovery+and+Development+of+Bevacizumab%2C+an+Anti-VEGF+Antibody+for+Treating+Cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer</span></div><div class="casAuthors">Ferrara, Napoleone; Hillan, Kenneth J.; Gerber, Hans-Peter; Novotny, William</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">391-400</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The existence of factors that stimulate blood vessel growth, thereby recruiting a neovascular supply to nourish a growing tumor, was postulated many decades ago, although the identification and isolation of these factors proved elusive.  Now, vascular endothelial growth factor (VEGF), which was identified in the 1980s, is recognized as an essential regulator of normal and abnormal blood vessel growth.  In 1993, it was shown that a monoclonal antibody that targeted VEGF results in a dramatic suppression of tumor growth in vivo, which led to the development of bevacizumab (Avastin; Genentech), a humanized variant of this anti-VEGF antibody, as an anticancer agent.  The recent approval of bevacizumab by the US FDA as a first-line therapy for metastatic colorectal cancer validates the ideas that VEGF is a key mediator of tumor angiogenesis and that blocking angiogenesis is an effective strategy to treat human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphaLbfhdBKOLVg90H21EOLACvtfcHk0lioOfA19DG-RA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXktlCrt78%253D&md5=4b1f647db4dfe2a24449cdf59b874e7c</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnrd1381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1381%26sid%3Dliteratum%253Aachs%26aulast%3DFerrara%26aufirst%3DN.%26aulast%3DHillan%26aufirst%3DK.%2BJ.%26aulast%3DGerber%26aufirst%3DH.-P.%26aulast%3DNovotny%26aufirst%3DW.%26atitle%3DDiscovery%2520and%2520Development%2520of%2520Bevacizumab%252C%2520an%2520Anti-VEGF%2520Antibody%2520for%2520Treating%2520Cancer%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D391%26epage%3D400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Gschwind, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, O. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ullrich, A.</span><span> </span><span class="NLM_article-title">The Discovery of Receptor Tyrosine Kinases: Targets for Cancer Therapy</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">361</span><span class="NLM_x">–</span> <span class="NLM_lpage">370</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm701397k&amp;key=10.1038%2Fnrc1360" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm701397k&amp;key=15122207" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm701397k&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjsFSlu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=361-370&author=A.+Gschwindauthor=O.+M.+Fischerauthor=A.+Ullrich&title=The+Discovery+of+Receptor+Tyrosine+Kinases%3A+Targets+for+Cancer+Therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Timeline: The discovery of receptor tyrosine kinases: targets for cancer therapy</span></div><div class="casAuthors">Gschwind, Andreas; Fischer, Oliver M.; Ullrich, Axel</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">361-370</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Receptor tyrosine kinases are a subclass of cell-surface growth-factor receptors with an intrinsic, ligand-controlled tyrosine-kinase activity.  They regulate diverse functions in normal cells and have a crucial role in oncogenesis.  Twenty years ago, the 1st primary structure of a receptor Tyr kinase, the epidermal growth factor receptor, was elucidated.  The characterization of both the mol. architecture of receptor Tyr kinases and the main functions of these proteins and their ligands in tumorigenesis opened the door to a new era in mol. oncol. and paved the way to the development of the 1st target-specific cancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1NLVNn4dw37Vg90H21EOLACvtfcHk0lioOfA19DG-RA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjsFSlu7g%253D&md5=ea24c0ccaea68b743b5da9587ed19406</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnrc1360&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1360%26sid%3Dliteratum%253Aachs%26aulast%3DGschwind%26aufirst%3DA.%26aulast%3DFischer%26aufirst%3DO.%2BM.%26aulast%3DUllrich%26aufirst%3DA.%26atitle%3DThe%2520Discovery%2520of%2520Receptor%2520Tyrosine%2520Kinases%253A%2520Targets%2520for%2520Cancer%2520Therapy%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2004%26volume%3D4%26spage%3D361%26epage%3D370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Board, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayson, G. C.</span><span> </span><span class="NLM_article-title">Platelet-Derived Growth Factor Receptor (PDGFR): A Target for Anticancer Therapeutics</span> <span class="citation_source-journal">Drug Resist. Updates</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">75</span><span class="NLM_x">–</span> <span class="NLM_lpage">83</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm701397k&amp;key=10.1016%2Fj.drup.2005.03.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm701397k&amp;key=15939344" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm701397k&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltVaqtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2005&pages=75-83&author=R.+Boardauthor=G.+C.+Jayson&title=Platelet-Derived+Growth+Factor+Receptor+%28PDGFR%29%3A+A+Target+for+Anticancer+Therapeutics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Platelet-derived growth factor receptor (PDGFR): A target for anticancer therapeutics</span></div><div class="casAuthors">Board, Ruth; Jayson, Gordon C.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Resistance Updates</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">75-83</span>CODEN:
                <span class="NLM_cas:coden">DRUPFW</span>;
        ISSN:<span class="NLM_cas:issn">1368-7646</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Platelet-derived growth factors (PDGFs) and their tyrosine kinase receptors (PDGFRs) have been implicated in the pathogenesis of a no. of tumor types and play an important role in angiogenesis.  Tumor growth can be promoted by PDGF via autocrine stimulation of malignant cells, by overexpression or overactivation of PDGFRs, or by stimulation of angiogenesis within the tumor.  These mechanisms could provide possible therapeutic targets.  PDGFR blockade may also lower the interstitial fluid pressure within solid tumors and enhance drug delivery.  Here we discuss the possible therapeutic roles of PDGFR antagonists in the treatment of cancer, alone and in combination with chemotherapy or other targeted agents.  Extensive exptl. data highlight the potential therapeutic advantage of targeting PDGFR.  However, recent clin. data suggest that antagonism of this growth factor is assocd. with fluid accumulation that could obscure any clin. benefit.  Further clin. research is required to optimize inhibition of this cytokine-receptor system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOZ-2MVJdiQbVg90H21EOLACvtfcHk0lioOfA19DG-RA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltVaqtLk%253D&md5=9083a98f34a4b2e6e775498a28d7923b</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.drup.2005.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drup.2005.03.004%26sid%3Dliteratum%253Aachs%26aulast%3DBoard%26aufirst%3DR.%26aulast%3DJayson%26aufirst%3DG.%2BC.%26atitle%3DPlatelet-Derived%2520Growth%2520Factor%2520Receptor%2520%2528PDGFR%2529%253A%2520A%2520Target%2520for%2520Anticancer%2520Therapeutics%26jtitle%3DDrug%2520Resist.%2520Updates%26date%3D2005%26volume%3D8%26spage%3D75%26epage%3D83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Sun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">App, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMahon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, C.</span><span> </span><span class="NLM_article-title">Synthesis and Biological Evaluations of 3-Substituted Indolin-2-ones: A Novel Class of Tyrosine Kinase Inhibitors That Exhibit Selectivity toward Particular Receptor Tyrosine Kinases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">2588</span><span class="NLM_x">–</span> <span class="NLM_lpage">2603</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm980123i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm701397k&amp;key=1%3ACAS%3A528%3ADyaK1cXkt12jtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=2588-2603&author=L.+Sunauthor=N.+Tranauthor=F.+Tangauthor=H.+Appauthor=P.+Hirthauthor=G.+McMahonauthor=C.+Tang&title=Synthesis+and+Biological+Evaluations+of+3-Substituted+Indolin-2-ones%3A+A+Novel+Class+of+Tyrosine+Kinase+Inhibitors+That+Exhibit+Selectivity+toward+Particular+Receptor+Tyrosine+Kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluations of 3-Substituted Indolin-2-ones: A Novel Class of Tyrosine Kinase Inhibitors That Exhibit Selectivity toward Particular Receptor Tyrosine Kinases</span></div><div class="casAuthors">Sun, Li; Tran, Ngoc; Tang, Flora; App, Harald; Hirth, Peter; McMahon, Gerald; Tang, Cho</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2588-2603</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">3-Substituted indolin-2-ones have been designed and synthesized as a novel class of tyrosine kinase inhibitors which exhibit selectivity toward different receptor tyrosine kinases (RTKs).  These compds. have been evaluated for their relative inhibitory properties against a panel of RTKs in intact cells.  By modifying the 3-substituted indolin-2-ones, we have identified compds. which showed selective inhibition of the ligand-dependent autophosphorylation of various RTKs at submicromolar levels in cells.  Structure-activity anal. for these compds. and their relative potency and selectivity to inhibit particular RTKs has detd. that (1) 3-[(five-membered heteroaryl ring)methylidenyl]indolin-2-ones are highly specific against the VEGF (Flk-1) RTK activity, (2) 3-(substituted benzylidenyl)indolin-2-ones contg. bulky group(s) in the Ph ring at the C-3 position of indolin-2-ones showed high selectivity toward the EGF and Her-2 RTKs, and (3) the compd. contg. an extended side chain at the C-3 position of the indolin-2-one exhibited high potency and selectivity when tested against the PDGF and VEGF (Flk-1) RTKs.  Recent published crystallog. data for two of these 3-substituted indolin-2-ones provides a rationale to suggest that these compds. may bind in the ATP binding pocket of RTKs.  The structure-activity anal. supports the use of subsets of these compds. as specific chem. leads for the development of RTK-specific drugs with broad application for the treatment of human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJoPixq8Am5rVg90H21EOLACvtfcHk0lgL3SFvk2thzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkt12jtrw%253D&md5=536302b717170a630008dac14832204c</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm980123i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm980123i%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DL.%26aulast%3DTran%26aufirst%3DN.%26aulast%3DTang%26aufirst%3DF.%26aulast%3DApp%26aufirst%3DH.%26aulast%3DHirth%26aufirst%3DP.%26aulast%3DMcMahon%26aufirst%3DG.%26aulast%3DTang%26aufirst%3DC.%26atitle%3DSynthesis%2520and%2520Biological%2520Evaluations%2520of%25203-Substituted%2520Indolin-2-ones%253A%2520A%2520Novel%2520Class%2520of%2520Tyrosine%2520Kinase%2520Inhibitors%2520That%2520Exhibit%2520Selectivity%2520toward%2520Particular%2520Receptor%2520Tyrosine%2520Kinases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D2588%26epage%3D2603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Laird, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vajkoczy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shawver, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thurnher, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohammadi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlessinger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ullrich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blake, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fong, T. A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strawn, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawtin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shenoy, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirth, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMahon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherrington, J. M.</span><span> </span><span class="NLM_article-title">SU6668 Is a Potent Antiangiogenic and Antitumor Agent That Induces Regression of Established Tumors</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">4152</span><span class="NLM_x">–</span> <span class="NLM_lpage">4160</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm701397k&amp;key=10945623" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm701397k&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlvFOkt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2000&pages=4152-4160&author=A.+D.+Lairdauthor=P.+Vajkoczyauthor=L.+K.+Shawverauthor=A.+Thurnherauthor=C.+Liangauthor=M.+Mohammadiauthor=J.+Schlessingerauthor=A.+Ullrichauthor=S.+R.+Hubbardauthor=R.+A.+Blakeauthor=T.+A.+T.+Fongauthor=L.+M.+Strawnauthor=L.+Sunauthor=C.+Tangauthor=R.+Hawtinauthor=F.+Tangauthor=N.+Shenoyauthor=K.+P.+Hirthauthor=G.+McMahonauthor=J.+M.+Cherrington&title=SU6668+Is+a+Potent+Antiangiogenic+and+Antitumor+Agent+That+Induces+Regression+of+Established+Tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors</span></div><div class="casAuthors">Laird, A. Douglas; Vajkoczy, Peter; Shawver, Laura K.; Thurnher, Andreas; Liang, Congxin; Mohammadi, Moosa; Schlessinger, Joseph; Ullrich, Axel; Hubbard, Stevan R.; Blake, Robert A.; Fong, T. Annie T.; Strawn, Laurie M.; Sun, Li; Tang, Cho; Hawtin, Rachael; Tang, Flora; Shenoy, Narmada; Hirth, K. Peter; McMahon, Gerald; Cherrington, Julie M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4152-4160</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Vascular endothelial growth factor, fibroblast growth factor (FGF), and platelet-derived growth factor (PDGF) and their cognate receptor tyrosine kinases are strongly implicated in angiogenesis assocd. with solid tumors.  Using rational drug design coupled with traditional screening technologies, we have discovered SU6668, a novel inhibitor of these receptors.  Biochem. kinetic studies using isolated Flk-1, FGF receptor 1, and PDGF receptor β kinases revealed that SU6668 has competitive inhibitory properties with respect to ATP.  Cocrystallog. studies of SU6668 in the catalytic domain of FGF receptor 1 substantiated the adenine mimetic properties of its oxindole core.  Mol. modeling of SU6668 in the ATP binding pockets of the Flk-1/KDR and PDGF receptor kinases provided insight to explain the relative potency and selectivity of SU6668 for these receptors.  In cellular systems, SU6668 inhibited receptor tyrosine phosphorylation and mitogenesis after stimulation of cells by appropriate ligands.  Oral or i.p. administration of SU6668 in athymic mice resulted in significant growth inhibition of a diverse panel of human tumor xenografts of glioma, melanoma, lung, colon, ovarian, and epidermoid origin.  Furthermore, intravital multifluorescence videomicroscopy of C6 glioma xenografts in the dorsal skin-fold chamber model revealed that SU6668 treatment suppressed tumor angiogenesis.  Finally, SU6668 treatment induced striking regression of large established human tumor xenografts.  Investigations of SU6668 activity in cancer patients are ongoing in Phase I clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTk0pWiW_VTLVg90H21EOLACvtfcHk0lgL3SFvk2thzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlvFOkt7s%253D&md5=328030bf6f79955394237b08877c07f6</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLaird%26aufirst%3DA.%2BD.%26aulast%3DVajkoczy%26aufirst%3DP.%26aulast%3DShawver%26aufirst%3DL.%2BK.%26aulast%3DThurnher%26aufirst%3DA.%26aulast%3DLiang%26aufirst%3DC.%26aulast%3DMohammadi%26aufirst%3DM.%26aulast%3DSchlessinger%26aufirst%3DJ.%26aulast%3DUllrich%26aufirst%3DA.%26aulast%3DHubbard%26aufirst%3DS.%2BR.%26aulast%3DBlake%26aufirst%3DR.%2BA.%26aulast%3DFong%26aufirst%3DT.%2BA.%2BT.%26aulast%3DStrawn%26aufirst%3DL.%2BM.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DTang%26aufirst%3DC.%26aulast%3DHawtin%26aufirst%3DR.%26aulast%3DTang%26aufirst%3DF.%26aulast%3DShenoy%26aufirst%3DN.%26aulast%3DHirth%26aufirst%3DK.%2BP.%26aulast%3DMcMahon%26aufirst%3DG.%26aulast%3DCherrington%26aufirst%3DJ.%2BM.%26atitle%3DSU6668%2520Is%2520a%2520Potent%2520Antiangiogenic%2520and%2520Antitumor%2520Agent%2520That%2520Induces%2520Regression%2520of%2520Established%2520Tumors%26jtitle%3DCancer%2520Res.%26date%3D2000%26volume%3D60%26spage%3D4152%26epage%3D4160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Fong, T. A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shawver, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">App, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreck, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Risau, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ullrich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirth, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMahon, G.</span><span> </span><span class="NLM_article-title">SU5416 Is a Potent and Selective Inhibitor of the Vascular Endothelial Growth Factor Receptor (Flk-1/KDR) That Inhibits Tyrosine Kinase Catalysis, Tumor Vascularization, and Growth of Multiple Tumor Types</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">106</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm701397k&amp;key=9892193" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm701397k&amp;key=1%3ACAS%3A528%3ADyaK1MXmsFOgug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1999&pages=99-106&author=T.+A.+T.+Fongauthor=L.+K.+Shawverauthor=L.+Sunauthor=C.+Tangauthor=H.+Appauthor=T.+J.+Powellauthor=Y.+H.+Kimauthor=R.+Schreckauthor=X.+Wangauthor=W.+Risauauthor=A.+Ullrichauthor=K.+P.+Hirthauthor=G.+McMahon&title=SU5416+Is+a+Potent+and+Selective+Inhibitor+of+the+Vascular+Endothelial+Growth+Factor+Receptor+%28Flk-1%2FKDR%29+That+Inhibits+Tyrosine+Kinase+Catalysis%2C+Tumor+Vascularization%2C+and+Growth+of+Multiple+Tumor+Types"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types</span></div><div class="casAuthors">Fong, T. Annie T.; Shawver, Laura K.; Sun, Li; Tang, Cho; App, Harald; Powell, T. Jeff; Kim, Young H.; Schreck, Randall; Wang, Xueyan; Risau, Werner; Ullrich, Axel; Hirth, K. Peter; McMahon, Gerald</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">99-106</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">AACR Subscription Office</span>)
        </div><div class="casAbstract">SU5416, a novel synthetic compd., is a potent and selective inhibitor of the Flk-1/KDR receptor tyrosine kinase that is presently under evaluation in Phase I clin. studies for the treatment of human cancers.  SU5416 was shown to inhibit vascular endothelial growth factor-dependent mitogenesis of human endothelial cells without inhibiting the growth of a variety of tumor cells in vitro.  In contrast, systemic administration of SU5416 at nontoxic doses in mice resulted in inhibition of s.c. tumor growth of cells derived from various tissue origins.  The antitumor effect of SU5416 was accompanied by the appearance of pale white tumors that were resected from drug-treated animals, supporting the antiangiogenic property of this agent.  These findings support that pharmacol. inhibition of the enzymic activity of the vascular endothelial growth factor receptor represents a novel strategy for limiting the growth of a wide variety of tumor types.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiq1KqJ-CsCrVg90H21EOLACvtfcHk0ljxorM-FmqmGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmsFOgug%253D%253D&md5=92a2610ecfcdc996a6a79b0b559c4852</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFong%26aufirst%3DT.%2BA.%2BT.%26aulast%3DShawver%26aufirst%3DL.%2BK.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DTang%26aufirst%3DC.%26aulast%3DApp%26aufirst%3DH.%26aulast%3DPowell%26aufirst%3DT.%2BJ.%26aulast%3DKim%26aufirst%3DY.%2BH.%26aulast%3DSchreck%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DRisau%26aufirst%3DW.%26aulast%3DUllrich%26aufirst%3DA.%26aulast%3DHirth%26aufirst%3DK.%2BP.%26aulast%3DMcMahon%26aufirst%3DG.%26atitle%3DSU5416%2520Is%2520a%2520Potent%2520and%2520Selective%2520Inhibitor%2520of%2520the%2520Vascular%2520Endothelial%2520Growth%2520Factor%2520Receptor%2520%2528Flk-1%252FKDR%2529%2520That%2520Inhibits%2520Tyrosine%2520Kinase%2520Catalysis%252C%2520Tumor%2520Vascularization%252C%2520and%2520Growth%2520of%2520Multiple%2520Tumor%2520Types%26jtitle%3DCancer%2520Res.%26date%3D1999%26volume%3D59%26spage%3D99%26epage%3D106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Sun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreck, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMahon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, C.</span><span> </span><span class="NLM_article-title">Identification of Substituted 3-[(4,5,6,7-Tetrahydro-1<i>H</i>-indol-2-yl)methylene]-1,3-dihydroindol-2-ones as Growth Factor Receptor Inhibitors for VEGF-R2 (Flk-1/KDR), FGF-R1, and PDGF-Rβ Tyrosine Kinases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">2655</span><span class="NLM_x">–</span> <span class="NLM_lpage">2663</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9906116" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=2655-2663&author=L.+Sunauthor=N.+Tranauthor=C.+Liangauthor=S.+Hubbardauthor=F.+Tangauthor=K.+Lipsonauthor=R.+Schreckauthor=Y.+Zhouauthor=G.+McMahonauthor=C.+Tang&title=Identification+of+Substituted+3-%5B%284%2C5%2C6%2C7-Tetrahydro-1H-indol-2-yl%29methylene%5D-1%2C3-dihydroindol-2-ones+as+Growth+Factor+Receptor+Inhibitors+for+VEGF-R2+%28Flk-1%2FKDR%29%2C+FGF-R1%2C+and+PDGF-R%CE%B2+Tyrosine+Kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm9906116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9906116%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DL.%26aulast%3DTran%26aufirst%3DN.%26aulast%3DLiang%26aufirst%3DC.%26aulast%3DHubbard%26aufirst%3DS.%26aulast%3DTang%26aufirst%3DF.%26aulast%3DLipson%26aufirst%3DK.%26aulast%3DSchreck%26aufirst%3DR.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DMcMahon%26aufirst%3DG.%26aulast%3DTang%26aufirst%3DC.%26atitle%3DIdentification%2520of%2520Substituted%25203-%255B%25284%252C5%252C6%252C7-Tetrahydro-1H-indol-2-yl%2529methylene%255D-1%252C3-dihydroindol-2-ones%2520as%2520Growth%2520Factor%2520Receptor%2520Inhibitors%2520for%2520VEGF-R2%2520%2528Flk-1%252FKDR%2529%252C%2520FGF-R1%252C%2520and%2520PDGF-R%25CE%25B2%2520Tyrosine%2520Kinases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D2655%26epage%3D2663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Klebl, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, G.</span><span> </span><span class="NLM_article-title">Second-generation kinase inhibitors</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">975</span><span class="NLM_x">–</span> <span class="NLM_lpage">993</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm701397k&amp;key=10.1517%2F14728222.9.5.975" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm701397k&amp;key=16185153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm701397k&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVartbfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2005&pages=975-993&author=B.+M.+Kleblauthor=G.+M%C3%BCller&title=Second-generation+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Second-generation kinase inhibitors</span></div><div class="casAuthors">Klebl, Bert M.; Mueller, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">975-993</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  An increasing no. of kinase inhibitor candidates are entering clin. development, representing an important change in the pharmaceutical industry; notably, the development of small-mol. kinase inhibitors for signal transduction therapies.  Today, kinase inhibitors garner substantial attention in cancer research.  Over the last few years, three distinct small-mol. kinase inhibitors reached the market for treatment of chronic myeloid leukemia, gastrointestinal stromal tumors, and non-small cell lung cancers.  These three drugs, imatinib, gefitinib and erlotinib, act on a distinct subset of dysregulated, and often cancer-relevant kinases.  Imatinib, gefitinib and erlotinib are considered the front-runners of targeted kinase inhibitor drugs.  The entire research field gains tremendous insights through the ongoing research and clin. trials with these three drugs and with fast following first-generation kinase inhibitors, many of which are in different phases of clin. development.  In addn., novel chemogenomic and chemoproteomic technologies are emanating from the current kinase research area, focussing efforts on the generation of spectrum-selective inhibitors for anticancer therapies as opposed to the monospecific inhibitors for the remaining therapeutic areas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJli31wX5cJbVg90H21EOLACvtfcHk0ljxorM-FmqmGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVartbfN&md5=81c46202984d0fe908b7315008839b03</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1517%2F14728222.9.5.975&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.9.5.975%26sid%3Dliteratum%253Aachs%26aulast%3DKlebl%26aufirst%3DB.%2BM.%26aulast%3DM%25C3%25BCller%26aufirst%3DG.%26atitle%3DSecond-generation%2520kinase%2520inhibitors%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2005%26volume%3D9%26spage%3D975%26epage%3D993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Hicklin, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, L. M.</span><span> </span><span class="NLM_article-title">Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1011</span><span class="NLM_x">–</span> <span class="NLM_lpage">1027</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm701397k&amp;key=10.1200%2FJCO.2005.06.081" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm701397k&amp;key=15585754" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm701397k&amp;key=1%3ACAS%3A528%3ADC%252BD2MXit1Gnsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=1011-1027&author=D.+J.+Hicklinauthor=L.+M.+Ellis&title=Role+of+the+Vascular+Endothelial+Growth+Factor+Pathway+in+Tumor+Growth+and+Angiogenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis</span></div><div class="casAuthors">Hicklin, Daniel J.; Ellis, Lee M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1011-1027</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">A review.  New blood vessel formation (angiogenesis) is a fundamental event in the process of tumor growth and metastatic dissemination.  Hence, the mol. basis of tumor angiogenesis has been of keen interest in the field of cancer research.  The vascular endothelial growth factor (VEGF) pathway is well established as one of the key regulators of this process.  The VEGF/VEGF-receptor axis is composed of multiple ligands and receptors with overlapping and distinct ligand-receptor binding specificities, cell-type expression, and function.  Activation of the VEGF-receptor pathway triggers a network of signaling processes that promote endothelial cell growth, migration, and survival from pre-existing vasculature.  In addn., VEGF mediates vessel permeability, and has been assocd. with malignant effusions.  More recently, an important role for VEGF has emerged in mobilization of endothelial progenitor cells from the bone marrow to distant sites of neovascularization.  The well-established role of VEGF in promoting tumor angiogenesis and the pathogenesis of human cancers has led to the rational design and development of agents that selectively target this pathway.  Studies with various anti-VEGF/VEGF-receptor therapies have shown that these agents can potently inhibit angiogenesis and tumor growth in preclin. models.  Recently, an anti-VEGF antibody (bevacizumab), when used in combination with chemotherapy, was shown to significantly improve survival and response rates in patients with metastatic colorectal cancer and thus, validate VEGF pathway inhibitors as an important new treatment modality in cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlR9xM1kwuKrVg90H21EOLACvtfcHk0ljxorM-FmqmGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXit1Gnsro%253D&md5=599f10c7b6d935c7bc2fa7ce6f6949b3</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1200%2FJCO.2005.06.081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2005.06.081%26sid%3Dliteratum%253Aachs%26aulast%3DHicklin%26aufirst%3DD.%2BJ.%26aulast%3DEllis%26aufirst%3DL.%2BM.%26atitle%3DRole%2520of%2520the%2520Vascular%2520Endothelial%2520Growth%2520Factor%2520Pathway%2520in%2520Tumor%2520Growth%2520and%2520Angiogenesis%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2005%26volume%3D23%26spage%3D1011%26epage%3D1027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Casanovas, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hicklin, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergers, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanahan, D.</span><span> </span><span class="NLM_article-title">Drug Resistance by Evasion of Antiangiogenic Targeting of VEGF Signaling in Late-Stage Pancreatic Islet Tumors</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">299</span><span class="NLM_x">–</span> <span class="NLM_lpage">309</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2005&pages=299-309&author=O.+Casanovasauthor=D.+J.+Hicklinauthor=G.+Bergersauthor=D.+Hanahan&title=Drug+Resistance+by+Evasion+of+Antiangiogenic+Targeting+of+VEGF+Signaling+in+Late-Stage+Pancreatic+Islet+Tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCasanovas%26aufirst%3DO.%26aulast%3DHicklin%26aufirst%3DD.%2BJ.%26aulast%3DBergers%26aufirst%3DG.%26aulast%3DHanahan%26aufirst%3DD.%26atitle%3DDrug%2520Resistance%2520by%2520Evasion%2520of%2520Antiangiogenic%2520Targeting%2520of%2520VEGF%2520Signaling%2520in%2520Late-Stage%2520Pancreatic%2520Islet%2520Tumors%26jtitle%3DCancer%2520Cell%26date%3D2005%26volume%3D8%26spage%3D299%26epage%3D309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Sun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirazian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuda, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, J.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nematalla, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sistla, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luu, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, C.</span><span> </span><span class="NLM_article-title">Discovery of 5-[5-Fluoro-2-oxo-1,2-dihydroindol-(3<i>Z</i>)-ylidenemethyl]-2,4-dimethyl-1<i>H</i>-pyrrole-3-carboxylic Acid (2-Dimethylaminoethyl)amide, a Novel Tyrosine Kinase Inhibitor Targeting Vascular Endothelial and Platelet-Derived Growth Factor Receptor Tyrosine Kinase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1116</span><span class="NLM_x">–</span> <span class="NLM_lpage">1119</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0204183" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=1116-1119&author=L.+Sunauthor=C.+Liangauthor=S.+Shirazianauthor=Y.+Zhouauthor=T.+Millerauthor=J.+Cuiauthor=J.+Y.+Fukudaauthor=J.-Y.+Chuauthor=A.+Nematallaauthor=X.+Wangauthor=H.+Chenauthor=A.+Sistlaauthor=T.+C.+Luuauthor=F.+Tangauthor=J.+Weiauthor=C.+Tang&title=Discovery+of+5-%5B5-Fluoro-2-oxo-1%2C2-dihydroindol-%283Z%29-ylidenemethyl%5D-2%2C4-dimethyl-1H-pyrrole-3-carboxylic+Acid+%282-Dimethylaminoethyl%29amide%2C+a+Novel+Tyrosine+Kinase+Inhibitor+Targeting+Vascular+Endothelial+and+Platelet-Derived+Growth+Factor+Receptor+Tyrosine+Kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm0204183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0204183%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DL.%26aulast%3DLiang%26aufirst%3DC.%26aulast%3DShirazian%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DMiller%26aufirst%3DT.%26aulast%3DCui%26aufirst%3DJ.%26aulast%3DFukuda%26aufirst%3DJ.%2BY.%26aulast%3DChu%26aufirst%3DJ.-Y.%26aulast%3DNematalla%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DSistla%26aufirst%3DA.%26aulast%3DLuu%26aufirst%3DT.%2BC.%26aulast%3DTang%26aufirst%3DF.%26aulast%3DWei%26aufirst%3DJ.%26aulast%3DTang%26aufirst%3DC.%26atitle%3DDiscovery%2520of%25205-%255B5-Fluoro-2-oxo-1%252C2-dihydroindol-%25283Z%2529-ylidenemethyl%255D-2%252C4-dimethyl-1H-pyrrole-3-carboxylic%2520Acid%2520%25282-Dimethylaminoethyl%2529amide%252C%2520a%2520Novel%2520Tyrosine%2520Kinase%2520Inhibitor%2520Targeting%2520Vascular%2520Endothelial%2520and%2520Platelet-Derived%2520Growth%2520Factor%2520Receptor%2520Tyrosine%2520Kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D1116%26epage%3D1119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Wilhelm, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkie, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNabola, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincent, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHugh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shujath, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gawlak, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eveleigh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adnane, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auclair, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gedrich, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voznesensky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riedl, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Post, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bollag, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trail, P. A.</span><span> </span><span class="NLM_article-title">BAY 43-9006 Exhibits Broad Spectrum Oral Antitumor Activity and Targets the RAF/MEK/ERK Pathway and Receptor Tyrosine Kinases Involved in Tumor Progression and Angiogenesis</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">7099</span><span class="NLM_x">–</span> <span class="NLM_lpage">7109</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=7099-7109&author=S.+M.+Wilhelmauthor=C.+Carterauthor=L.+Tangauthor=D.+Wilkieauthor=A.+McNabolaauthor=H.+Rongauthor=C.+Chenauthor=X.+Zhangauthor=P.+Vincentauthor=M.+McHughauthor=Y.+Caoauthor=J.+Shujathauthor=S.+Gawlakauthor=D.+Eveleighauthor=B.+Rowleyauthor=L.+Liuauthor=L.+Adnaneauthor=M.+Lynchauthor=D.+Auclairauthor=I.+Taylorauthor=R.+Gedrichauthor=A.+Voznesenskyauthor=B.+Riedlauthor=L.+E.+Postauthor=G.+Bollagauthor=P.+A.+Trail&title=BAY+43-9006+Exhibits+Broad+Spectrum+Oral+Antitumor+Activity+and+Targets+the+RAF%2FMEK%2FERK+Pathway+and+Receptor+Tyrosine+Kinases+Involved+in+Tumor+Progression+and+Angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilhelm%26aufirst%3DS.%2BM.%26aulast%3DCarter%26aufirst%3DC.%26aulast%3DTang%26aufirst%3DL.%26aulast%3DWilkie%26aufirst%3DD.%26aulast%3DMcNabola%26aufirst%3DA.%26aulast%3DRong%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DVincent%26aufirst%3DP.%26aulast%3DMcHugh%26aufirst%3DM.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DShujath%26aufirst%3DJ.%26aulast%3DGawlak%26aufirst%3DS.%26aulast%3DEveleigh%26aufirst%3DD.%26aulast%3DRowley%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DAdnane%26aufirst%3DL.%26aulast%3DLynch%26aufirst%3DM.%26aulast%3DAuclair%26aufirst%3DD.%26aulast%3DTaylor%26aufirst%3DI.%26aulast%3DGedrich%26aufirst%3DR.%26aulast%3DVoznesensky%26aufirst%3DA.%26aulast%3DRiedl%26aufirst%3DB.%26aulast%3DPost%26aufirst%3DL.%2BE.%26aulast%3DBollag%26aufirst%3DG.%26aulast%3DTrail%26aufirst%3DP.%2BA.%26atitle%3DBAY%252043-9006%2520Exhibits%2520Broad%2520Spectrum%2520Oral%2520Antitumor%2520Activity%2520and%2520Targets%2520the%2520RAF%252FMEK%252FERK%2520Pathway%2520and%2520Receptor%2520Tyrosine%2520Kinases%2520Involved%2520in%2520Tumor%2520Progression%2520and%2520Angiogenesis%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D7099%26epage%3D7109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Dai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frey, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtin, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arries, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barlozzari, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauch, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouska, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bousquet, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunha, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glaser, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcotte, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moskey, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pease, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoll, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tapang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wishart, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidsen, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michaelides, M. R.</span><span> </span><span class="NLM_article-title">Thienopyrimidine Ureas as Novel and Potent Multitargeted Receptor Tyrosine Kinase Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6066</span><span class="NLM_x">–</span> <span class="NLM_lpage">6083</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050458h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm701397k&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpt1Wht7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=6066-6083&author=Y.+Daiauthor=Y.+Guoauthor=R.+R.+Freyauthor=Z.+Jiauthor=M.+L.+Curtinauthor=A.+A.+Ahmedauthor=D.+H.+Albertauthor=L.+Arnoldauthor=S.+S.+Arriesauthor=T.+Barlozzariauthor=J.+L.+Bauchauthor=J.+J.+Bouskaauthor=P.+F.+Bousquetauthor=G.+A.+Cunhaauthor=K.+B.+Glaserauthor=J.+Guoauthor=J.+Liauthor=P.+A.+Marcotteauthor=K.+C.+Marshauthor=M.+D.+Moskeyauthor=L.+J.+Peaseauthor=K.+D.+Stewartauthor=V.+S.+Stollauthor=P.+Tapangauthor=N.+Wishartauthor=S.+K.+Davidsenauthor=M.+R.+Michaelides&title=Thienopyrimidine+Ureas+as+Novel+and+Potent+Multitargeted+Receptor+Tyrosine+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Thienopyrimidine Ureas as Novel and Potent Multitargeted Receptor Tyrosine Kinase Inhibitors</span></div><div class="casAuthors">Dai, Yujia; Guo, Yan; Frey, Robin R.; Ji, Zhiqin; Curtin, Michael L.; Ahmed, Asma A.; Albert, Daniel H.; Arnold, Lee; Arries, Shannon S.; Barlozzari, Teresa; Bauch, Joy L.; Bouska, Jennifer J.; Bousquet, Peter F.; Cunha, George A.; Glaser, Keith B.; Guo, Jun; Li, Junling; Marcotte, Patrick A.; Marsh, Kennan C.; Moskey, Maria D.; Pease, Lori J.; Stewart, Kent D.; Stoll, Vincent S.; Tapang, Paul; Wishart, Neil; Davidsen, Steven K.; Michaelides, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6066-6083</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of novel thienopyrimidine-based receptor tyrosine kinase inhibitors has been discovered.  Investigation of structure-activity relationships at the 5- and 6-positions of the thienopyrimidine nucleus led to a series of N,N'-diaryl ureas that potently inhibit all of the vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF) receptor tyrosine kinases.  A kinase insert domain-contg. receptor (KDR) homol. model suggests that these compds. bind to the "inactive conformation" of the enzyme with the urea portion extending into the back hydrophobic pocket adjacent to the ATP (ATP) binding site.  A no. of compds. have been identified as displaying excellent in vivo potency.  In particular, compds. 28 and 76 possess favorable pharmacokinetic (PK) profiles and demonstrate potent antitumor efficacy against the HT1080 human fibrosarcoma xenograft tumor growth model (tumor growth inhibition (TGI) = 75% at 25 mg/kg·day, per os (po)).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYifOiC_HYHrVg90H21EOLACvtfcHk0lihGDfJjDzlPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpt1Wht7Y%253D&md5=ef245a26e40d18cfaf7f98260827f274</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm050458h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050458h%26sid%3Dliteratum%253Aachs%26aulast%3DDai%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DY.%26aulast%3DFrey%26aufirst%3DR.%2BR.%26aulast%3DJi%26aufirst%3DZ.%26aulast%3DCurtin%26aufirst%3DM.%2BL.%26aulast%3DAhmed%26aufirst%3DA.%2BA.%26aulast%3DAlbert%26aufirst%3DD.%2BH.%26aulast%3DArnold%26aufirst%3DL.%26aulast%3DArries%26aufirst%3DS.%2BS.%26aulast%3DBarlozzari%26aufirst%3DT.%26aulast%3DBauch%26aufirst%3DJ.%2BL.%26aulast%3DBouska%26aufirst%3DJ.%2BJ.%26aulast%3DBousquet%26aufirst%3DP.%2BF.%26aulast%3DCunha%26aufirst%3DG.%2BA.%26aulast%3DGlaser%26aufirst%3DK.%2BB.%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DMarcotte%26aufirst%3DP.%2BA.%26aulast%3DMarsh%26aufirst%3DK.%2BC.%26aulast%3DMoskey%26aufirst%3DM.%2BD.%26aulast%3DPease%26aufirst%3DL.%2BJ.%26aulast%3DStewart%26aufirst%3DK.%2BD.%26aulast%3DStoll%26aufirst%3DV.%2BS.%26aulast%3DTapang%26aufirst%3DP.%26aulast%3DWishart%26aufirst%3DN.%26aulast%3DDavidsen%26aufirst%3DS.%2BK.%26aulast%3DMichaelides%26aufirst%3DM.%2BR.%26atitle%3DThienopyrimidine%2520Ureas%2520as%2520Novel%2520and%2520Potent%2520Multitargeted%2520Receptor%2520Tyrosine%2520Kinase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D6066%26epage%3D6083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Curtin, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frey, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heyman, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarris, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinman, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holms, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bousquet, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunha, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moskey, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pease, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glaser, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidsen, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michaelides, M. R.</span><span> </span><span class="NLM_article-title">Isoindolinone Ureas: A Novel Class of KDR Kinase Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">4505</span><span class="NLM_x">–</span> <span class="NLM_lpage">4509</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=4505-4509&author=M.+L.+Curtinauthor=R.+R.+Freyauthor=H.+R.+Heymanauthor=K.+A.+Sarrisauthor=D.+H.+Steinmanauthor=J.+H.+Holmsauthor=P.+F.+Bousquetauthor=G.+A.+Cunhaauthor=M.+D.+Moskeyauthor=A.+A.+Ahmedauthor=L.+J.+Peaseauthor=K.+B.+Glaserauthor=K.+D.+Stewartauthor=S.+K.+Davidsenauthor=M.+R.+Michaelides&title=Isoindolinone+Ureas%3A+A+Novel+Class+of+KDR+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCurtin%26aufirst%3DM.%2BL.%26aulast%3DFrey%26aufirst%3DR.%2BR.%26aulast%3DHeyman%26aufirst%3DH.%2BR.%26aulast%3DSarris%26aufirst%3DK.%2BA.%26aulast%3DSteinman%26aufirst%3DD.%2BH.%26aulast%3DHolms%26aufirst%3DJ.%2BH.%26aulast%3DBousquet%26aufirst%3DP.%2BF.%26aulast%3DCunha%26aufirst%3DG.%2BA.%26aulast%3DMoskey%26aufirst%3DM.%2BD.%26aulast%3DAhmed%26aufirst%3DA.%2BA.%26aulast%3DPease%26aufirst%3DL.%2BJ.%26aulast%3DGlaser%26aufirst%3DK.%2BB.%26aulast%3DStewart%26aufirst%3DK.%2BD.%26aulast%3DDavidsen%26aufirst%3DS.%2BK.%26aulast%3DMichaelides%26aufirst%3DM.%2BR.%26atitle%3DIsoindolinone%2520Ureas%253A%2520A%2520Novel%2520Class%2520of%2520KDR%2520Kinase%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D4505%26epage%3D4509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Albert, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tapang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magoc, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pease, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reuter, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, R.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bousquet, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghoreishi-Haack, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bukofzer, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stavropoulos, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartandi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niquette, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soni, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCall, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouska, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donawho, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcotte, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glaser, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michaelides, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidsen, S. K.</span><span> </span><span class="NLM_article-title">Preclinical activity of ABT-869, a multitargeted receptor tyrosine kinase inhibitor</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">995</span><span class="NLM_x">–</span> <span class="NLM_lpage">1006</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=16&amp;doi=10.1021%2Fjm701397k&amp;key=10.1158%2F1535-7163.MCT-05-0410" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=8&amp;doi=10.1021%2Fjm701397k&amp;key=16648571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=32&amp;doi=10.1021%2Fjm701397k&amp;key=1%3ACAS%3A528%3ADC%252BD28XjvFCkt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=995-1006&author=D.+H.+Albertauthor=P.+Tapangauthor=T.+J.+Magocauthor=L.+J.+Peaseauthor=D.+R.+Reuterauthor=R.-Q.+Weiauthor=J.+Liauthor=J.+Guoauthor=P.+F.+Bousquetauthor=N.+S.+Ghoreishi-Haackauthor=B.+Wangauthor=G.+T.+Bukofzerauthor=Y.-C.+Wangauthor=J.+A.+Stavropoulosauthor=K.+Hartandiauthor=A.+L.+Niquetteauthor=N.+Soniauthor=E.+F.+Johnsonauthor=J.+O.+McCallauthor=J.+J.+Bouskaauthor=Y.+Luoauthor=C.+K.+Donawhoauthor=Y.+Daiauthor=P.+A.+Marcotteauthor=K.+B.+Glaserauthor=M.+R.+Michaelidesauthor=S.+K.+Davidsen&title=Preclinical+activity+of+ABT-869%2C+a+multitargeted+receptor+tyrosine+kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24aR"><div class="casContent"><span class="casTitleNuber">24a</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical activity of ABT-869, a multitargeted receptor tyrosine kinase inhibitor</span></div><div class="casAuthors">Albert, Daniel H.; Tapang, Paul; Magoc, Terrance J.; Pease, Lori J.; Reuter, David R.; Wei, Ru-Qi; Li, Junling; Guo, Jun; Bousquet, Peter F.; Ghoreishi-Haack, Nayereh S.; Wang, Baole; Bukofzer, Gail T.; Wang, Yi-Chun; Stavropoulos, Jason A.; Hartandi, Kresna; Niquette, Amanda L.; Soni, Nirupama; Johnson, Eric F.; McCall, J. Owen; Bouska, Jennifer J.; Luo, Yanping; Donawho, Cherrie K.; Dai, Yujia; Marcotte, Patrick A.; Glaser, Keith B.; Michaelides, Michael R.; Davidsen, Steven K.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">995-1006</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">ABT-869 is a structurally novel, receptor tyrosine kinase (RTK) inhibitor that is a potent inhibitor of members of the vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF) receptor families (e.g., KDR IC50 = 4 nmol/L) but has much less activity (IC50s > 1 μmol/L) against unrelated RTKs, sol. tyrosine kinases, or serine/threonine kinases.  The inhibition profile of ABT-869 is evident in cellular assays of RTK phosphorylation (IC50 = 2, 4, and 7 nmol/L for PDGFR-β, KDR, and CSF-1R, resp.) and VEGF-stimulated proliferation (IC50 = 0.2 nmol/L for human endothelial cells).  ABT-869 is not a general antiproliferative agent because, in most cancer cells, >1,000-fold higher concns. of ABT-869 are required for inhibition of proliferation.  However, ABT-869 exhibits potent antiproliferative and apoptotic effects on cancer cells whose proliferation is dependent on mutant kinases, such as FLT3.  In vivo ABT-869 is effective orally in the mechanism-based murine models of VEGF-induced uterine edema (ED50 = 0.5 mg/kg) and corneal angiogenesis (>50% inhibition, 15 mg/kg).  In tumor growth studies, ABT-869 exhibits efficacy in human fibrosarcoma and breast, colon, and small cell lung carcinoma xenograft models (ED50 = 1.5-5 mg/kg, twice daily) and is also effective (>50% inhibition) in orthotopic breast and glioma models.  Redn. in tumor size and tumor regression was obsd. in epidermoid carcinoma and leukemia xenograft models, resp.  In combination, ABT-869 produced at least additive effects when given with cytotoxic therapies.  Based on pharmacokinetic anal. from tumor growth studies, efficacy correlated more strongly with time over a threshold value (cellular KDR IC50 cor. for blood plasma protein binding = 0.08 μg/mL, ≥7 h) than with plasma area under the curve or Cmax.  These results support clin. assessment of ABT-869 as a therapeutic agent for cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkn2KBvMa4wrVg90H21EOLACvtfcHk0lgPaVWWDkprbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjvFCkt7g%253D&md5=a5a60b591b4da7a3c589f1618d9cffb9</span></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-05-0410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-05-0410%26sid%3Dliteratum%253Aachs%26aulast%3DAlbert%26aufirst%3DD.%2BH.%26aulast%3DTapang%26aufirst%3DP.%26aulast%3DMagoc%26aufirst%3DT.%2BJ.%26aulast%3DPease%26aufirst%3DL.%2BJ.%26aulast%3DReuter%26aufirst%3DD.%2BR.%26aulast%3DWei%26aufirst%3DR.-Q.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DBousquet%26aufirst%3DP.%2BF.%26aulast%3DGhoreishi-Haack%26aufirst%3DN.%2BS.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DBukofzer%26aufirst%3DG.%2BT.%26aulast%3DWang%26aufirst%3DY.-C.%26aulast%3DStavropoulos%26aufirst%3DJ.%2BA.%26aulast%3DHartandi%26aufirst%3DK.%26aulast%3DNiquette%26aufirst%3DA.%2BL.%26aulast%3DSoni%26aufirst%3DN.%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26aulast%3DMcCall%26aufirst%3DJ.%2BO.%26aulast%3DBouska%26aufirst%3DJ.%2BJ.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DDonawho%26aufirst%3DC.%2BK.%26aulast%3DDai%26aufirst%3DY.%26aulast%3DMarcotte%26aufirst%3DP.%2BA.%26aulast%3DGlaser%26aufirst%3DK.%2BB.%26aulast%3DMichaelides%26aufirst%3DM.%2BR.%26aulast%3DDavidsen%26aufirst%3DS.%2BK.%26atitle%3DPreclinical%2520activity%2520of%2520ABT-869%252C%2520a%2520multitargeted%2520receptor%2520tyrosine%2520kinase%2520inhibitor%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2006%26volume%3D5%26spage%3D995%26epage%3D1006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit24b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Dai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartandi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauch, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouska, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bousquet, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunha, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glaser, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcotte, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moskey, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osterling, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pease, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soni, N. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoll, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tapang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reuter, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidsen, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michaelides, M. R.</span><span> </span><span class="NLM_article-title">Discovery of <i>N</i>-(4-(3-Amino-1<i>H</i>-indazol-4-yl)phenyl)-<i>N</i>′-(2-fluoro-5-methylphenyl)urea (ABT-869), a 3-Aminoindazole-Based Orally Active Multitargeted Receptor Tyrosine Kinase Inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1584</span><span class="NLM_x">–</span> <span class="NLM_lpage">1597</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm061280h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=1584-1597&author=Y.+Daiauthor=K.+Hartandiauthor=Z.+Jiauthor=A.+A.+Ahmedauthor=D.+H.+Albertauthor=J.+L.+Bauchauthor=J.+J.+Bouskaauthor=P.+F.+Bousquetauthor=G.+A.+Cunhaauthor=K.+B.+Glaserauthor=C.+M.+Harrisauthor=D.+Hickmanauthor=J.+Guoauthor=J.+Liauthor=P.+A.+Marcotteauthor=K.+C.+Marshauthor=M.+D.+Moskeyauthor=R.+L.+Martinauthor=A.+M.+Olsonauthor=D.+J.+Osterlingauthor=L.+J.+Peaseauthor=N.+B.+Soniauthor=K.+D.+Stewartauthor=V.+S.+Stollauthor=P.+Tapangauthor=D.+R.+Reuterauthor=S.+K.+Davidsenauthor=M.+R.+Michaelides&title=Discovery+of+N-%284-%283-Amino-1H-indazol-4-yl%29phenyl%29-N%E2%80%B2-%282-fluoro-5-methylphenyl%29urea+%28ABT-869%29%2C+a+3-Aminoindazole-Based+Orally+Active+Multitargeted+Receptor+Tyrosine+Kinase+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=10.1021%2Fjm061280h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061280h%26sid%3Dliteratum%253Aachs%26aulast%3DDai%26aufirst%3DY.%26aulast%3DHartandi%26aufirst%3DK.%26aulast%3DJi%26aufirst%3DZ.%26aulast%3DAhmed%26aufirst%3DA.%2BA.%26aulast%3DAlbert%26aufirst%3DD.%2BH.%26aulast%3DBauch%26aufirst%3DJ.%2BL.%26aulast%3DBouska%26aufirst%3DJ.%2BJ.%26aulast%3DBousquet%26aufirst%3DP.%2BF.%26aulast%3DCunha%26aufirst%3DG.%2BA.%26aulast%3DGlaser%26aufirst%3DK.%2BB.%26aulast%3DHarris%26aufirst%3DC.%2BM.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DMarcotte%26aufirst%3DP.%2BA.%26aulast%3DMarsh%26aufirst%3DK.%2BC.%26aulast%3DMoskey%26aufirst%3DM.%2BD.%26aulast%3DMartin%26aufirst%3DR.%2BL.%26aulast%3DOlson%26aufirst%3DA.%2BM.%26aulast%3DOsterling%26aufirst%3DD.%2BJ.%26aulast%3DPease%26aufirst%3DL.%2BJ.%26aulast%3DSoni%26aufirst%3DN.%2BB.%26aulast%3DStewart%26aufirst%3DK.%2BD.%26aulast%3DStoll%26aufirst%3DV.%2BS.%26aulast%3DTapang%26aufirst%3DP.%26aulast%3DReuter%26aufirst%3DD.%2BR.%26aulast%3DDavidsen%26aufirst%3DS.%2BK.%26aulast%3DMichaelides%26aufirst%3DM.%2BR.%26atitle%3DDiscovery%2520of%2520N-%25284-%25283-Amino-1H-indazol-4-yl%2529phenyl%2529-N%25E2%2580%25B2-%25282-fluoro-5-methylphenyl%2529urea%2520%2528ABT-869%2529%252C%2520a%25203-Aminoindazole-Based%2520Orally%2520Active%2520Multitargeted%2520Receptor%2520Tyrosine%2520Kinase%2520Inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D1584%26epage%3D1597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="note"><p class="first last">The development of RTK inhibitors in the clinic has been extensively reviewed. For recent reviews, see the following:</p></div><div class="NLM_citation" id="cit25a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Arora, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scholar, E. M.</span><span> </span><span class="NLM_article-title">Role of Tyrosine Kinase Inhibitors in Cancer Therapy</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">315</span><span class="NLM_x">, </span> <span class="NLM_fpage">971</span><span class="NLM_x">–</span> <span class="NLM_lpage">979</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=16&amp;doi=10.1021%2Fjm701397k&amp;key=10.1124%2Fjpet.105.084145" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=8&amp;doi=10.1021%2Fjm701397k&amp;key=16002463" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=32&amp;doi=10.1021%2Fjm701397k&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlalur3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=315&publication_year=2005&pages=971-979&author=A.+Aroraauthor=E.+M.+Scholar&title=Role+of+Tyrosine+Kinase+Inhibitors+in+Cancer+Therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25aR"><div class="casContent"><span class="casTitleNuber">25a</span><div class="casTitle"><span class="NLM_cas:atitle">Role of tyrosine kinase inhibitors in cancer therapy</span></div><div class="casAuthors">Arora, Amit; Scholar, Eric M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">315</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">971-979</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  Cancer chemotherapy has been one of the major medical advances in the last few decades.  However, the drugs used for this therapy have a narrow therapeutic index, and often the responses produced are only just palliative as well as unpredictable.  In contrast, targeted therapy that has been introduced in recent years is directed against cancer-specific mols. and signaling pathways and thus has more limited nonspecific toxicities.  Tyrosine kinases are an esp. important target because they play an important role in the modulation of growth factor signaling.  This review focuses on small mol. inhibitors of tyrosine kinase.  They compete with the ATP binding site of the catalytic domain of several oncogenic tyrosine kinases.  They are orally active, small mols. that have a favorable safety profile and can be easily combined with other forms of chemotherapy or radiation therapy.  Several tyrosine kinase inhibitors (TKIs) have been found to have effective antitumor activity and have been approved or are in clin. trials.  The inhibitors discussed in this manuscript are imatinib mesylate (STI571; Gleevec), gefitinib (Iressa), erlotinib (OSI-1774; Tarceva), lapatinib (GW-572016), canertinib (CI-1033), semaxinib (SU5416), vatalanib (PTK787/ZK222584), sorafenib (BAY 43-9006), sutent (SU11248), and leflunomide (SU101).  TKIs are thus an important new class of targeted therapy that interfere with specific cell signaling pathways and thus allow target-specific therapy for selected malignancies.  The pharmacol. properties and anticancer activities of these inhibitors are discussed in this review.  Use of these targeted therapies is not without limitations such as the development of resistance and the lack of tumor response in the general population.  The availability of newer inhibitors and improved patient selection will help overcome these problems in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMwimbtjJbArVg90H21EOLACvtfcHk0lgWZXpTSsPPgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlalur3L&md5=c5671a8b1154ba8658ea0845666c7473</span></div><a href="/servlet/linkout?suffix=cit25a&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.084145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.084145%26sid%3Dliteratum%253Aachs%26aulast%3DArora%26aufirst%3DA.%26aulast%3DScholar%26aufirst%3DE.%2BM.%26atitle%3DRole%2520of%2520Tyrosine%2520Kinase%2520Inhibitors%2520in%2520Cancer%2520Therapy%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D315%26spage%3D971%26epage%3D979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit25b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Laird, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherrington, J. M.</span><span> </span><span class="NLM_article-title">Small Molecule Tyrosine Kinase Inhibitors: Clinical Development of Anticancer Agents</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">51</span><span class="NLM_x">–</span> <span class="NLM_lpage">64</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=16&amp;doi=10.1021%2Fjm701397k&amp;key=10.1517%2F13543784.12.1.51" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=8&amp;doi=10.1021%2Fjm701397k&amp;key=12517254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=32&amp;doi=10.1021%2Fjm701397k&amp;key=1%3ACAS%3A528%3ADC%252BD3sXovFKk" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2003&pages=51-64&author=A.+D.+Lairdauthor=J.+M.+Cherrington&title=Small+Molecule+Tyrosine+Kinase+Inhibitors%3A+Clinical+Development+of+Anticancer+Agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25bR"><div class="casContent"><span class="casTitleNuber">25b</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule tyrosine kinase inhibitors: clinical development of anticancer agents</span></div><div class="casAuthors">Laird, A. Douglas; Cherrington, Julie M.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">51-64</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Numerous small mol. synthetic tyrosine kinase inhibitors are in clin. development for the treatment of human cancers.  These fall into three broad categories: inhibitors of the epidermal growth factor receptor tyrosine kinase family (e.g., Iressa and Tarceva), inhibitors of the split kinase domain receptor tyrosine kinase subgroup (e.g., PTK787/ZK 222584 and SU11248) and inhibitors of tyrosine kinases from multiple subgroups (e.g., Gleevec).  In addn., agents targeting other tyrosine kinases implicated in cancer, such as Met, Tie-2 and Src, are in preclin. development.  As experience is gained in the clinic, it has become clear that unleashing the full therapeutic potential of tyrosine kinase inhibitors will require patient preselection, better assays to guide dose selection, knowledge of mechanism-based side effects and ways to predict and overcome drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpA62Xd2ANILrVg90H21EOLACvtfcHk0lgWZXpTSsPPgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXovFKk&md5=3c8b0b358d79e7eea44eca260d568ad4</span></div><a href="/servlet/linkout?suffix=cit25b&amp;dbid=16384&amp;doi=10.1517%2F13543784.12.1.51&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.12.1.51%26sid%3Dliteratum%253Aachs%26aulast%3DLaird%26aufirst%3DA.%2BD.%26aulast%3DCherrington%26aufirst%3DJ.%2BM.%26atitle%3DSmall%2520Molecule%2520Tyrosine%2520Kinase%2520Inhibitors%253A%2520Clinical%2520Development%2520of%2520Anticancer%2520Agents%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2003%26volume%3D12%26spage%3D51%26epage%3D64" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit25c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Manley, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bold, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Br̈uggen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fendrich, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mestan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stolz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyhack, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stark, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strauss, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, J.</span><span> </span><span class="NLM_article-title">Advances in the Structural Biology, Design and Clinical Development of VEGF-R Kinase Inhibitors for the Treatment of Angiogenesis</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1697</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1697&publication_year=2004&pages=17-27&author=P.+W.+Manleyauthor=G.+Boldauthor=J.+Br%CC%88uggenauthor=G.+Fendrichauthor=P.+Furetauthor=J.+Mestanauthor=C.+Schnellauthor=B.+Stolzauthor=T.+Meyerauthor=B.+Meyhackauthor=W.+Starkauthor=A.+Straussauthor=J.+Wood&title=Advances+in+the+Structural+Biology%2C+Design+and+Clinical+Development+of+VEGF-R+Kinase+Inhibitors+for+the+Treatment+of+Angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManley%26aufirst%3DP.%2BW.%26aulast%3DBold%26aufirst%3DG.%26aulast%3DBr%25CC%2588uggen%26aufirst%3DJ.%26aulast%3DFendrich%26aufirst%3DG.%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DMestan%26aufirst%3DJ.%26aulast%3DSchnell%26aufirst%3DC.%26aulast%3DStolz%26aufirst%3DB.%26aulast%3DMeyer%26aufirst%3DT.%26aulast%3DMeyhack%26aufirst%3DB.%26aulast%3DStark%26aufirst%3DW.%26aulast%3DStrauss%26aufirst%3DA.%26aulast%3DWood%26aufirst%3DJ.%26atitle%3DAdvances%2520in%2520the%2520Structural%2520Biology%252C%2520Design%2520and%2520Clinical%2520Development%2520of%2520VEGF-R%2520Kinase%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Angiogenesis%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2004%26volume%3D1697%26spage%3D17%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Traxler, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furet, P.</span><span> </span><span class="NLM_article-title">Strategies toward the Design of Novel and Selective Protein Tyrosine Kinase Inhibitors</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">195</span><span class="NLM_x">–</span> <span class="NLM_lpage">206</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm701397k&amp;key=10.1016%2FS0163-7258%2898%2900044-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm701397k&amp;key=10454197" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm701397k&amp;key=1%3ACAS%3A528%3ADyaK1MXjvFOht7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1999&pages=195-206&author=P.+Traxlerauthor=P.+Furet&title=Strategies+toward+the+Design+of+Novel+and+Selective+Protein+Tyrosine+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Strategies toward the design of novel and selective protein tyrosine kinase inhibitors</span></div><div class="casAuthors">Traxler, Peter; Furet, Pascal</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">195-206</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review with 37 refs.  Protein tyrosine kinases play a fundamental role in signal transduction pathways.  Deregulated tyrosine kinase activity has been obsd. in many proliferative diseases (e.g., cancer, psoriasis, restenosis, etc.).  Tyrosine kinases are, therefore, attractive targets for the design of new therapeutic agents against cancer.  We have built up a pharmacophore model of the ATP-binding site of the epidermal growth factor receptor (EGFR) kinase and used it for the rational design of kinase inhibitors.  Several examples of the successful use of this model are presented in this review.  Amongst these, 4-substituted-pyrrolo[2,3-d]pyrimidines, a new class of highly potent and selective inhibitors of the EGFR kinase, have been identified and further optimized.  The most active derivs. inhibited the EGFR tyrosine kinase with IC50 values between 1 and 5 nM.  In EGF-dependent cellular systems, tyrosine phosphorylation, as well as c-fos mRNA expression, was inhibited with similar IC50 values.  Further successful application of this pharmacophore model led to the identification and optimization of phenylamino-pyrazolo[4,3-d]pyrimidines and substituted isoflavones and quinolones, other classes of potent, selective, and ATP competitive EGFR kinase inhibitors with IC50 values in the low nanomolar range.  Structure-activity relationships of both classes are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzTOVAYLwK77Vg90H21EOLACvtfcHk0lgWZXpTSsPPgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjvFOht7Y%253D&md5=26e5ed297e37b0cb188a0676e5b27f5b</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2FS0163-7258%2898%2900044-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0163-7258%252898%252900044-8%26sid%3Dliteratum%253Aachs%26aulast%3DTraxler%26aufirst%3DP.%26aulast%3DFuret%26aufirst%3DP.%26atitle%3DStrategies%2520toward%2520the%2520Design%2520of%2520Novel%2520and%2520Selective%2520Protein%2520Tyrosine%2520Kinase%2520Inhibitors%26jtitle%3DPharmacol.%2520Ther.%26date%3D1999%26volume%3D82%26spage%3D195%26epage%3D206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><div class="note"><p class="first last">Bold, G.; Florsheimer, A.; Furet, P.; Imbach, P.; Masuya, K.; Schoepfer, R. Scientists at Novartis have independently discovered 7-amino-pyrazolo[1,5-<i>a</i>]pyrimidine ureas as kinase inhibitors: Organic compounds,</p></div> US2005/0222171 A1,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Bold%2C+G.%3B+Florsheimer%2C+A.%3B+Furet%2C+P.%3B+Imbach%2C+P.%3B+Masuya%2C+K.%3B+Schoepfer%2C+R.+Scientists+at+Novartis+have+independently+discovered+7-amino-pyrazolo%5B1%2C5-a%5Dpyrimidine+ureas+as+kinase+inhibitors%3A+Organic+compounds%2C+US2005%2F0222171+A1%2C+2005."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Alcade, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">deMendoza, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Marquina, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almera, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elguero, J.</span><span> </span><span class="NLM_article-title">Etude de la Réaction du β-Aminocrotonitrile et du α-Formyl Phénylacétonitrile avec l’Hydrazine: Synthèse d’Amino-7-pyrazolo[1,5-<i>a</i>]pyrimidines</span> <span class="citation_source-journal">J. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1974</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">423</span><span class="NLM_x">–</span> <span class="NLM_lpage">429</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1974&pages=423-429&author=E.+Alcadeauthor=J.+deMendozaauthor=J.+M.+Garcia-Marquinaauthor=C.+Almeraauthor=J.+Elguero&title=Etude+de+la+R%C3%A9action+du+%CE%B2-Aminocrotonitrile+et+du+%CE%B1-Formyl+Ph%C3%A9nylac%C3%A9tonitrile+avec+l%E2%80%99Hydrazine%3A+Synth%C3%A8se+d%E2%80%99Amino-7-pyrazolo%5B1%2C5-a%5Dpyrimidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAlcade%26aufirst%3DE.%26aulast%3DdeMendoza%26aufirst%3DJ.%26aulast%3DGarcia-Marquina%26aufirst%3DJ.%2BM.%26aulast%3DAlmera%26aufirst%3DC.%26aulast%3DElguero%26aufirst%3DJ.%26atitle%3DEtude%2520de%2520la%2520R%25C3%25A9action%2520du%2520%25CE%25B2-Aminocrotonitrile%2520et%2520du%2520%25CE%25B1-Formyl%2520Ph%25C3%25A9nylac%25C3%25A9tonitrile%2520avec%2520l%25E2%2580%2599Hydrazine%253A%2520Synth%25C3%25A8se%2520d%25E2%2580%2599Amino-7-pyrazolo%255B1%252C5-a%255Dpyrimidines%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1974%26volume%3D11%26spage%3D423%26epage%3D429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Miyaura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, A.</span><span> </span><span class="NLM_article-title">Palladium-Catalyzed Cross-Coupling Reactions of Organoboron Compounds</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">2457</span><span class="NLM_x">–</span> <span class="NLM_lpage">2483</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr00039a007" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm701397k&amp;key=1%3ACAS%3A528%3ADyaK2MXoslGiurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1995&pages=2457-2483&author=N.+Miyauraauthor=A.+Suzuki&title=Palladium-Catalyzed+Cross-Coupling+Reactions+of+Organoboron+Compounds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium-Catalyzed Cross-Coupling Reactions of Organoboron Compounds</span></div><div class="casAuthors">Miyaura, Norio; Suzuki, Akira</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2457-83</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with >250 refs. including title reactions and their mechanisms, prepn. of organoboron reagents, alkoxycarbonylation and dimerization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHwupBJT1UCbVg90H21EOLACvtfcHk0liK9Z2EtyD0pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXoslGiurg%253D&md5=d127b414a75161652876eebc3ed0c486</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fcr00039a007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr00039a007%26sid%3Dliteratum%253Aachs%26aulast%3DMiyaura%26aufirst%3DN.%26aulast%3DSuzuki%26aufirst%3DA.%26atitle%3DPalladium-Catalyzed%2520Cross-Coupling%2520Reactions%2520of%2520Organoboron%2520Compounds%26jtitle%3DChem.%2520Rev.%26date%3D1995%26volume%3D95%26spage%3D2457%26epage%3D2483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Fraley, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubino, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hungate, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tebben, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rutledge, R. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McFall, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huckle, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kendall, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coll, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, K. A.</span><span> </span><span class="NLM_article-title">Synthesis and Initial SAR Studies of 3,6-Disubstituted Pyrazolo[1,5-<i>a</i>]pyrimidines: A New Class of KDR Kinase Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">2767</span><span class="NLM_x">–</span> <span class="NLM_lpage">2770</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=2767-2770&author=M.+E.+Fraleyauthor=W.+F.+Hoffmanauthor=R.+S.+Rubinoauthor=R.+W.+Hungateauthor=A.+J.+Tebbenauthor=R.+Z.+Rutledgeauthor=R.+C.+McFallauthor=W.+R.+Huckleauthor=R.+L.+Kendallauthor=K.+E.+Collauthor=K.+A.+Thomas&title=Synthesis+and+Initial+SAR+Studies+of+3%2C6-Disubstituted+Pyrazolo%5B1%2C5-a%5Dpyrimidines%3A+A+New+Class+of+KDR+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFraley%26aufirst%3DM.%2BE.%26aulast%3DHoffman%26aufirst%3DW.%2BF.%26aulast%3DRubino%26aufirst%3DR.%2BS.%26aulast%3DHungate%26aufirst%3DR.%2BW.%26aulast%3DTebben%26aufirst%3DA.%2BJ.%26aulast%3DRutledge%26aufirst%3DR.%2BZ.%26aulast%3DMcFall%26aufirst%3DR.%2BC.%26aulast%3DHuckle%26aufirst%3DW.%2BR.%26aulast%3DKendall%26aufirst%3DR.%2BL.%26aulast%3DColl%26aufirst%3DK.%2BE.%26aulast%3DThomas%26aufirst%3DK.%2BA.%26atitle%3DSynthesis%2520and%2520Initial%2520SAR%2520Studies%2520of%25203%252C6-Disubstituted%2520Pyrazolo%255B1%252C5-a%255Dpyrimidines%253A%2520A%2520New%2520Class%2520of%2520KDR%2520Kinase%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D2767%26epage%3D2770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Nam, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grandberg, I. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorokin, V. I.</span><span> </span><span class="NLM_article-title">Pyrazolopyrimidines Based on 5-Aminopyrazoles Unsubstituted at the Position 1</span> <span class="citation_source-journal">Chem. Heterocycl. Compd.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">1371</span><span class="NLM_x">–</span> <span class="NLM_lpage">1374</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm701397k&amp;key=10.1023%2FA%3A1022186627777" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm701397k&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjt1SltbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2002&pages=1371-1374&author=N.+L.+Namauthor=I.+I.+Grandbergauthor=V.+I.+Sorokin&title=Pyrazolopyrimidines+Based+on+5-Aminopyrazoles+Unsubstituted+at+the+Position+1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrazolopyrimidines based on 5-aminopyrazoles unsubstituted at the position 1</span></div><div class="casAuthors">Nam, N. L.; Grandberg, I. I.; Sorokin, V. I.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry of Heterocyclic Compounds (New York, NY, United States)(Translation of Khimiya Geterotsiklicheskikh Soedinenii)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1371-1374</span>CODEN:
                <span class="NLM_cas:coden">CHCCAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-3122</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic/Consultants Bureau</span>)
        </div><div class="casAbstract">By condensation of various sym. β-diketones with a series of 5-aminopyrazoles that are unsubstituted at the position 1, we have obtained a series of pyrazolo[1,5-a]pyrimidines that are of interest as physiol. active compds.  Hexafluoroacetylacetone reacts in another direction, forming pyrazolo[4,5-b]pyridine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYuJ4oIruamrVg90H21EOLACvtfcHk0liK9Z2EtyD0pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjt1SltbY%253D&md5=6c0919c181b38eeafcbebcef029640d3</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1023%2FA%3A1022186627777&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1022186627777%26sid%3Dliteratum%253Aachs%26aulast%3DNam%26aufirst%3DN.%2BL.%26aulast%3DGrandberg%26aufirst%3DI.%2BI.%26aulast%3DSorokin%26aufirst%3DV.%2BI.%26atitle%3DPyrazolopyrimidines%2520Based%2520on%25205-Aminopyrazoles%2520Unsubstituted%2520at%2520the%2520Position%25201%26jtitle%3DChem.%2520Heterocycl.%2520Compd.%26date%3D2002%26volume%3D38%26spage%3D1371%26epage%3D1374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Gribble, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loussouarn, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tucker, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashcroft, F. M.</span><span> </span><span class="NLM_article-title">A Novel Method for Measurement of Submembrane ATP Concentration</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">30046</span><span class="NLM_x">–</span> <span class="NLM_lpage">30049</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm701397k&amp;key=10.1074%2Fjbc.M001010200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm701397k&amp;key=10866996" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm701397k&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnt1ahuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=30046-30049&author=F.+M.+Gribbleauthor=G.+Loussouarnauthor=S.+J.+Tuckerauthor=C.+Zhaoauthor=C.+G.+Nicholsauthor=F.+M.+Ashcroft&title=A+Novel+Method+for+Measurement+of+Submembrane+ATP+Concentration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">A novel method for measurement of submembrane ATP concentration</span></div><div class="casAuthors">Gribble, Fiona M.; Loussouarn, Gildas; Tucker, Stephen J.; Zhao, Chao; Nichols, Colin G.; Ashcroft, Frances M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">30046-30049</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">There has been considerable debate as to whether ATP (ATP) is compartmentalized within cells and, in particular, whether the ATP concn. directly beneath the plasma membrane, experienced by membrane proteins, is the same as that of the bulk cytoplasm.  This issue has been difficult to address because there is no indicator of cytosolic ATP, such as those available for Ca2+, capable of resolving the submembrane ATP concn. ([ATP]sm) in real time within a single cell.  We show here that mutant ATP-sensitive K+ channels can be used to measure [ATP]sm by comparing the increase in current amplitude on patch excision with the ATP dose-response curve.  In Xenopus oocytes, [ATP]sm was 4.6±0.3 mM (n = 29) under resting conditions, slightly higher than that measured for the bulk cytoplasm (2.3 mM).  In mammalian (COSm6) cells, [ATP]sm was slightly lower and averaged 1.4±0.1 mM (n = 66).  Metabolic poisoning (10 min of 3 mM azide) produced a significant fall in [ATP]sm in both types of cells: to 1.2±0.1 mM (n = 24) in oocytes and 0.8±0.11 mM for COSm6 cells.  We conclude that [ATP]sm lies in the low millimolar range and that there is no gradient between bulk cytosolic and submembrane [ATP].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-yulyqd3I6LVg90H21EOLACvtfcHk0liH2UF8LfaCkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnt1ahuro%253D&md5=a3b5602e5c3ba8f1bda318adf5108d6b</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M001010200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M001010200%26sid%3Dliteratum%253Aachs%26aulast%3DGribble%26aufirst%3DF.%2BM.%26aulast%3DLoussouarn%26aufirst%3DG.%26aulast%3DTucker%26aufirst%3DS.%2BJ.%26aulast%3DZhao%26aufirst%3DC.%26aulast%3DNichols%26aufirst%3DC.%2BG.%26aulast%3DAshcroft%26aufirst%3DF.%2BM.%26atitle%3DA%2520Novel%2520Method%2520for%2520Measurement%2520of%2520Submembrane%2520ATP%2520Concentration%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D30046%26epage%3D30049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Miyazaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsunaga, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philippe, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibahara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolte, R. T.</span><span> </span><span class="NLM_article-title">Novel 4-Amino-furo[2,3-<i>d</i>]pyrimidines as Tie-2 and VEGFR2 Dual Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2203</span><span class="NLM_x">–</span> <span class="NLM_lpage">2207</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=2203-2207&author=Y.+Miyazakiauthor=S.+Matsunagaauthor=J.+Tangauthor=Y.+Maedaauthor=M.+Nakanoauthor=R.+J.+Philippeauthor=M.+Shibaharaauthor=W.+Liuauthor=H.+Satoauthor=L.+Wangauthor=R.+T.+Nolte&title=Novel+4-Amino-furo%5B2%2C3-d%5Dpyrimidines+as+Tie-2+and+VEGFR2+Dual+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMiyazaki%26aufirst%3DY.%26aulast%3DMatsunaga%26aufirst%3DS.%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DMaeda%26aufirst%3DY.%26aulast%3DNakano%26aufirst%3DM.%26aulast%3DPhilippe%26aufirst%3DR.%2BJ.%26aulast%3DShibahara%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DSato%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DNolte%26aufirst%3DR.%2BT.%26atitle%3DNovel%25204-Amino-furo%255B2%252C3-d%255Dpyrimidines%2520as%2520Tie-2%2520and%2520VEGFR2%2520Dual%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D2203%26epage%3D2207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Fraley, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubino, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hambaugh, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrington, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hungate, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilodeau, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tebben, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rutledge, R. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kendall, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McFall, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huckle, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coll, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, K. A.</span><span> </span><span class="NLM_article-title">Optimization of a Pyrazolo[1,5-<i>a</i>]pyrimidine Class of KDR Kinase Inhibitors: Improvements in Physical Properties Enhance Cellular Activity and Pharmacokinetics</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">3537</span><span class="NLM_x">–</span> <span class="NLM_lpage">3541</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=3537-3541&author=M.+E.+Fraleyauthor=R.+S.+Rubinoauthor=W.+F.+Hoffmanauthor=S.+R.+Hambaughauthor=K.+L.+Arringtonauthor=R.+W.+Hungateauthor=M.+T.+Bilodeauauthor=A.+J.+Tebbenauthor=R.+Z.+Rutledgeauthor=R.+L.+Kendallauthor=R.+C.+McFallauthor=W.+R.+Huckleauthor=K.+E.+Collauthor=K.+A.+Thomas&title=Optimization+of+a+Pyrazolo%5B1%2C5-a%5Dpyrimidine+Class+of+KDR+Kinase+Inhibitors%3A+Improvements+in+Physical+Properties+Enhance+Cellular+Activity+and+Pharmacokinetics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFraley%26aufirst%3DM.%2BE.%26aulast%3DRubino%26aufirst%3DR.%2BS.%26aulast%3DHoffman%26aufirst%3DW.%2BF.%26aulast%3DHambaugh%26aufirst%3DS.%2BR.%26aulast%3DArrington%26aufirst%3DK.%2BL.%26aulast%3DHungate%26aufirst%3DR.%2BW.%26aulast%3DBilodeau%26aufirst%3DM.%2BT.%26aulast%3DTebben%26aufirst%3DA.%2BJ.%26aulast%3DRutledge%26aufirst%3DR.%2BZ.%26aulast%3DKendall%26aufirst%3DR.%2BL.%26aulast%3DMcFall%26aufirst%3DR.%2BC.%26aulast%3DHuckle%26aufirst%3DW.%2BR.%26aulast%3DColl%26aufirst%3DK.%2BE.%26aulast%3DThomas%26aufirst%3DK.%2BA.%26atitle%3DOptimization%2520of%2520a%2520Pyrazolo%255B1%252C5-a%255Dpyrimidine%2520Class%2520of%2520KDR%2520Kinase%2520Inhibitors%253A%2520Improvements%2520in%2520Physical%2520Properties%2520Enhance%2520Cellular%2520Activity%2520and%2520Pharmacokinetics%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D3537%26epage%3D3541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Aronov, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bemis, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Germann, U. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobs, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janetka, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maltais, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez-Botella, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Namchuk, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Straub, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, X.</span><span> </span><span class="NLM_article-title">Flipped Out: Structure-Guided Design of Selective Pyrazolylpyrrole ERK Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1280</span><span class="NLM_x">–</span> <span class="NLM_lpage">1287</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm061381f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=1280-1287&author=A.+M.+Aronovauthor=C.+Bakerauthor=G.+W.+Bemisauthor=J.+Caoauthor=G.+Chenauthor=P.+J.+Fordauthor=U.+A.+Germannauthor=J.+Greenauthor=M.+R.+Haleauthor=M.+Jacobsauthor=J.+W.+Janetkaauthor=F.+Maltaisauthor=G.+Martinez-Botellaauthor=M.+N.+Namchukauthor=J.+Straubauthor=Q.+Tangauthor=X.+Xie&title=Flipped+Out%3A+Structure-Guided+Design+of+Selective+Pyrazolylpyrrole+ERK+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm061381f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061381f%26sid%3Dliteratum%253Aachs%26aulast%3DAronov%26aufirst%3DA.%2BM.%26aulast%3DBaker%26aufirst%3DC.%26aulast%3DBemis%26aufirst%3DG.%2BW.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DFord%26aufirst%3DP.%2BJ.%26aulast%3DGermann%26aufirst%3DU.%2BA.%26aulast%3DGreen%26aufirst%3DJ.%26aulast%3DHale%26aufirst%3DM.%2BR.%26aulast%3DJacobs%26aufirst%3DM.%26aulast%3DJanetka%26aufirst%3DJ.%2BW.%26aulast%3DMaltais%26aufirst%3DF.%26aulast%3DMartinez-Botella%26aufirst%3DG.%26aulast%3DNamchuk%26aufirst%3DM.%2BN.%26aulast%3DStraub%26aufirst%3DJ.%26aulast%3DTang%26aufirst%3DQ.%26aulast%3DXie%26aufirst%3DX.%26atitle%3DFlipped%2520Out%253A%2520Structure-Guided%2520Design%2520of%2520Selective%2520Pyrazolylpyrrole%2520ERK%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D1280%26epage%3D1287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Ma, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robert, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrahamson, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dey, S. K.</span><span> </span><span class="NLM_article-title">Adult Tissue Angiogenesis: Evidence for Negative Regulation by Estrogen in the Uterus</span> <span class="citation_source-journal">Mol. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1983</span><span class="NLM_x">–</span> <span class="NLM_lpage">1992</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm701397k&amp;key=10.1210%2Fme.15.11.1983" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm701397k&amp;key=11682628" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm701397k&amp;key=1%3ACAS%3A528%3ADC%252BD3MXotFKjtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2001&pages=1983-1992&author=W.+Maauthor=J.+Tanauthor=H.+Matsumotoauthor=B.+Robertauthor=D.+R.+Abrahamsonauthor=S.+K.+Dasauthor=S.+K.+Dey&title=Adult+Tissue+Angiogenesis%3A+Evidence+for+Negative+Regulation+by+Estrogen+in+the+Uterus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Adult tissue angiogenesis: evidence for negative regulation by estrogen in the uterus</span></div><div class="casAuthors">Ma, W.; Tan, J.; Matsumoto, H.; Robert, B.; Abrahamson, D. R.; Das, S. K.; Dey, S. K.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1983-1992</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Increased uterine vascular permeability and angiogenesis are two major events of embryo implantation and placentation during pregnancy.  These latter processes require coordinated, uterine-specific interactions between progesterone (P4) and estrogen (E) signaling.  Although roles of these steroids have long been suspected, definitive functions of E and/or P4 in uterine angiogenesis still remain elusive.  The authors have therefore exploited the availability of reporter and mutant mice to explore the regulation of angiogenesis in response to steroid hormonal changes in vivo.  The authors present here mol., genetic, physiol., and pharmacol. evidence that E and P4 have different effects in vivo: E promotes uterine vascular permeability but profoundly inhibits angiogenesis, whereas P4 stimulates angiogenesis with little effect on vascular permeability.  These effects of E and P4 are mediated by differential spatiotemporal expression of proangiogenic factors in the uterus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2L9CNTcN1OLVg90H21EOLACvtfcHk0lhzGwushTI8hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXotFKjtrw%253D&md5=c1b547382095f74aed4501ed55f622b9</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1210%2Fme.15.11.1983&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.15.11.1983%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DW.%26aulast%3DTan%26aufirst%3DJ.%26aulast%3DMatsumoto%26aufirst%3DH.%26aulast%3DRobert%26aufirst%3DB.%26aulast%3DAbrahamson%26aufirst%3DD.%2BR.%26aulast%3DDas%26aufirst%3DS.%2BK.%26aulast%3DDey%26aufirst%3DS.%2BK.%26atitle%3DAdult%2520Tissue%2520Angiogenesis%253A%2520Evidence%2520for%2520Negative%2520Regulation%2520by%2520Estrogen%2520in%2520the%2520Uterus%26jtitle%3DMol.%2520Endocrinol.%26date%3D2001%26volume%3D15%26spage%3D1983%26epage%3D1992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><div class="note"><p class="first last">Inhibition values exceeding 30% were significantly different (<i>p</i> < 0.05) from vehicle-treated controls.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Inhibition+values+exceeding+30%25+were+significantly+different+%28p+%3C+0.05%29+from+vehicle-treated+controls."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><div class="note"><p class="first last">Compound <b>34a</b> was screened against a wider panel of 150 kinases. At 1 mM ATP concentration, IC<sub>50</sub> values of <1000 nM were noted for TrkA (99 nM) and TrkB (52 nM). Kinases showing IC<sub>50</sub> < 1000 nM at lower ATP concentration included Src, Lck, JAK2, Abl, and Fyn. Without inhibition data at 1 mM ATP, however, it is not possible to make a direct comparison of these screening data with the data reported in Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Compound+34a+was+screened+against+a+wider+panel+of+150+kinases.+At+1+mM+ATP+concentration%2C+IC50+values+of+%3C1000+nM+were+noted+for+TrkA+%2899+nM%29+and+TrkB+%2852+nM%29.+Kinases+showing+IC50+%3C+1000+nM+at+lower+ATP+concentration+included+Src%2C+Lck%2C+JAK2%2C+Abl%2C+and+Fyn.+Without+inhibition+data+at+1+mM+ATP%2C+however%2C+it+is+not+possible+to+make+a+direct+comparison+of+these+screening+data+with+the+data+reported+in+Table+7."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Kolb, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplita, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, Y.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pernell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Major, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathis, G.</span><span> </span><span class="NLM_article-title">Tyrosine Kinase Assays Adapted to Homogeneous Time-Resolved Fluorescence</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">333</span><span class="NLM_x">–</span> <span class="NLM_lpage">342</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1998&pages=333-342&author=A.+J.+Kolbauthor=P.+V.+Kaplitaauthor=D.+J.+Hayesauthor=Y.-W.+Parkauthor=C.+Pernellauthor=J.+S.+Majorauthor=G.+Mathis&title=Tyrosine+Kinase+Assays+Adapted+to+Homogeneous+Time-Resolved+Fluorescence"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKolb%26aufirst%3DA.%2BJ.%26aulast%3DKaplita%26aufirst%3DP.%2BV.%26aulast%3DHayes%26aufirst%3DD.%2BJ.%26aulast%3DPark%26aufirst%3DY.-W.%26aulast%3DPernell%26aufirst%3DC.%26aulast%3DMajor%26aufirst%3DJ.%2BS.%26aulast%3DMathis%26aufirst%3DG.%26atitle%3DTyrosine%2520Kinase%2520Assays%2520Adapted%2520to%2520Homogeneous%2520Time-Resolved%2520Fluorescence%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D1998%26volume%3D3%26spage%3D333%26epage%3D342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24a','cit24b'],'ref25':['cit25a','cit25b','cit25c'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 34 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Francesca  Musumeci</span>, <span class="hlFld-ContribAuthor ">Marco  Radi</span>, <span class="hlFld-ContribAuthor ">Chiara  Brullo</span>, and <span class="hlFld-ContribAuthor ">Silvia  Schenone</span>  . </span><span class="cited-content_cbyCitation_article-title">Vascular Endothelial Growth Factor (VEGF) Receptors: Drugs and New Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (24)
                                     , 10797-10822. <a href="https://doi.org/10.1021/jm301085w" title="DOI URL">https://doi.org/10.1021/jm301085w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm301085w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm301085w%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DVascular%252BEndothelial%252BGrowth%252BFactor%252B%252528VEGF%252529%252BReceptors%25253A%252BDrugs%252Band%252BNew%252BInhibitors%26aulast%3DMusumeci%26aufirst%3DFrancesca%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D25072012%26date%3D06112012%26date%3D27122012%26date%3D25102012%26volume%3D55%26issue%3D24%26spage%3D10797%26epage%3D10822" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhuo  Chen</span>, <span class="hlFld-ContribAuthor ">Xin  Wang</span>, <span class="hlFld-ContribAuthor ">Weiping  Zhu</span>, <span class="hlFld-ContribAuthor ">Xianwen  Cao</span>, <span class="hlFld-ContribAuthor ">Linjiang  Tong</span>, <span class="hlFld-ContribAuthor ">Honglin  Li</span>, <span class="hlFld-ContribAuthor ">Hua  Xie</span>, <span class="hlFld-ContribAuthor ">Yufang  Xu</span>, <span class="hlFld-ContribAuthor ">Shaoying  Tan</span>, <span class="hlFld-ContribAuthor ">Dong  Kuang</span>, <span class="hlFld-ContribAuthor ">Jian  Ding</span>, and <span class="hlFld-ContribAuthor ">Xuhong  Qian</span>  . </span><span class="cited-content_cbyCitation_article-title">Acenaphtho[1,2-b]pyrrole-Based Selective Fibroblast Growth Factor Receptors 1 (FGFR1) Inhibitors: Design, Synthesis, and Biological Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (11)
                                     , 3732-3745. <a href="https://doi.org/10.1021/jm200258t" title="DOI URL">https://doi.org/10.1021/jm200258t</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm200258t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm200258t%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAcenaphtho%25255B1%25252C2-b%25255Dpyrrole-Based%252BSelective%252BFibroblast%252BGrowth%252BFactor%252BReceptors%252B1%252B%252528FGFR1%252529%252BInhibitors%25253A%252BDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BActivity%26aulast%3DChen%26aufirst%3DZhuo%26date%3D2011%26date%3D2011%26date%3D2010%26date%3D16122010%26date%3D13052011%26date%3D09062011%26date%3D25042011%26volume%3D54%26issue%3D11%26spage%3D3732%26epage%3D3745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yi-Cong  Wu</span>, <span class="hlFld-ContribAuthor ">Xin-Yue  Ren</span>, <span class="hlFld-ContribAuthor ">Guo-Wu  Rao</span>. </span><span class="cited-content_cbyCitation_article-title">Research Progress of Diphenyl Urea Derivatives as Anticancer Agents and Synthetic Methodologies. </span><span class="cited-content_cbyCitation_journal-name">Mini-Reviews in Organic Chemistry</span><span> <strong>2019,</strong> <em>16 </em>
                                    (7)
                                     , 617-630. <a href="https://doi.org/10.2174/1570193X15666181029130418" title="DOI URL">https://doi.org/10.2174/1570193X15666181029130418</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1570193X15666181029130418&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1570193X15666181029130418%26sid%3Dliteratum%253Aachs%26jtitle%3DMini-Reviews%2520in%2520Organic%2520Chemistry%26atitle%3DResearch%252BProgress%252Bof%252BDiphenyl%252BUrea%252BDerivatives%252Bas%252BAnticancer%252BAgents%252Band%252BSynthetic%252BMethodologies%26aulast%3DWu%26aufirst%3DYi-Cong%26date%3D2019%26volume%3D16%26issue%3D7%26spage%3D617%26epage%3D630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amal  Al-Azmi</span>. </span><span class="cited-content_cbyCitation_article-title">Pyrazolo[1,5-a]pyrimidines: A Close Look into their Synthesis and Applications. </span><span class="cited-content_cbyCitation_journal-name">Current Organic Chemistry</span><span> <strong>2019,</strong> <em>23 </em>
                                    (6)
                                     , 721-743. <a href="https://doi.org/10.2174/1385272823666190410145238" title="DOI URL">https://doi.org/10.2174/1385272823666190410145238</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1385272823666190410145238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1385272823666190410145238%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Organic%2520Chemistry%26atitle%3DPyrazolo%25255B1%25252C5-a%25255Dpyrimidines%25253A%252BA%252BClose%252BLook%252Binto%252Btheir%252BSynthesis%252Band%252BApplications%26aulast%3DAl-Azmi%26aufirst%3DAmal%26date%3D2019%26volume%3D23%26issue%3D6%26spage%3D721%26epage%3D743" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ci-Di  Chen</span>, <span class="hlFld-ContribAuthor ">Ella  Zeldich</span>, <span class="hlFld-ContribAuthor ">Christina  Khodr</span>, <span class="hlFld-ContribAuthor ">Kaddy  Camara</span>, <span class="hlFld-ContribAuthor ">Tze Yu  Tung</span>, <span class="hlFld-ContribAuthor ">Emma C.  Lauder</span>, <span class="hlFld-ContribAuthor ">Patrick  Mullen</span>, <span class="hlFld-ContribAuthor ">Taryn J.  Polanco</span>, <span class="hlFld-ContribAuthor ">Yen-Yu  Liu</span>, <span class="hlFld-ContribAuthor ">Dean  Zeldich</span>, <span class="hlFld-ContribAuthor ">Weiming  Xia</span>, <span class="hlFld-ContribAuthor ">William E.  Van Nostrand</span>, <span class="hlFld-ContribAuthor ">Lauren E.  Brown</span>, <span class="hlFld-ContribAuthor ">John A.  Porco</span>, <span class="hlFld-ContribAuthor ">Carmela R.  Abraham</span>, . </span><span class="cited-content_cbyCitation_article-title">Small Molecule Amyloid-β Protein Precursor Processing Modulators Lower Amyloid-β Peptide Levels via cKit Signaling. </span><span class="cited-content_cbyCitation_journal-name">Journal of Alzheimer's Disease</span><span> <strong>2019,</strong> <em>67 </em>
                                    (3)
                                     , 1089-1106. <a href="https://doi.org/10.3233/JAD-180923" title="DOI URL">https://doi.org/10.3233/JAD-180923</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3233/JAD-180923&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3233%2FJAD-180923%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Alzheimer%2527s%2520Disease%26atitle%3DSmall%252BMolecule%252BAmyloid-%2525CE%2525B2%252BProtein%252BPrecursor%252BProcessing%252BModulators%252BLower%252BAmyloid-%2525CE%2525B2%252BPeptide%252BLevels%252Bvia%252BcKit%252BSignaling%26aulast%3DChen%26aufirst%3DCi-Di%26date%3D2019%26volume%3D67%26issue%3D3%26spage%3D1089%26epage%3D1106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Enayatollah  Sheikhhosseini</span>. </span><span class="cited-content_cbyCitation_article-title">Design and effective synthesis of novel furo[2,3-d]pyrimidine derivatives containing ethylene ether spacers. </span><span class="cited-content_cbyCitation_journal-name">Journal of Saudi Chemical Society</span><span> <strong>2018,</strong> <em>22 </em>
                                    (3)
                                     , 337-342. <a href="https://doi.org/10.1016/j.jscs.2016.05.005" title="DOI URL">https://doi.org/10.1016/j.jscs.2016.05.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jscs.2016.05.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jscs.2016.05.005%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Saudi%2520Chemical%2520Society%26atitle%3DDesign%252Band%252Beffective%252Bsynthesis%252Bof%252Bnovel%252Bfuro%25255B2%25252C3-d%25255Dpyrimidine%252Bderivatives%252Bcontaining%252Bethylene%252Bether%252Bspacers%26aulast%3DSheikhhosseini%26aufirst%3DEnayatollah%26date%3D2018%26volume%3D22%26issue%3D3%26spage%3D337%26epage%3D342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiangjun  Peng</span>, <span class="hlFld-ContribAuthor ">Xianyun  Xu</span>, <span class="hlFld-ContribAuthor ">Shuangyang  Chen</span>, <span class="hlFld-ContribAuthor ">Zeng  Tian</span>, <span class="hlFld-ContribAuthor ">Liangxian  Liu</span>, <span class="hlFld-ContribAuthor ">Qian  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Cu(I)-catalyzed one-pot reactions of isatins, indoles, and amines toward unsymmetrically substituted 2-carbonylarylureas. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2018,</strong> <em>74 </em>
                                    (13)
                                     , 1505-1512. <a href="https://doi.org/10.1016/j.tet.2018.02.019" title="DOI URL">https://doi.org/10.1016/j.tet.2018.02.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2018.02.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2018.02.019%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DCu%252528I%252529-catalyzed%252Bone-pot%252Breactions%252Bof%252Bisatins%25252C%252Bindoles%25252C%252Band%252Bamines%252Btoward%252Bunsymmetrically%252Bsubstituted%252B2-carbonylarylureas%26aulast%3DPeng%26aufirst%3DXiangjun%26date%3D2018%26volume%3D74%26issue%3D13%26spage%3D1505%26epage%3D1512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jean Le  Bras</span>, <span class="hlFld-ContribAuthor ">Jacques  Muzart</span>. </span><span class="cited-content_cbyCitation_article-title">N
              ,
              N
              -Dimethylformamide and
              N
              ,
              N
              -Dimethylacetamide as Carbon, Hydrogen, Nitrogen, and/or Oxygen Sources. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 199-314. <a href="https://doi.org/10.1002/9783527805624.ch6" title="DOI URL">https://doi.org/10.1002/9783527805624.ch6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527805624.ch6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527805624.ch6%26sid%3Dliteratum%253Aachs%26atitle%3DN%252B%25252C%252BN%252B-Dimethylformamide%252Band%252BN%252B%25252C%252BN%252B-Dimethylacetamide%252Bas%252BCarbon%25252C%252BHydrogen%25252C%252BNitrogen%25252C%252Band%25252For%252BOxygen%252BSources%26aulast%3DBras%26aufirst%3DJean%2BLe%26date%3D2017%26date%3D2017%26spage%3D199%26epage%3D314%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DSolvents%252Bas%252BReagents%252Bin%252BOrganic%252BSynthesis%26aulast%3DWu%26aufirst%3DXiao-Feng%2BWu%26date%3D2017%26date%3D2017%26volume%3D358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Srinivasulu  Cherukupalli</span>, <span class="hlFld-ContribAuthor ">Rajshekhar  Karpoormath</span>, <span class="hlFld-ContribAuthor ">Balakumar  Chandrasekaran</span>, <span class="hlFld-ContribAuthor ">Girish. A.  Hampannavar</span>, <span class="hlFld-ContribAuthor ">Neeta  Thapliyal</span>, <span class="hlFld-ContribAuthor ">Venkata Narayana  Palakollu</span>. </span><span class="cited-content_cbyCitation_article-title">An insight on synthetic and medicinal aspects of pyrazolo[1,5-a]pyrimidine scaffold. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>126 </em>, 298-352. <a href="https://doi.org/10.1016/j.ejmech.2016.11.019" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.11.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.11.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.11.019%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAn%252Binsight%252Bon%252Bsynthetic%252Band%252Bmedicinal%252Baspects%252Bof%252Bpyrazolo%25255B1%25252C5-a%25255Dpyrimidine%252Bscaffold%26aulast%3DCherukupalli%26aufirst%3DSrinivasulu%26date%3D2017%26volume%3D126%26spage%3D298%26epage%3D352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xun-Li  Zhang</span>, <span class="hlFld-ContribAuthor ">Yu  Ma</span>, <span class="hlFld-ContribAuthor ">Qing  Pan</span>, <span class="hlFld-ContribAuthor ">Zhong-Gang  Bai</span>, <span class="hlFld-ContribAuthor ">Hui  Qi</span>, <span class="hlFld-ContribAuthor ">Qun-Zheng  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of (5,6-Dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)-methanamine. </span><span class="cited-content_cbyCitation_journal-name">HETEROCYCLES</span><span> <strong>2017,</strong> <em>94 </em>
                                    (10)
                                     , 1923. <a href="https://doi.org/10.3987/COM-17-13772" title="DOI URL">https://doi.org/10.3987/COM-17-13772</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3987/COM-17-13772&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3987%2FCOM-17-13772%26sid%3Dliteratum%253Aachs%26jtitle%3DHETEROCYCLES%26atitle%3DSynthesis%252Bof%252B%2525285%25252C6-Dihydro-4H-pyrrolo%25255B1%25252C2-b%25255Dpyrazol-3-yl%252529-methanamine%26aulast%3DZhang%26aufirst%3DXun-Li%26date%3D2017%26volume%3D94%26issue%3D10%26spage%3D1923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nasser S.M.  Ismail</span>, <span class="hlFld-ContribAuthor ">Ghada M.E.  Ali</span>, <span class="hlFld-ContribAuthor ">Diaa A.  Ibrahim</span>, <span class="hlFld-ContribAuthor ">Amira M.  Elmetwali</span>. </span><span class="cited-content_cbyCitation_article-title">Medicinal attributes of pyrazolo[1,5-a]pyrimidine based scaffold derivatives targeting kinases as anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Future Journal of Pharmaceutical Sciences</span><span> <strong>2016,</strong> <em>2 </em>
                                    (2)
                                     , 60-70. <a href="https://doi.org/10.1016/j.fjps.2016.08.004" title="DOI URL">https://doi.org/10.1016/j.fjps.2016.08.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.fjps.2016.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.fjps.2016.08.004%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Journal%2520of%2520Pharmaceutical%2520Sciences%26atitle%3DMedicinal%252Battributes%252Bof%252Bpyrazolo%25255B1%25252C5-a%25255Dpyrimidine%252Bbased%252Bscaffold%252Bderivatives%252Btargeting%252Bkinases%252Bas%252Banticancer%252Bagents%26aulast%3DIsmail%26aufirst%3DNasser%2BS.M.%26date%3D2016%26volume%3D2%26issue%3D2%26spage%3D60%26epage%3D70" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Seddigheh  Sheikhi-Mohammareh</span>, <span class="hlFld-ContribAuthor ">Ali  Shiri</span>, <span class="hlFld-ContribAuthor ">Mehdi  Bakavoli</span>, <span class="hlFld-ContribAuthor ">Joel  Mague</span>. </span><span class="cited-content_cbyCitation_article-title">A Straightforward Approach for the Synthesis of Novel Derivatives of Benzo[b]pyrazolo[5′,1′:2,3]pyrimido[4,5-e][1,4]thiazine. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2016,</strong> <em>53 </em>
                                    (4)
                                     , 1231-1235. <a href="https://doi.org/10.1002/jhet.2432" title="DOI URL">https://doi.org/10.1002/jhet.2432</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.2432&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.2432%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DA%252BStraightforward%252BApproach%252Bfor%252Bthe%252BSynthesis%252Bof%252BNovel%252BDerivatives%252Bof%252BBenzo%25255Bb%25255Dpyrazolo%25255B5%2525E2%252580%2525B2%25252C1%2525E2%252580%2525B2%25253A2%25252C3%25255Dpyrimido%25255B4%25252C5-e%25255D%25255B1%25252C4%25255Dthiazine%26aulast%3DSheikhi-Mohammareh%26aufirst%3DSeddigheh%26date%3D2016%26date%3D2015%26volume%3D53%26issue%3D4%26spage%3D1231%26epage%3D1235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jingya  Zhang</span>, <span class="hlFld-ContribAuthor ">Linna  Zhang</span>, <span class="hlFld-ContribAuthor ">Yuanyou  Wang</span>, <span class="hlFld-ContribAuthor ">Guisen  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Development of anti-angiogenic tyrosine kinases inhibitors: molecular structures and binding modes. </span><span class="cited-content_cbyCitation_journal-name">Cancer Chemotherapy and Pharmacology</span><span> <strong>2016,</strong> <em>77 </em>
                                    (5)
                                     , 905-926. <a href="https://doi.org/10.1007/s00280-016-2961-6" title="DOI URL">https://doi.org/10.1007/s00280-016-2961-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00280-016-2961-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00280-016-2961-6%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Chemotherapy%2520and%2520Pharmacology%26atitle%3DDevelopment%252Bof%252Banti-angiogenic%252Btyrosine%252Bkinases%252Binhibitors%25253A%252Bmolecular%252Bstructures%252Band%252Bbinding%252Bmodes%26aulast%3DZhang%26aufirst%3DJingya%26date%3D2016%26date%3D2016%26volume%3D77%26issue%3D5%26spage%3D905%26epage%3D926" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shunan  Kaping</span>, <span class="hlFld-ContribAuthor ">Ivee  Boiss</span>, <span class="hlFld-ContribAuthor ">Laishram Indira  Singha</span>, <span class="hlFld-ContribAuthor ">Philippe  Helissey</span>, <span class="hlFld-ContribAuthor ">Jai N.  Vishwakarma</span>. </span><span class="cited-content_cbyCitation_article-title">A facile, regioselective synthesis of novel 3-(N-phenylcarboxamide)pyrazolo[1,5-a]pyrimidine analogs in the presence of KHSO $$_{4}$$ 4 in aqueous media assisted by ultrasound and their antibacterial activities. </span><span class="cited-content_cbyCitation_journal-name">Molecular Diversity</span><span> <strong>2016,</strong> <em>20 </em>
                                    (2)
                                     , 379-390. <a href="https://doi.org/10.1007/s11030-015-9639-6" title="DOI URL">https://doi.org/10.1007/s11030-015-9639-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11030-015-9639-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11030-015-9639-6%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Diversity%26atitle%3DA%252Bfacile%25252C%252Bregioselective%252Bsynthesis%252Bof%252Bnovel%252B3-%252528N-phenylcarboxamide%252529pyrazolo%25255B1%25252C5-a%25255Dpyrimidine%252Banalogs%252Bin%252Bthe%252Bpresence%252Bof%252BKHSO%252B%252524%252524_%25257B4%25257D%252524%252524%252B4%252Bin%252Baqueous%252Bmedia%252Bassisted%252Bby%252Bultrasound%252Band%252Btheir%252Bantibacterial%252Bactivities%26aulast%3DKaping%26aufirst%3DShunan%26date%3D2016%26date%3D2015%26volume%3D20%26issue%3D2%26spage%3D379%26epage%3D390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ibtissam  Bassoude</span>, <span class="hlFld-ContribAuthor ">Zahira  Tber</span>, <span class="hlFld-ContribAuthor ">El Mokhtar  Essassi</span>, <span class="hlFld-ContribAuthor ">Gérald  Guillaumet</span>, <span class="hlFld-ContribAuthor ">Sabine  Berteina-Raboin</span>. </span><span class="cited-content_cbyCitation_article-title">A one-pot process for the microwave-assisted synthesis of 7-substituted pyrazolo[1,5-a]pyrimidine. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2016,</strong> <em>6 </em>
                                    (4)
                                     , 3301-3306. <a href="https://doi.org/10.1039/C5RA23417D" title="DOI URL">https://doi.org/10.1039/C5RA23417D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5RA23417D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5RA23417D%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DA%252Bone-pot%252Bprocess%252Bfor%252Bthe%252Bmicrowave-assisted%252Bsynthesis%252Bof%252B7-substituted%252Bpyrazolo%25255B1%25252C5-a%25255Dpyrimidine%26aulast%3DBassoude%26aufirst%3DIbtissam%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D4%26spage%3D3301%26epage%3D3306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maksim A.  Kolosov</span>, <span class="hlFld-ContribAuthor ">Dmitriy A.  Beloborodov</span>, <span class="hlFld-ContribAuthor ">Valeriy D.  Orlov</span>, <span class="hlFld-ContribAuthor ">Victor V.  Dotsenko</span>. </span><span class="cited-content_cbyCitation_article-title">Catalyst-free Biginelli-type synthesis of new functionalized 4,7-dihydropyrazolo[1,5-a]pyrimidines. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2016,</strong> <em>40 </em>
                                    (9)
                                     , 7573-7579. <a href="https://doi.org/10.1039/C6NJ00336B" title="DOI URL">https://doi.org/10.1039/C6NJ00336B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6NJ00336B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6NJ00336B%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DCatalyst-free%252BBiginelli-type%252Bsynthesis%252Bof%252Bnew%252Bfunctionalized%252B4%25252C7-dihydropyrazolo%25255B1%25252C5-a%25255Dpyrimidines%26aulast%3DKolosov%26aufirst%3DMaksim%2BA.%26date%3D2016%26date%3D2016%26volume%3D40%26issue%3D9%26spage%3D7573%26epage%3D7579" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Asem Satyapati  Devi</span>, <span class="hlFld-ContribAuthor ">Shunan  Kaping</span>, <span class="hlFld-ContribAuthor ">Jai Narain  Vishwakarma</span>. </span><span class="cited-content_cbyCitation_article-title">A facile environment-friendly one-pot two-step regioselective synthetic strategy for 3,7-diarylpyrazolo[1,5-a]pyrimidines related to zaleplon and 3,6-diarylpyrazolo[1,5-a]pyrimidine-7-amines assisted by KHSO $$_{4}$$ 4 in aqueous media. </span><span class="cited-content_cbyCitation_journal-name">Molecular Diversity</span><span> <strong>2015,</strong> <em>19 </em>
                                    (4)
                                     , 759-771. <a href="https://doi.org/10.1007/s11030-015-9606-2" title="DOI URL">https://doi.org/10.1007/s11030-015-9606-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11030-015-9606-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11030-015-9606-2%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Diversity%26atitle%3DA%252Bfacile%252Benvironment-friendly%252Bone-pot%252Btwo-step%252Bregioselective%252Bsynthetic%252Bstrategy%252Bfor%252B3%25252C7-diarylpyrazolo%25255B1%25252C5-a%25255Dpyrimidines%252Brelated%252Bto%252Bzaleplon%252Band%252B3%25252C6-diarylpyrazolo%25255B1%25252C5-a%25255Dpyrimidine-7-amines%252Bassisted%252Bby%252BKHSO%252B%252524%252524_%25257B4%25257D%252524%252524%252B4%252Bin%252Baqueous%252Bmedia%26aulast%3DDevi%26aufirst%3DAsem%2BSatyapati%26date%3D2015%26date%3D2015%26volume%3D19%26issue%3D4%26spage%3D759%26epage%3D771" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong Deog  Hong</span>, <span class="hlFld-ContribAuthor ">Kyoung Hee  Byoun</span>, <span class="hlFld-ContribAuthor ">Miyoung  Park</span>, <span class="hlFld-ContribAuthor ">Jun Seong  Park</span>, <span class="hlFld-ContribAuthor ">Song Seok  Shin</span>. </span><span class="cited-content_cbyCitation_article-title">Improved One-pot Regioselective Synthesis of 3,7-Diarylpyrazolo[1,5-α]pyrimidines and Their CB1R Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of the Society of Cosmetic Scientists of Korea</span><span> <strong>2015,</strong> <em>41 </em>
                                    (2)
                                     , 143-150. <a href="https://doi.org/10.15230/SCSK.2015.41.2.143" title="DOI URL">https://doi.org/10.15230/SCSK.2015.41.2.143</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.15230/SCSK.2015.41.2.143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.15230%2FSCSK.2015.41.2.143%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520Society%2520of%2520Cosmetic%2520Scientists%2520of%2520Korea%26atitle%3DImproved%252BOne-pot%252BRegioselective%252BSynthesis%252Bof%252B3%25252C7-Diarylpyrazolo%25255B1%25252C5-%2525CE%2525B1%25255Dpyrimidines%252Band%252BTheir%252BCB1R%252BActivity%26aulast%3DHong%26aufirst%3DYong%2BDeog%26date%3D2015%26volume%3D41%26issue%3D2%26spage%3D143%26epage%3D150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qile  Xu</span>, <span class="hlFld-ContribAuthor ">Huan  Qi</span>, <span class="hlFld-ContribAuthor ">Maolin  Sun</span>, <span class="hlFld-ContribAuthor ">Daiying  Zuo</span>, <span class="hlFld-ContribAuthor ">Xuewei  Jiang</span>, <span class="hlFld-ContribAuthor ">Zhiyong  Wen</span>, <span class="hlFld-ContribAuthor ">Zhiwei  Wang</span>, <span class="hlFld-ContribAuthor ">Yingliang  Wu</span>, <span class="hlFld-ContribAuthor ">Weige  Zhang</span>, . </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Evaluation of 3-Alkyl-1,5-Diaryl-1H-Pyrazoles as Rigid Analogues of Combretastatin A-4 with Potent Antiproliferative Activity. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2015,</strong> <em>10 </em>
                                    (6)
                                     , e0128710. <a href="https://doi.org/10.1371/journal.pone.0128710" title="DOI URL">https://doi.org/10.1371/journal.pone.0128710</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0128710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0128710%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252B3-Alkyl-1%25252C5-Diaryl-1H-Pyrazoles%252Bas%252BRigid%252BAnalogues%252Bof%252BCombretastatin%252BA-4%252Bwith%252BPotent%252BAntiproliferative%252BActivity%26aulast%3DXu%26aufirst%3DQile%26date%3D2015%26date%3D2015%26volume%3D10%26issue%3D6%26spage%3De0128710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wen  Lu</span>, <span class="hlFld-ContribAuthor ">Pengfei  Li</span>, <span class="hlFld-ContribAuthor ">Yuanyuan  Shan</span>, <span class="hlFld-ContribAuthor ">Ping  Su</span>, <span class="hlFld-ContribAuthor ">Jinfeng  Wang</span>, <span class="hlFld-ContribAuthor ">Yaling  Shi</span>, <span class="hlFld-ContribAuthor ">Jie  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of biphenyl-based VEGFR-2 inhibitors. Part 3: Design, synthesis and 3D-QSAR studies. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2015,</strong> <em>23 </em>
                                    (5)
                                     , 1044-1054. <a href="https://doi.org/10.1016/j.bmc.2015.01.006" title="DOI URL">https://doi.org/10.1016/j.bmc.2015.01.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2015.01.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2015.01.006%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bbiphenyl-based%252BVEGFR-2%252Binhibitors.%252BPart%252B3%25253A%252BDesign%25252C%252Bsynthesis%252Band%252B3D-QSAR%252Bstudies%26aulast%3DLu%26aufirst%3DWen%26date%3D2015%26volume%3D23%26issue%3D5%26spage%3D1044%26epage%3D1054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Korany A.  Ali</span>, <span class="hlFld-ContribAuthor ">Eman A.  Ragab</span>, <span class="hlFld-ContribAuthor ">Grzegorz  Mlostoń</span>, <span class="hlFld-ContribAuthor ">Małgorzata  Celeda</span>, <span class="hlFld-ContribAuthor ">Anthony  Linden</span>, <span class="hlFld-ContribAuthor ">Heinz  Heimgartner</span>. </span><span class="cited-content_cbyCitation_article-title">Unexpected Reaction Course of 3-Amino-5-aryl-1
              H
              -pyrazoles with Dialkyl Dicyanofumarates. </span><span class="cited-content_cbyCitation_journal-name">Helvetica Chimica Acta</span><span> <strong>2013,</strong> <em>96 </em>
                                    (4)
                                     , 633-643. <a href="https://doi.org/10.1002/hlca.201200633" title="DOI URL">https://doi.org/10.1002/hlca.201200633</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/hlca.201200633&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fhlca.201200633%26sid%3Dliteratum%253Aachs%26jtitle%3DHelvetica%2520Chimica%2520Acta%26atitle%3DUnexpected%252BReaction%252BCourse%252Bof%252B3-Amino-5-aryl-1%252BH%252B-pyrazoles%252Bwith%252BDialkyl%252BDicyanofumarates%26aulast%3DAli%26aufirst%3DKorany%2BA.%26date%3D2013%26date%3D2013%26volume%3D96%26issue%3D4%26spage%3D633%26epage%3D643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jian  Sun</span>, <span class="hlFld-ContribAuthor ">Dong-Dong  Li</span>, <span class="hlFld-ContribAuthor ">Jing-Ran  Li</span>, <span class="hlFld-ContribAuthor ">Fei  Fang</span>, <span class="hlFld-ContribAuthor ">Qian-Ru  Du</span>, <span class="hlFld-ContribAuthor ">Yong  Qian</span>, <span class="hlFld-ContribAuthor ">Hai-Liang  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, biological evaluation, and molecular modeling study of 4-alkoxyquinazoline derivatives as potential VEGFR2 kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2013,</strong> <em>11 </em>
                                    (44)
                                     , 7676. <a href="https://doi.org/10.1039/c3ob41136b" title="DOI URL">https://doi.org/10.1039/c3ob41136b</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c3ob41136b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc3ob41136b%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Bbiological%252Bevaluation%25252C%252Band%252Bmolecular%252Bmodeling%252Bstudy%252Bof%252B4-alkoxyquinazoline%252Bderivatives%252Bas%252Bpotential%252BVEGFR2%252Bkinase%252Binhibitors%26aulast%3DSun%26aufirst%3DJian%26date%3D2013%26volume%3D11%26issue%3D44%26spage%3D7676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arun K.  Ghosh</span>, <span class="hlFld-ContribAuthor ">Satyendra  Pandey</span>, <span class="hlFld-ContribAuthor ">Sudhakar  Gangarajula</span>, <span class="hlFld-ContribAuthor ">Sarang  Kulkarni</span>, <span class="hlFld-ContribAuthor ">Xiaoming  Xu</span>, <span class="hlFld-ContribAuthor ">Kalapala Venkateswara  Rao</span>, <span class="hlFld-ContribAuthor ">Xiangping  Huang</span>, <span class="hlFld-ContribAuthor ">Jordan  Tang</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based design, synthesis, and biological evaluation of dihydroquinazoline-derived potent β-secretase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (17)
                                     , 5460-5465. <a href="https://doi.org/10.1016/j.bmcl.2012.07.043" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.07.043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.07.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.07.043%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure-based%252Bdesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252Bdihydroquinazoline-derived%252Bpotent%252B%2525CE%2525B2-secretase%252Binhibitors%26aulast%3DGhosh%26aufirst%3DArun%2BK.%26date%3D2012%26volume%3D22%26issue%3D17%26spage%3D5460%26epage%3D5465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lingyi  Huang</span>, <span class="hlFld-ContribAuthor ">Zhengui  Huang</span>, <span class="hlFld-ContribAuthor ">Zhiqiang  Bai</span>, <span class="hlFld-ContribAuthor ">Rui  Xie</span>, <span class="hlFld-ContribAuthor ">Liping  Sun</span>, <span class="hlFld-ContribAuthor ">Kejiang  Lin</span>. </span><span class="cited-content_cbyCitation_article-title">Development and strategies of VEGFR-2/KDR inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2012,</strong> <em>4 </em>
                                    (14)
                                     , 1839-1852. <a href="https://doi.org/10.4155/fmc.12.121" title="DOI URL">https://doi.org/10.4155/fmc.12.121</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.12.121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.12.121%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Band%252Bstrategies%252Bof%252BVEGFR-2%25252FKDR%252Binhibitors%26aulast%3DHuang%26aufirst%3DLingyi%26date%3D2012%26volume%3D4%26issue%3D14%26spage%3D1839%26epage%3D1852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Abbas  Rahmati</span>. </span><span class="cited-content_cbyCitation_article-title">One-pot synthesis of 2-alkyl-7-amino-5-aryl-pyrazolo[1,5-a]pyrimidine-6-carbonitriles via a domino three-component condensation-oxidation reaction. </span><span class="cited-content_cbyCitation_journal-name">Comptes Rendus Chimie</span><span> <strong>2012,</strong> <em>15 </em>
                                    (8)
                                     , 647-652. <a href="https://doi.org/10.1016/j.crci.2012.06.006" title="DOI URL">https://doi.org/10.1016/j.crci.2012.06.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.crci.2012.06.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.crci.2012.06.006%26sid%3Dliteratum%253Aachs%26jtitle%3DComptes%2520Rendus%2520Chimie%26atitle%3DOne-pot%252Bsynthesis%252Bof%252B2-alkyl-7-amino-5-aryl-pyrazolo%25255B1%25252C5-a%25255Dpyrimidine-6-carbonitriles%252Bvia%252Ba%252Bdomino%252Bthree-component%252Bcondensation-oxidation%252Breaction%26aulast%3DRahmati%26aufirst%3DAbbas%26date%3D2012%26volume%3D15%26issue%3D8%26spage%3D647%26epage%3D652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Charles S.  Elmore</span>, <span class="hlFld-ContribAuthor ">Mark E.  Powell</span>, <span class="hlFld-ContribAuthor ">Hui  Xiong</span>, <span class="hlFld-ContribAuthor ">Ye  Wu</span>, <span class="hlFld-ContribAuthor ">Lijuan  Wang</span>, <span class="hlFld-ContribAuthor ">David  Saunders</span>, <span class="hlFld-ContribAuthor ">Rebecca A.  Urbanek</span>. </span><span class="cited-content_cbyCitation_article-title">Preparation of two D2 partial agonists in C-14 and stable isotope labeled forms. </span><span class="cited-content_cbyCitation_journal-name">Journal of Labelled Compounds and Radiopharmaceuticals</span><span> <strong>2012,</strong> <em>55 </em>
                                    (9)
                                     , 359-365. <a href="https://doi.org/10.1002/jlcr.2951" title="DOI URL">https://doi.org/10.1002/jlcr.2951</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jlcr.2951&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjlcr.2951%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Labelled%2520Compounds%2520and%2520Radiopharmaceuticals%26atitle%3DPreparation%252Bof%252Btwo%252BD2%252Bpartial%252Bagonists%252Bin%252BC-14%252Band%252Bstable%252Bisotope%252Blabeled%252Bforms%26aulast%3DElmore%26aufirst%3DCharles%2BS.%26date%3D2012%26date%3D2012%26volume%3D55%26issue%3D9%26spage%3D359%26epage%3D365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dan  Xu</span>, <span class="hlFld-ContribAuthor ">Haopeng  Sun</span>, <span class="hlFld-ContribAuthor ">Yadong  Chen</span>, <span class="hlFld-ContribAuthor ">Liping  Sun</span>, <span class="hlFld-ContribAuthor ">Qidong  You</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacophore Modeling and in Silico Screening Studies to Design Potential KDR Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chinese Journal of Chemistry</span><span> <strong>2011,</strong> <em>29 </em>
                                    (6)
                                     , 1107-1113. <a href="https://doi.org/10.1002/cjoc.201190208" title="DOI URL">https://doi.org/10.1002/cjoc.201190208</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cjoc.201190208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcjoc.201190208%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Journal%2520of%2520Chemistry%26atitle%3DPharmacophore%252BModeling%252Band%252Bin%252BSilico%252BScreening%252BStudies%252Bto%252BDesign%252BPotential%252BKDR%252BKinase%252BInhibitors%26aulast%3DXu%26aufirst%3DDan%26date%3D2011%26date%3D2011%26volume%3D29%26issue%3D6%26spage%3D1107%26epage%3D1113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Milan  Remko</span>, <span class="hlFld-ContribAuthor ">Andrej  Boháč</span>, <span class="hlFld-ContribAuthor ">Lucia  Kováčiková</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular structure, pKa, lipophilicity, solubility, absorption, polar surface area, and blood brain barrier penetration of some antiangiogenic agents. </span><span class="cited-content_cbyCitation_journal-name">Structural Chemistry</span><span> <strong>2011,</strong> <em>22 </em>
                                    (3)
                                     , 635-648. <a href="https://doi.org/10.1007/s11224-011-9741-z" title="DOI URL">https://doi.org/10.1007/s11224-011-9741-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11224-011-9741-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11224-011-9741-z%26sid%3Dliteratum%253Aachs%26jtitle%3DStructural%2520Chemistry%26atitle%3DMolecular%252Bstructure%25252C%252BpKa%25252C%252Blipophilicity%25252C%252Bsolubility%25252C%252Babsorption%25252C%252Bpolar%252Bsurface%252Barea%25252C%252Band%252Bblood%252Bbrain%252Bbarrier%252Bpenetration%252Bof%252Bsome%252Bantiangiogenic%252Bagents%26aulast%3DRemko%26aufirst%3DMilan%26date%3D2011%26date%3D2011%26volume%3D22%26issue%3D3%26spage%3D635%26epage%3D648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yang-Gen  Hu</span>, <span class="hlFld-ContribAuthor ">Yan  Wang</span>, <span class="hlFld-ContribAuthor ">Shi-Ming  Du</span>, <span class="hlFld-ContribAuthor ">Xiao-Bao  Chen</span>, <span class="hlFld-ContribAuthor ">Ming-Wu  Ding</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient synthesis and biological evaluation of some 2,4-diamino-furo[2,3-d]pyrimidine derivatives. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (21)
                                     , 6188-6190. <a href="https://doi.org/10.1016/j.bmcl.2010.08.122" title="DOI URL">https://doi.org/10.1016/j.bmcl.2010.08.122</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2010.08.122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2010.08.122%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DEfficient%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bsome%252B2%25252C4-diamino-furo%25255B2%25252C3-d%25255Dpyrimidine%252Bderivatives%26aulast%3DHu%26aufirst%3DYang-Gen%26date%3D2010%26volume%3D20%26issue%3D21%26spage%3D6188%26epage%3D6190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nina  Gommermann</span>, <span class="hlFld-ContribAuthor ">Peter  Buehlmayer</span>, <span class="hlFld-ContribAuthor ">Anette  von Matt</span>, <span class="hlFld-ContribAuthor ">Werner  Breitenstein</span>, <span class="hlFld-ContribAuthor ">Keiichi  Masuya</span>, <span class="hlFld-ContribAuthor ">Bernard  Pirard</span>, <span class="hlFld-ContribAuthor ">Pascal  Furet</span>, <span class="hlFld-ContribAuthor ">Sandra W.  Cowan-Jacob</span>, <span class="hlFld-ContribAuthor ">Gisbert  Weckbecker</span>. </span><span class="cited-content_cbyCitation_article-title">New pyrazolo[1,5a]pyrimidines as orally active inhibitors of Lck. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (12)
                                     , 3628-3631. <a href="https://doi.org/10.1016/j.bmcl.2010.04.112" title="DOI URL">https://doi.org/10.1016/j.bmcl.2010.04.112</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2010.04.112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2010.04.112%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DNew%252Bpyrazolo%25255B1%25252C5a%25255Dpyrimidines%252Bas%252Borally%252Bactive%252Binhibitors%252Bof%252BLck%26aulast%3DGommermann%26aufirst%3DNina%26date%3D2010%26volume%3D20%26issue%3D12%26spage%3D3628%26epage%3D3631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Antonio  Garofalo</span>, <span class="hlFld-ContribAuthor ">Laurence  Goossens</span>, <span class="hlFld-ContribAuthor ">Amelie  Lemoine</span>, <span class="hlFld-ContribAuthor ">Amaury  Farce</span>, <span class="hlFld-ContribAuthor ">Yannick  Arlot</span>, <span class="hlFld-ContribAuthor ">Patrick  Depreux</span>. </span><span class="cited-content_cbyCitation_article-title">Quinazoline-urea, new protein kinase inhibitors in treatment of prostate cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2010,</strong> <em>25 </em>
                                    (2)
                                     , 158-171. <a href="https://doi.org/10.3109/14756360903169485" title="DOI URL">https://doi.org/10.3109/14756360903169485</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3109/14756360903169485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3109%2F14756360903169485%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DQuinazoline-urea%25252C%252Bnew%252Bprotein%252Bkinase%252Binhibitors%252Bin%252Btreatment%252Bof%252Bprostate%252Bcancer%26aulast%3DGarofalo%26aufirst%3DAntonio%26date%3D2010%26date%3D2010%26volume%3D25%26issue%3D2%26spage%3D158%26epage%3D171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephen G.  Spanton</span>, <span class="hlFld-ContribAuthor ">David  Whittern</span>. </span><span class="cited-content_cbyCitation_article-title">The development of an NMR chemical shift prediction application with the accuracy necessary to grade proton NMR spectra for identity. </span><span class="cited-content_cbyCitation_journal-name">Magnetic Resonance in Chemistry</span><span> <strong>2009,</strong> <em>47 </em>
                                    (12)
                                     , 1055-1061. <a href="https://doi.org/10.1002/mrc.2512" title="DOI URL">https://doi.org/10.1002/mrc.2512</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/mrc.2512&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmrc.2512%26sid%3Dliteratum%253Aachs%26jtitle%3DMagnetic%2520Resonance%2520in%2520Chemistry%26atitle%3DThe%252Bdevelopment%252Bof%252Ban%252BNMR%252Bchemical%252Bshift%252Bprediction%252Bapplication%252Bwith%252Bthe%252Baccuracy%252Bnecessary%252Bto%252Bgrade%252Bproton%252BNMR%252Bspectra%252Bfor%252Bidentity%26aulast%3DSpanton%26aufirst%3DStephen%2BG.%26date%3D2009%26date%3D2009%26volume%3D47%26issue%3D12%26spage%3D1055%26epage%3D1061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoyun  Lu</span>, <span class="hlFld-ContribAuthor ">Yadong  Chen</span>, <span class="hlFld-ContribAuthor ">Qidong  You</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacophore Guided 3D-QSAR CoMFA Analysis of Amino Substituted Nitrogen Heterocycle Ureas as KDR Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">QSAR & Combinatorial Science</span><span> <strong>2009,</strong> <em>28 </em>
                                    (11-12)
                                     , 1524-1536. <a href="https://doi.org/10.1002/qsar.200960032" title="DOI URL">https://doi.org/10.1002/qsar.200960032</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/qsar.200960032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fqsar.200960032%26sid%3Dliteratum%253Aachs%26jtitle%3DQSAR%2520%2526%2520Combinatorial%2520Science%26atitle%3DPharmacophore%252BGuided%252B3D-QSAR%252BCoMFA%252BAnalysis%252Bof%252BAmino%252BSubstituted%252BNitrogen%252BHeterocycle%252BUreas%252Bas%252BKDR%252BInhibitors%26aulast%3DLu%26aufirst%3DXiaoyun%26date%3D2009%26date%3D2009%26volume%3D28%26issue%3D11-12%26spage%3D1524%26epage%3D1536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amelia  Manlove</span>, <span class="hlFld-ContribAuthor ">Michael P.  Groziak</span>. </span><span class="cited-content_cbyCitation_article-title">Chapter 6.2: Six-Membered Ring Systems: Diazines and Benzo Derivatives. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2009,</strong>,, 375-414. <a href="https://doi.org/10.1016/S0959-6380(09)70040-6" title="DOI URL">https://doi.org/10.1016/S0959-6380(09)70040-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/S0959-6380(09)70040-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FS0959-6380%2809%2970040-6%26sid%3Dliteratum%253Aachs%26atitle%3DChapter%252B6.2%25253A%252BSix-Membered%252BRing%252BSystems%25253A%252BDiazines%252Band%252BBenzo%252BDerivatives%26aulast%3DManlove%26aufirst%3DAmelia%26date%3D2009%26spage%3D375%26epage%3D414%26pub%3DElsevier%26date%3D2009%26volume%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/medium/jm-2007-01397k_0019.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/large/jm-2007-01397k_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701397k&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/medium/jm-2007-01397k_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/large/jm-2007-01397k_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Compound <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/large/jm-2007-01397k_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701397k&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/medium/jm-2007-01397k_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/large/jm-2007-01397k_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Lead structure <b>2</b> and pyrazolo[1,5-<i>a</i>]pyrimidine <b>14</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/large/jm-2007-01397k_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701397k&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/medium/jm-2007-01397k_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/large/jm-2007-01397k_0005.jpeg" id="rightTab-gs1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of 7-Aminopyrazolo[1,5-<i>a</i>]pyrimidines <b>6</b> and <b>7</b> via Nitration<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/large/jm-2007-01397k_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701397k&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) concentrated HCl, EtOH, reflux, 74%; (b) HNO<sub>3</sub>, H<sub>2</sub>SO<sub>4</sub>, −20 °C to room temp; (c) Fe<sup>0</sup>, NH<sub>4</sub>Cl, THF, EtOH, H<sub>2</sub>O, 80 °C, 29% (two-step yield); (d) <i>m</i>-tolyl isocyanate, DMF, −20 °C to room temp, 47%; (e) benzoic acid, EDCI, HOBt, <i>N</i>-methylmorpholine, DMF, 60%.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/medium/jm-2007-01397k_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/large/jm-2007-01397k_0006.jpeg" id="rightTab-gs2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of 7-<i>des</i>-Aminopyrazolo[1,5-<i>a</i>]pyrimidine Urea <b>10</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/large/jm-2007-01397k_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701397k&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) concentrated HCl, EtOH, reflux, 93%; (b) HNO<sub>3</sub>, H<sub>2</sub>SO<sub>4</sub>, −20 °C to room temp; (c) Fe<sup>0</sup>, NH<sub>4</sub>Cl, THF, EtOH, H<sub>2</sub>O, 80 °C, 34% (two-step yield); (d) <i>m</i>-tolyl isocyanate, DMF, −20 °C to room temp, 51%.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/medium/jm-2007-01397k_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/large/jm-2007-01397k_0007.jpeg" id="rightTab-gs3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of 7-Aminopyrazolo[1,5-<i>a</i>]pyrimidine Urea <b>14</b> from 4-Nitrophenylacetonitrile<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/large/jm-2007-01397k_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701397k&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) CH(OCH<sub>3</sub>)<sub>2</sub>N(CH<sub>3</sub>)<sub>2</sub>, toluene, reflux, 95%; (b) 3-aminopyrazole, concentrated HCl, EtOH, reflux, 86%; (c) H<sub>2</sub> (1 atm), Pd/C, MeOH, 94%; (d) <i>m</i>-tolyl isocyanate, DMF, −20 °C to room temp, 75%.</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/medium/jm-2007-01397k_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/large/jm-2007-01397k_0008.jpeg" id="rightTab-gs4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of C3-Substituted 7-Aminopyrazolo[1,5-<i>a</i>]pyrimidine Urea <b>34</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/large/jm-2007-01397k_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701397k&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) POCl<sub>3</sub>, DMF, 0−70 °C, 79%; (b) NaBH<sub>4</sub>, MeOH, 92%; (c) SOCl<sub>2</sub>, CHCl<sub>3</sub>, reflux; (d) NaCN, DMSO, 43% (two-steps); (e) HCO<sub>2</sub>Et, NaH, catalytic EtOH, toluene; (f) H<sub>2</sub>NNH<sub>2</sub>·H<sub>2</sub>O, concentrated HCl, EtOH, reflux, 45% (two steps); (g) <b>11</b>, concentrated HCl, EtOH, reflux, 79%; (h) SnCl<sub>2</sub>, HCl, 0 °C to room temp, 80%; (i) <i>m</i>-tolyl isocyanate, DMF, −20 °C to room temp, 80%.</p></p></figure><figure data-id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/medium/jm-2007-01397k_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/large/jm-2007-01397k_0009.jpeg" id="rightTab-gs5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of C5-Substituted 7-Aminopyrazolo[1,5-<i>a</i>]pyrimidine <b>28</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/large/jm-2007-01397k_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701397k&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) CH<sub>3</sub>C(OCH<sub>3</sub>)<sub>2</sub>N(CH<sub>3</sub>)<sub>2</sub>, toluene, reflux, 76%; (b) 3-aminopyrazole, concentrated HCl, EtOH, reflux, 46%.</p></p></figure><figure data-id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/medium/jm-2007-01397k_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/large/jm-2007-01397k_0010.jpeg" id="rightTab-gs6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Compounds <b>36</b>−<b>38</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/large/jm-2007-01397k_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701397k&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) LiOH, H<sub>2</sub>O, THF, MeOH, 70 °C 84%; (b) MeNH<sub>2</sub>·HCl, EDCI, HOBt, NMM, DMF, 56%.</p></p></figure><figure data-id="fig3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/medium/jm-2007-01397k_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/large/jm-2007-01397k_0003.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Model of compound <b>6</b> bound to KDR kinase. Hydrogen bonds in black are shown between the urea and Glu 885 carboxylate, between the exocyclic amine and Glu 917 backbone carbonyl, and between the ring nitrogen and Cys 919 N−H. Also in thick bond are residues Asp 1046−Phe 1047 of the “DFG” motif in the “inactive” conformation (“DFG-out”).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/large/jm-2007-01397k_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701397k&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/medium/jm-2007-01397k_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/large/jm-2007-01397k_0004.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Comparison of proposed binding modes for compounds <b>43</b><a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> and <b>6</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm701397k/production/images/large/jm-2007-01397k_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm701397k&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i64">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54716" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54716" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 39 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Manning, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whyte, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sudarsanam, S.</span><span> </span><span class="NLM_article-title">The Protein Kinase Complement of the Human Genome</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">298</span><span class="NLM_x">, </span> <span class="NLM_fpage">1912</span><span class="NLM_x">–</span> <span class="NLM_lpage">1934</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm701397k&amp;key=10.1126%2Fscience.1075762" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm701397k&amp;key=12471243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm701397k&amp;key=1%3ACAS%3A528%3ADC%252BD38Xpt1Wisb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=298&publication_year=2002&pages=1912-1934&author=G.+Manningauthor=D.+B.+Whyteauthor=R.+Martinezauthor=T.+Hunterauthor=S.+Sudarsanam&title=The+Protein+Kinase+Complement+of+the+Human+Genome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The Protein Kinase Complement of the Human Genome</span></div><div class="casAuthors">Manning, G.; Whyte, D. B.; Martinez, R.; Hunter, T.; Sudarsanam, S.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">298</span>
        (<span class="NLM_cas:issue">5600</span>),
    <span class="NLM_cas:pages">1912-1916, 1933-1934</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">We have catalogued the protein kinase complement of the human genome (the "kinome") using public and proprietary genomic, complementary DNA, and expressed sequence tag (EST) sequences.  This provides a starting point for comprehensive anal. of protein phosphorylation in normal and disease states, as well as a detailed view of the current state of human genome anal. through a focus on one large gene family.  We identify 518 putative protein kinase genes, of which 71 have not previously been reported or described as kinases, and we extend or correct the protein sequences of 56 more kinases.  New genes include members of well-studied families as well as previously unidentified families, some of which are conserved in model organisms.  Classification and comparison with model organism kinomes identified orthologous groups and highlighted expansions specific to human and other lineages.  We also identified 106 protein kinase pseudogenes.  Chromosomal mapping revealed several small clusters of kinase genes and revealed that 244 kinases map to disease loci or cancer amplicons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTj1hf_0cQcrVg90H21EOLACvtfcHk0lhnSHk_k-WkoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xpt1Wisb0%253D&md5=b3def83bace52257a3252a3347b8bb92</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1126%2Fscience.1075762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1075762%26sid%3Dliteratum%253Aachs%26aulast%3DManning%26aufirst%3DG.%26aulast%3DWhyte%26aufirst%3DD.%2BB.%26aulast%3DMartinez%26aufirst%3DR.%26aulast%3DHunter%26aufirst%3DT.%26aulast%3DSudarsanam%26aufirst%3DS.%26atitle%3DThe%2520Protein%2520Kinase%2520Complement%2520of%2520the%2520Human%2520Genome%26jtitle%3DScience%26date%3D2002%26volume%3D298%26spage%3D1912%26epage%3D1934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Blume-Jensen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, T.</span><span> </span><span class="NLM_article-title">Oncogenic Kinase Signalling</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">411</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">365</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm701397k&amp;key=10.1038%2F35077225" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm701397k&amp;key=11357143" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm701397k&amp;key=1%3ACAS%3A528%3ADC%252BD3MXktVSjsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=411&publication_year=2001&pages=355-365&author=P.+Blume-Jensenauthor=T.+Hunter&title=Oncogenic+Kinase+Signalling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Oncogenic kinase signaling</span></div><div class="casAuthors">Blume-Jensen, Peter; Hunter, Tony</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">411</span>
        (<span class="NLM_cas:issue">6835</span>),
    <span class="NLM_cas:pages">355-365</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review with 93 refs.  Protein-tyrosine kinases (PTKs) are important regulators of intracellular signal-transduction pathways mediating development and multicellular communication in metazoans.  Their activity is normally tightly controlled and regulated.  Perturbation of PTK signaling by mutations and other genetic alterations results in deregulated kinase activity and malignant transformation.  The lipid kinase phosphoinositide 3-OH kinase (PI(3)K) and some of its downstream targets, such as the protein-serine/threonine kinases Akt and p70 S6 kinase (p70S6K), are crucial effectors in oncogenic PTK signaling.  This review emphasizes how oncogenic conversion of protein kinases results from perturbation of the normal autoinhibitory constraints on kinase activity and provides an update on our knowledge about the role of deregulated PI(3)K/Akt and mammalian target of rapamycin/p70S6K signaling in human malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJiBzQk4vjZbVg90H21EOLACvtfcHk0lhnSHk_k-WkoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXktVSjsr0%253D&md5=cd1bce803c2daadb98cbdba8550be43b</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2F35077225&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35077225%26sid%3Dliteratum%253Aachs%26aulast%3DBlume-Jensen%26aufirst%3DP.%26aulast%3DHunter%26aufirst%3DT.%26atitle%3DOncogenic%2520Kinase%2520Signalling%26jtitle%3DNature%26date%3D2001%26volume%3D411%26spage%3D355%26epage%3D365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Holmgren, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Reilly, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folkman, J.</span><span> </span><span class="NLM_article-title">Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">149</span><span class="NLM_x">–</span> <span class="NLM_lpage">153</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm701397k&amp;key=10.1038%2Fnm0295-149" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm701397k&amp;key=7585012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm701397k&amp;key=1%3ACAS%3A528%3ADyaK2MXksVeru78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1995&pages=149-153&author=L.+Holmgrenauthor=M.+S.+O%E2%80%99Reillyauthor=J.+Folkman&title=Dormancy+of+micrometastases%3A+Balanced+proliferation+and+apoptosis+in+the+presence+of+angiogenesis+suppression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression</span></div><div class="casAuthors">Holmgren, Lars; O'Reilly, Michael S.; Folkman, Judah</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">149-53</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Co.</span>)
        </div><div class="casAbstract">In cancer patients, dormant micrometastases are often asymptomatic and clin. undetectable, for months or years, until relapse.  We have studied dormant lung metastases under angiogenesis suppression in mice.  The metastases exhibited rapid growth when the inhibition of angiogenesis was removed.  Tumor cell proliferation, as measured by bromodeoxyuridine incorporation and immunohistochem. staining proliferating cell nuclear antigen, was not significantly different in dormant and growing metastases.  However, tumor cells of dormant metastases exhibited a more than threefold higher incidence of apoptosis.  These data show that metastases remain dormant when tumor cell proliferation is balanced by an equiv. rate of cell death and suggest that angiogenesis inhibitors control metastatic growth by indirectly increasing apoptosis in tumor cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqY4QX7Mmzn-7Vg90H21EOLACvtfcHk0lhnSHk_k-WkoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXksVeru78%253D&md5=ddda458c40fb17faf3d59781c47942fd</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnm0295-149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm0295-149%26sid%3Dliteratum%253Aachs%26aulast%3DHolmgren%26aufirst%3DL.%26aulast%3DO%25E2%2580%2599Reilly%26aufirst%3DM.%2BS.%26aulast%3DFolkman%26aufirst%3DJ.%26atitle%3DDormancy%2520of%2520micrometastases%253A%2520Balanced%2520proliferation%2520and%2520apoptosis%2520in%2520the%2520presence%2520of%2520angiogenesis%2520suppression%26jtitle%3DNat.%2520Med.%26date%3D1995%26volume%3D1%26spage%3D149%26epage%3D153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Fukumura, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gohongi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seed, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, R. K.</span><span> </span><span class="NLM_article-title">Hypoxia and Acidosis Independently Up-Regulate Vascular Endothelial Growth Factor Transcription in Brain Tumors in Vivo</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">6020</span><span class="NLM_x">–</span> <span class="NLM_lpage">6024</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=6020-6024&author=D.+Fukumuraauthor=L.+Xuauthor=Y.+Chenauthor=T.+Gohongiauthor=B.+Seedauthor=R.+K.+Jain&title=Hypoxia+and+Acidosis+Independently+Up-Regulate+Vascular+Endothelial+Growth+Factor+Transcription+in+Brain+Tumors+in+Vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFukumura%26aufirst%3DD.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DGohongi%26aufirst%3DT.%26aulast%3DSeed%26aufirst%3DB.%26aulast%3DJain%26aufirst%3DR.%2BK.%26atitle%3DHypoxia%2520and%2520Acidosis%2520Independently%2520Up-Regulate%2520Vascular%2520Endothelial%2520Growth%2520Factor%2520Transcription%2520in%2520Brain%2520Tumors%2520in%2520Vivo%26jtitle%3DCancer%2520Res.%26date%3D2001%26volume%3D61%26spage%3D6020%26epage%3D6024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Dvorak, H. F.</span><span> </span><span class="NLM_article-title">Vascular Permeability Factor/Vascular Endothelial Growth Factor: A Critical Cytokine in Tumor Angiogenesis and a Potential Target for Diagnosis and Therapy</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">4368</span><span class="NLM_x">–</span> <span class="NLM_lpage">4380</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm701397k&amp;key=10.1200%2FJCO.2002.10.088" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm701397k&amp;key=12409337" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm701397k&amp;key=1%3ACAS%3A528%3ADC%252BD38Xpt1CjtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2002&pages=4368-4380&author=H.+F.+Dvorak&title=Vascular+Permeability+Factor%2FVascular+Endothelial+Growth+Factor%3A+A+Critical+Cytokine+in+Tumor+Angiogenesis+and+a+Potential+Target+for+Diagnosis+and+Therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Vascular Permeability Factor/Vascular Endothelial Growth Factor: A Critical Cytokine in Tumor Angiogenesis and a Potential Target for Diagnosis and Therapy</span></div><div class="casAuthors">Dvorak, Harold F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">4368-4380</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review.  Vascular endothelial growth factor A (VEGF-A), the founding member of the vascular permeability factor (VPF)/VEGF family of proteins, is an important angiogenic cytokine with crit. roles in tumor angiogenesis.  This article reviews the literature with regard to VEGF-A's multiple functions, the mechanisms by which it induces angiogenesis, and its current and projected roles in clin. oncol.  VEGF-A is a multifunctional cytokine that is widely expressed by tumor cells and that acts through receptors (VEGFR-1, VEGFR-2, and neuropilin) that are expressed on vascular endothelium and on some other cells.  It increases microvascular permeability, induces endothelial cell migration and division, reprograms gene expression, promotes endothelial cell survival, prevents senescence, and induces angiogenesis.  Recently, VEGF-A has also been shown to induce lymphangiogenesis.  Measurements of circulating levels of VEGF-A may have value in estg. prognosis, and VEGF-A and its receptors are potential targets for therapy.  Recognized as the single most important angiogenic cytokine, VEGF-A has a central role in tumor biol. and will likely have an important role in future approaches designed to evaluate patient prognosis.  It may also become an important target for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7hJeymF1RYLVg90H21EOLACvtfcHk0liWbgPfzcLQBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xpt1CjtL0%253D&md5=3f173a57f2060a949d5ae17f46191df6</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1200%2FJCO.2002.10.088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2002.10.088%26sid%3Dliteratum%253Aachs%26aulast%3DDvorak%26aufirst%3DH.%2BF.%26atitle%3DVascular%2520Permeability%2520Factor%252FVascular%2520Endothelial%2520Growth%2520Factor%253A%2520A%2520Critical%2520Cytokine%2520in%2520Tumor%2520Angiogenesis%2520and%2520a%2520Potential%2520Target%2520for%2520Diagnosis%2520and%2520Therapy%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2002%26volume%3D20%26spage%3D4368%26epage%3D4380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Carmeliet, P.</span><span> </span><span class="NLM_article-title">VEGF as a Key Mediator of Angiogenesis in Cancer</span> <span class="citation_source-journal">Oncology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 3</span><span class="NLM_x">) </span> <span class="NLM_fpage">4</span><span class="NLM_x">–</span> <span class="NLM_lpage">10</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2005&pages=4-10&issue=Suppl.+3&author=P.+Carmeliet&title=VEGF+as+a+Key+Mediator+of+Angiogenesis+in+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarmeliet%26aufirst%3DP.%26atitle%3DVEGF%2520as%2520a%2520Key%2520Mediator%2520of%2520Angiogenesis%2520in%2520Cancer%26jtitle%3DOncology%26date%3D2005%26volume%3D69%26issue%3DSuppl.%25203%26spage%3D4%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Beck, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Amore, P. A.</span><span> </span><span class="NLM_article-title">Vascular development: cellular and molecular regulation</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">365</span><span class="NLM_x">–</span> <span class="NLM_lpage">373</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1997&pages=365-373&author=L.+Beckauthor=P.+A.+D%E2%80%99Amore&title=Vascular+development%3A+cellular+and+molecular+regulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeck%26aufirst%3DL.%26aulast%3DD%25E2%2580%2599Amore%26aufirst%3DP.%2BA.%26atitle%3DVascular%2520development%253A%2520cellular%2520and%2520molecular%2520regulation%26jtitle%3DFASEB%2520J.%26date%3D1997%26volume%3D11%26spage%3D365%26epage%3D373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Reynolds, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Killilea, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redmer, D. A.</span><span> </span><span class="NLM_article-title">Angiogenesis in the female reproductive system</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">886</span><span class="NLM_x">–</span> <span class="NLM_lpage">892</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1992&pages=886-892&author=L.+P.+Reynoldsauthor=S.+D.+Killileaauthor=D.+A.+Redmer&title=Angiogenesis+in+the+female+reproductive+system"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReynolds%26aufirst%3DL.%2BP.%26aulast%3DKillilea%26aufirst%3DS.%2BD.%26aulast%3DRedmer%26aufirst%3DD.%2BA.%26atitle%3DAngiogenesis%2520in%2520the%2520female%2520reproductive%2520system%26jtitle%3DFASEB%2520J.%26date%3D1992%26volume%3D6%26spage%3D886%26epage%3D892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Augustin, H. G.</span><span> </span><span class="NLM_article-title">Antiangiogenic tumor therapy: will it work?</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">216</span><span class="NLM_x">–</span> <span class="NLM_lpage">222</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1998&pages=216-222&author=H.+G.+Augustin&title=Antiangiogenic+tumor+therapy%3A+will+it+work%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAugustin%26aufirst%3DH.%2BG.%26atitle%3DAntiangiogenic%2520tumor%2520therapy%253A%2520will%2520it%2520work%253F%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D1998%26volume%3D19%26spage%3D216%26epage%3D222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Ferrara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillan, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerber, H.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novotny, W.</span><span> </span><span class="NLM_article-title">Discovery and Development of Bevacizumab, an Anti-VEGF Antibody for Treating Cancer</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">391</span><span class="NLM_x">–</span> <span class="NLM_lpage">400</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm701397k&amp;key=10.1038%2Fnrd1381" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm701397k&amp;key=15136787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm701397k&amp;key=1%3ACAS%3A528%3ADC%252BD2cXktlCrt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=391-400&author=N.+Ferraraauthor=K.+J.+Hillanauthor=H.-P.+Gerberauthor=W.+Novotny&title=Discovery+and+Development+of+Bevacizumab%2C+an+Anti-VEGF+Antibody+for+Treating+Cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer</span></div><div class="casAuthors">Ferrara, Napoleone; Hillan, Kenneth J.; Gerber, Hans-Peter; Novotny, William</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">391-400</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The existence of factors that stimulate blood vessel growth, thereby recruiting a neovascular supply to nourish a growing tumor, was postulated many decades ago, although the identification and isolation of these factors proved elusive.  Now, vascular endothelial growth factor (VEGF), which was identified in the 1980s, is recognized as an essential regulator of normal and abnormal blood vessel growth.  In 1993, it was shown that a monoclonal antibody that targeted VEGF results in a dramatic suppression of tumor growth in vivo, which led to the development of bevacizumab (Avastin; Genentech), a humanized variant of this anti-VEGF antibody, as an anticancer agent.  The recent approval of bevacizumab by the US FDA as a first-line therapy for metastatic colorectal cancer validates the ideas that VEGF is a key mediator of tumor angiogenesis and that blocking angiogenesis is an effective strategy to treat human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphaLbfhdBKOLVg90H21EOLACvtfcHk0liWbgPfzcLQBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXktlCrt78%253D&md5=4b1f647db4dfe2a24449cdf59b874e7c</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnrd1381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1381%26sid%3Dliteratum%253Aachs%26aulast%3DFerrara%26aufirst%3DN.%26aulast%3DHillan%26aufirst%3DK.%2BJ.%26aulast%3DGerber%26aufirst%3DH.-P.%26aulast%3DNovotny%26aufirst%3DW.%26atitle%3DDiscovery%2520and%2520Development%2520of%2520Bevacizumab%252C%2520an%2520Anti-VEGF%2520Antibody%2520for%2520Treating%2520Cancer%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D391%26epage%3D400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Gschwind, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, O. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ullrich, A.</span><span> </span><span class="NLM_article-title">The Discovery of Receptor Tyrosine Kinases: Targets for Cancer Therapy</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">361</span><span class="NLM_x">–</span> <span class="NLM_lpage">370</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm701397k&amp;key=10.1038%2Fnrc1360" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm701397k&amp;key=15122207" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm701397k&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjsFSlu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=361-370&author=A.+Gschwindauthor=O.+M.+Fischerauthor=A.+Ullrich&title=The+Discovery+of+Receptor+Tyrosine+Kinases%3A+Targets+for+Cancer+Therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Timeline: The discovery of receptor tyrosine kinases: targets for cancer therapy</span></div><div class="casAuthors">Gschwind, Andreas; Fischer, Oliver M.; Ullrich, Axel</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">361-370</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Receptor tyrosine kinases are a subclass of cell-surface growth-factor receptors with an intrinsic, ligand-controlled tyrosine-kinase activity.  They regulate diverse functions in normal cells and have a crucial role in oncogenesis.  Twenty years ago, the 1st primary structure of a receptor Tyr kinase, the epidermal growth factor receptor, was elucidated.  The characterization of both the mol. architecture of receptor Tyr kinases and the main functions of these proteins and their ligands in tumorigenesis opened the door to a new era in mol. oncol. and paved the way to the development of the 1st target-specific cancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1NLVNn4dw37Vg90H21EOLACvtfcHk0liWbgPfzcLQBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjsFSlu7g%253D&md5=ea24c0ccaea68b743b5da9587ed19406</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnrc1360&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1360%26sid%3Dliteratum%253Aachs%26aulast%3DGschwind%26aufirst%3DA.%26aulast%3DFischer%26aufirst%3DO.%2BM.%26aulast%3DUllrich%26aufirst%3DA.%26atitle%3DThe%2520Discovery%2520of%2520Receptor%2520Tyrosine%2520Kinases%253A%2520Targets%2520for%2520Cancer%2520Therapy%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2004%26volume%3D4%26spage%3D361%26epage%3D370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Board, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayson, G. C.</span><span> </span><span class="NLM_article-title">Platelet-Derived Growth Factor Receptor (PDGFR): A Target for Anticancer Therapeutics</span> <span class="citation_source-journal">Drug Resist. Updates</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">75</span><span class="NLM_x">–</span> <span class="NLM_lpage">83</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm701397k&amp;key=10.1016%2Fj.drup.2005.03.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm701397k&amp;key=15939344" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm701397k&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltVaqtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2005&pages=75-83&author=R.+Boardauthor=G.+C.+Jayson&title=Platelet-Derived+Growth+Factor+Receptor+%28PDGFR%29%3A+A+Target+for+Anticancer+Therapeutics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Platelet-derived growth factor receptor (PDGFR): A target for anticancer therapeutics</span></div><div class="casAuthors">Board, Ruth; Jayson, Gordon C.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Resistance Updates</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">75-83</span>CODEN:
                <span class="NLM_cas:coden">DRUPFW</span>;
        ISSN:<span class="NLM_cas:issn">1368-7646</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Platelet-derived growth factors (PDGFs) and their tyrosine kinase receptors (PDGFRs) have been implicated in the pathogenesis of a no. of tumor types and play an important role in angiogenesis.  Tumor growth can be promoted by PDGF via autocrine stimulation of malignant cells, by overexpression or overactivation of PDGFRs, or by stimulation of angiogenesis within the tumor.  These mechanisms could provide possible therapeutic targets.  PDGFR blockade may also lower the interstitial fluid pressure within solid tumors and enhance drug delivery.  Here we discuss the possible therapeutic roles of PDGFR antagonists in the treatment of cancer, alone and in combination with chemotherapy or other targeted agents.  Extensive exptl. data highlight the potential therapeutic advantage of targeting PDGFR.  However, recent clin. data suggest that antagonism of this growth factor is assocd. with fluid accumulation that could obscure any clin. benefit.  Further clin. research is required to optimize inhibition of this cytokine-receptor system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOZ-2MVJdiQbVg90H21EOLACvtfcHk0lh-auyIjWJ2Vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltVaqtLk%253D&md5=9083a98f34a4b2e6e775498a28d7923b</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.drup.2005.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drup.2005.03.004%26sid%3Dliteratum%253Aachs%26aulast%3DBoard%26aufirst%3DR.%26aulast%3DJayson%26aufirst%3DG.%2BC.%26atitle%3DPlatelet-Derived%2520Growth%2520Factor%2520Receptor%2520%2528PDGFR%2529%253A%2520A%2520Target%2520for%2520Anticancer%2520Therapeutics%26jtitle%3DDrug%2520Resist.%2520Updates%26date%3D2005%26volume%3D8%26spage%3D75%26epage%3D83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Sun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">App, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMahon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, C.</span><span> </span><span class="NLM_article-title">Synthesis and Biological Evaluations of 3-Substituted Indolin-2-ones: A Novel Class of Tyrosine Kinase Inhibitors That Exhibit Selectivity toward Particular Receptor Tyrosine Kinases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">2588</span><span class="NLM_x">–</span> <span class="NLM_lpage">2603</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm980123i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm701397k&amp;key=1%3ACAS%3A528%3ADyaK1cXkt12jtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=2588-2603&author=L.+Sunauthor=N.+Tranauthor=F.+Tangauthor=H.+Appauthor=P.+Hirthauthor=G.+McMahonauthor=C.+Tang&title=Synthesis+and+Biological+Evaluations+of+3-Substituted+Indolin-2-ones%3A+A+Novel+Class+of+Tyrosine+Kinase+Inhibitors+That+Exhibit+Selectivity+toward+Particular+Receptor+Tyrosine+Kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluations of 3-Substituted Indolin-2-ones: A Novel Class of Tyrosine Kinase Inhibitors That Exhibit Selectivity toward Particular Receptor Tyrosine Kinases</span></div><div class="casAuthors">Sun, Li; Tran, Ngoc; Tang, Flora; App, Harald; Hirth, Peter; McMahon, Gerald; Tang, Cho</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2588-2603</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">3-Substituted indolin-2-ones have been designed and synthesized as a novel class of tyrosine kinase inhibitors which exhibit selectivity toward different receptor tyrosine kinases (RTKs).  These compds. have been evaluated for their relative inhibitory properties against a panel of RTKs in intact cells.  By modifying the 3-substituted indolin-2-ones, we have identified compds. which showed selective inhibition of the ligand-dependent autophosphorylation of various RTKs at submicromolar levels in cells.  Structure-activity anal. for these compds. and their relative potency and selectivity to inhibit particular RTKs has detd. that (1) 3-[(five-membered heteroaryl ring)methylidenyl]indolin-2-ones are highly specific against the VEGF (Flk-1) RTK activity, (2) 3-(substituted benzylidenyl)indolin-2-ones contg. bulky group(s) in the Ph ring at the C-3 position of indolin-2-ones showed high selectivity toward the EGF and Her-2 RTKs, and (3) the compd. contg. an extended side chain at the C-3 position of the indolin-2-one exhibited high potency and selectivity when tested against the PDGF and VEGF (Flk-1) RTKs.  Recent published crystallog. data for two of these 3-substituted indolin-2-ones provides a rationale to suggest that these compds. may bind in the ATP binding pocket of RTKs.  The structure-activity anal. supports the use of subsets of these compds. as specific chem. leads for the development of RTK-specific drugs with broad application for the treatment of human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJoPixq8Am5rVg90H21EOLACvtfcHk0lh-auyIjWJ2Vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkt12jtrw%253D&md5=536302b717170a630008dac14832204c</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm980123i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm980123i%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DL.%26aulast%3DTran%26aufirst%3DN.%26aulast%3DTang%26aufirst%3DF.%26aulast%3DApp%26aufirst%3DH.%26aulast%3DHirth%26aufirst%3DP.%26aulast%3DMcMahon%26aufirst%3DG.%26aulast%3DTang%26aufirst%3DC.%26atitle%3DSynthesis%2520and%2520Biological%2520Evaluations%2520of%25203-Substituted%2520Indolin-2-ones%253A%2520A%2520Novel%2520Class%2520of%2520Tyrosine%2520Kinase%2520Inhibitors%2520That%2520Exhibit%2520Selectivity%2520toward%2520Particular%2520Receptor%2520Tyrosine%2520Kinases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D2588%26epage%3D2603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Laird, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vajkoczy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shawver, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thurnher, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohammadi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlessinger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ullrich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blake, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fong, T. A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strawn, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawtin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shenoy, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirth, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMahon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherrington, J. M.</span><span> </span><span class="NLM_article-title">SU6668 Is a Potent Antiangiogenic and Antitumor Agent That Induces Regression of Established Tumors</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">4152</span><span class="NLM_x">–</span> <span class="NLM_lpage">4160</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm701397k&amp;key=10945623" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm701397k&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlvFOkt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2000&pages=4152-4160&author=A.+D.+Lairdauthor=P.+Vajkoczyauthor=L.+K.+Shawverauthor=A.+Thurnherauthor=C.+Liangauthor=M.+Mohammadiauthor=J.+Schlessingerauthor=A.+Ullrichauthor=S.+R.+Hubbardauthor=R.+A.+Blakeauthor=T.+A.+T.+Fongauthor=L.+M.+Strawnauthor=L.+Sunauthor=C.+Tangauthor=R.+Hawtinauthor=F.+Tangauthor=N.+Shenoyauthor=K.+P.+Hirthauthor=G.+McMahonauthor=J.+M.+Cherrington&title=SU6668+Is+a+Potent+Antiangiogenic+and+Antitumor+Agent+That+Induces+Regression+of+Established+Tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors</span></div><div class="casAuthors">Laird, A. Douglas; Vajkoczy, Peter; Shawver, Laura K.; Thurnher, Andreas; Liang, Congxin; Mohammadi, Moosa; Schlessinger, Joseph; Ullrich, Axel; Hubbard, Stevan R.; Blake, Robert A.; Fong, T. Annie T.; Strawn, Laurie M.; Sun, Li; Tang, Cho; Hawtin, Rachael; Tang, Flora; Shenoy, Narmada; Hirth, K. Peter; McMahon, Gerald; Cherrington, Julie M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4152-4160</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Vascular endothelial growth factor, fibroblast growth factor (FGF), and platelet-derived growth factor (PDGF) and their cognate receptor tyrosine kinases are strongly implicated in angiogenesis assocd. with solid tumors.  Using rational drug design coupled with traditional screening technologies, we have discovered SU6668, a novel inhibitor of these receptors.  Biochem. kinetic studies using isolated Flk-1, FGF receptor 1, and PDGF receptor β kinases revealed that SU6668 has competitive inhibitory properties with respect to ATP.  Cocrystallog. studies of SU6668 in the catalytic domain of FGF receptor 1 substantiated the adenine mimetic properties of its oxindole core.  Mol. modeling of SU6668 in the ATP binding pockets of the Flk-1/KDR and PDGF receptor kinases provided insight to explain the relative potency and selectivity of SU6668 for these receptors.  In cellular systems, SU6668 inhibited receptor tyrosine phosphorylation and mitogenesis after stimulation of cells by appropriate ligands.  Oral or i.p. administration of SU6668 in athymic mice resulted in significant growth inhibition of a diverse panel of human tumor xenografts of glioma, melanoma, lung, colon, ovarian, and epidermoid origin.  Furthermore, intravital multifluorescence videomicroscopy of C6 glioma xenografts in the dorsal skin-fold chamber model revealed that SU6668 treatment suppressed tumor angiogenesis.  Finally, SU6668 treatment induced striking regression of large established human tumor xenografts.  Investigations of SU6668 activity in cancer patients are ongoing in Phase I clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTk0pWiW_VTLVg90H21EOLACvtfcHk0lh-auyIjWJ2Vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlvFOkt7s%253D&md5=328030bf6f79955394237b08877c07f6</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLaird%26aufirst%3DA.%2BD.%26aulast%3DVajkoczy%26aufirst%3DP.%26aulast%3DShawver%26aufirst%3DL.%2BK.%26aulast%3DThurnher%26aufirst%3DA.%26aulast%3DLiang%26aufirst%3DC.%26aulast%3DMohammadi%26aufirst%3DM.%26aulast%3DSchlessinger%26aufirst%3DJ.%26aulast%3DUllrich%26aufirst%3DA.%26aulast%3DHubbard%26aufirst%3DS.%2BR.%26aulast%3DBlake%26aufirst%3DR.%2BA.%26aulast%3DFong%26aufirst%3DT.%2BA.%2BT.%26aulast%3DStrawn%26aufirst%3DL.%2BM.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DTang%26aufirst%3DC.%26aulast%3DHawtin%26aufirst%3DR.%26aulast%3DTang%26aufirst%3DF.%26aulast%3DShenoy%26aufirst%3DN.%26aulast%3DHirth%26aufirst%3DK.%2BP.%26aulast%3DMcMahon%26aufirst%3DG.%26aulast%3DCherrington%26aufirst%3DJ.%2BM.%26atitle%3DSU6668%2520Is%2520a%2520Potent%2520Antiangiogenic%2520and%2520Antitumor%2520Agent%2520That%2520Induces%2520Regression%2520of%2520Established%2520Tumors%26jtitle%3DCancer%2520Res.%26date%3D2000%26volume%3D60%26spage%3D4152%26epage%3D4160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Fong, T. A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shawver, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">App, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreck, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Risau, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ullrich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirth, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMahon, G.</span><span> </span><span class="NLM_article-title">SU5416 Is a Potent and Selective Inhibitor of the Vascular Endothelial Growth Factor Receptor (Flk-1/KDR) That Inhibits Tyrosine Kinase Catalysis, Tumor Vascularization, and Growth of Multiple Tumor Types</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">99</span><span class="NLM_x">–</span> <span class="NLM_lpage">106</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm701397k&amp;key=9892193" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm701397k&amp;key=1%3ACAS%3A528%3ADyaK1MXmsFOgug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1999&pages=99-106&author=T.+A.+T.+Fongauthor=L.+K.+Shawverauthor=L.+Sunauthor=C.+Tangauthor=H.+Appauthor=T.+J.+Powellauthor=Y.+H.+Kimauthor=R.+Schreckauthor=X.+Wangauthor=W.+Risauauthor=A.+Ullrichauthor=K.+P.+Hirthauthor=G.+McMahon&title=SU5416+Is+a+Potent+and+Selective+Inhibitor+of+the+Vascular+Endothelial+Growth+Factor+Receptor+%28Flk-1%2FKDR%29+That+Inhibits+Tyrosine+Kinase+Catalysis%2C+Tumor+Vascularization%2C+and+Growth+of+Multiple+Tumor+Types"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types</span></div><div class="casAuthors">Fong, T. Annie T.; Shawver, Laura K.; Sun, Li; Tang, Cho; App, Harald; Powell, T. Jeff; Kim, Young H.; Schreck, Randall; Wang, Xueyan; Risau, Werner; Ullrich, Axel; Hirth, K. Peter; McMahon, Gerald</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">99-106</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">AACR Subscription Office</span>)
        </div><div class="casAbstract">SU5416, a novel synthetic compd., is a potent and selective inhibitor of the Flk-1/KDR receptor tyrosine kinase that is presently under evaluation in Phase I clin. studies for the treatment of human cancers.  SU5416 was shown to inhibit vascular endothelial growth factor-dependent mitogenesis of human endothelial cells without inhibiting the growth of a variety of tumor cells in vitro.  In contrast, systemic administration of SU5416 at nontoxic doses in mice resulted in inhibition of s.c. tumor growth of cells derived from various tissue origins.  The antitumor effect of SU5416 was accompanied by the appearance of pale white tumors that were resected from drug-treated animals, supporting the antiangiogenic property of this agent.  These findings support that pharmacol. inhibition of the enzymic activity of the vascular endothelial growth factor receptor represents a novel strategy for limiting the growth of a wide variety of tumor types.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiq1KqJ-CsCrVg90H21EOLACvtfcHk0ljydSq9HVJjAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmsFOgug%253D%253D&md5=92a2610ecfcdc996a6a79b0b559c4852</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFong%26aufirst%3DT.%2BA.%2BT.%26aulast%3DShawver%26aufirst%3DL.%2BK.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DTang%26aufirst%3DC.%26aulast%3DApp%26aufirst%3DH.%26aulast%3DPowell%26aufirst%3DT.%2BJ.%26aulast%3DKim%26aufirst%3DY.%2BH.%26aulast%3DSchreck%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DRisau%26aufirst%3DW.%26aulast%3DUllrich%26aufirst%3DA.%26aulast%3DHirth%26aufirst%3DK.%2BP.%26aulast%3DMcMahon%26aufirst%3DG.%26atitle%3DSU5416%2520Is%2520a%2520Potent%2520and%2520Selective%2520Inhibitor%2520of%2520the%2520Vascular%2520Endothelial%2520Growth%2520Factor%2520Receptor%2520%2528Flk-1%252FKDR%2529%2520That%2520Inhibits%2520Tyrosine%2520Kinase%2520Catalysis%252C%2520Tumor%2520Vascularization%252C%2520and%2520Growth%2520of%2520Multiple%2520Tumor%2520Types%26jtitle%3DCancer%2520Res.%26date%3D1999%26volume%3D59%26spage%3D99%26epage%3D106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Sun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hubbard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreck, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMahon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, C.</span><span> </span><span class="NLM_article-title">Identification of Substituted 3-[(4,5,6,7-Tetrahydro-1<i>H</i>-indol-2-yl)methylene]-1,3-dihydroindol-2-ones as Growth Factor Receptor Inhibitors for VEGF-R2 (Flk-1/KDR), FGF-R1, and PDGF-Rβ Tyrosine Kinases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">2655</span><span class="NLM_x">–</span> <span class="NLM_lpage">2663</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9906116" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=2655-2663&author=L.+Sunauthor=N.+Tranauthor=C.+Liangauthor=S.+Hubbardauthor=F.+Tangauthor=K.+Lipsonauthor=R.+Schreckauthor=Y.+Zhouauthor=G.+McMahonauthor=C.+Tang&title=Identification+of+Substituted+3-%5B%284%2C5%2C6%2C7-Tetrahydro-1H-indol-2-yl%29methylene%5D-1%2C3-dihydroindol-2-ones+as+Growth+Factor+Receptor+Inhibitors+for+VEGF-R2+%28Flk-1%2FKDR%29%2C+FGF-R1%2C+and+PDGF-R%CE%B2+Tyrosine+Kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm9906116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9906116%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DL.%26aulast%3DTran%26aufirst%3DN.%26aulast%3DLiang%26aufirst%3DC.%26aulast%3DHubbard%26aufirst%3DS.%26aulast%3DTang%26aufirst%3DF.%26aulast%3DLipson%26aufirst%3DK.%26aulast%3DSchreck%26aufirst%3DR.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DMcMahon%26aufirst%3DG.%26aulast%3DTang%26aufirst%3DC.%26atitle%3DIdentification%2520of%2520Substituted%25203-%255B%25284%252C5%252C6%252C7-Tetrahydro-1H-indol-2-yl%2529methylene%255D-1%252C3-dihydroindol-2-ones%2520as%2520Growth%2520Factor%2520Receptor%2520Inhibitors%2520for%2520VEGF-R2%2520%2528Flk-1%252FKDR%2529%252C%2520FGF-R1%252C%2520and%2520PDGF-R%25CE%25B2%2520Tyrosine%2520Kinases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D2655%26epage%3D2663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Klebl, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, G.</span><span> </span><span class="NLM_article-title">Second-generation kinase inhibitors</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">975</span><span class="NLM_x">–</span> <span class="NLM_lpage">993</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm701397k&amp;key=10.1517%2F14728222.9.5.975" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm701397k&amp;key=16185153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm701397k&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVartbfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2005&pages=975-993&author=B.+M.+Kleblauthor=G.+M%C3%BCller&title=Second-generation+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Second-generation kinase inhibitors</span></div><div class="casAuthors">Klebl, Bert M.; Mueller, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">975-993</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  An increasing no. of kinase inhibitor candidates are entering clin. development, representing an important change in the pharmaceutical industry; notably, the development of small-mol. kinase inhibitors for signal transduction therapies.  Today, kinase inhibitors garner substantial attention in cancer research.  Over the last few years, three distinct small-mol. kinase inhibitors reached the market for treatment of chronic myeloid leukemia, gastrointestinal stromal tumors, and non-small cell lung cancers.  These three drugs, imatinib, gefitinib and erlotinib, act on a distinct subset of dysregulated, and often cancer-relevant kinases.  Imatinib, gefitinib and erlotinib are considered the front-runners of targeted kinase inhibitor drugs.  The entire research field gains tremendous insights through the ongoing research and clin. trials with these three drugs and with fast following first-generation kinase inhibitors, many of which are in different phases of clin. development.  In addn., novel chemogenomic and chemoproteomic technologies are emanating from the current kinase research area, focussing efforts on the generation of spectrum-selective inhibitors for anticancer therapies as opposed to the monospecific inhibitors for the remaining therapeutic areas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJli31wX5cJbVg90H21EOLACvtfcHk0ljydSq9HVJjAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVartbfN&md5=81c46202984d0fe908b7315008839b03</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1517%2F14728222.9.5.975&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.9.5.975%26sid%3Dliteratum%253Aachs%26aulast%3DKlebl%26aufirst%3DB.%2BM.%26aulast%3DM%25C3%25BCller%26aufirst%3DG.%26atitle%3DSecond-generation%2520kinase%2520inhibitors%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2005%26volume%3D9%26spage%3D975%26epage%3D993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Hicklin, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, L. M.</span><span> </span><span class="NLM_article-title">Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1011</span><span class="NLM_x">–</span> <span class="NLM_lpage">1027</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm701397k&amp;key=10.1200%2FJCO.2005.06.081" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm701397k&amp;key=15585754" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm701397k&amp;key=1%3ACAS%3A528%3ADC%252BD2MXit1Gnsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=1011-1027&author=D.+J.+Hicklinauthor=L.+M.+Ellis&title=Role+of+the+Vascular+Endothelial+Growth+Factor+Pathway+in+Tumor+Growth+and+Angiogenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis</span></div><div class="casAuthors">Hicklin, Daniel J.; Ellis, Lee M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1011-1027</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">A review.  New blood vessel formation (angiogenesis) is a fundamental event in the process of tumor growth and metastatic dissemination.  Hence, the mol. basis of tumor angiogenesis has been of keen interest in the field of cancer research.  The vascular endothelial growth factor (VEGF) pathway is well established as one of the key regulators of this process.  The VEGF/VEGF-receptor axis is composed of multiple ligands and receptors with overlapping and distinct ligand-receptor binding specificities, cell-type expression, and function.  Activation of the VEGF-receptor pathway triggers a network of signaling processes that promote endothelial cell growth, migration, and survival from pre-existing vasculature.  In addn., VEGF mediates vessel permeability, and has been assocd. with malignant effusions.  More recently, an important role for VEGF has emerged in mobilization of endothelial progenitor cells from the bone marrow to distant sites of neovascularization.  The well-established role of VEGF in promoting tumor angiogenesis and the pathogenesis of human cancers has led to the rational design and development of agents that selectively target this pathway.  Studies with various anti-VEGF/VEGF-receptor therapies have shown that these agents can potently inhibit angiogenesis and tumor growth in preclin. models.  Recently, an anti-VEGF antibody (bevacizumab), when used in combination with chemotherapy, was shown to significantly improve survival and response rates in patients with metastatic colorectal cancer and thus, validate VEGF pathway inhibitors as an important new treatment modality in cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlR9xM1kwuKrVg90H21EOLACvtfcHk0lgbLc0hKUmfeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXit1Gnsro%253D&md5=599f10c7b6d935c7bc2fa7ce6f6949b3</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1200%2FJCO.2005.06.081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2005.06.081%26sid%3Dliteratum%253Aachs%26aulast%3DHicklin%26aufirst%3DD.%2BJ.%26aulast%3DEllis%26aufirst%3DL.%2BM.%26atitle%3DRole%2520of%2520the%2520Vascular%2520Endothelial%2520Growth%2520Factor%2520Pathway%2520in%2520Tumor%2520Growth%2520and%2520Angiogenesis%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2005%26volume%3D23%26spage%3D1011%26epage%3D1027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Casanovas, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hicklin, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergers, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanahan, D.</span><span> </span><span class="NLM_article-title">Drug Resistance by Evasion of Antiangiogenic Targeting of VEGF Signaling in Late-Stage Pancreatic Islet Tumors</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">299</span><span class="NLM_x">–</span> <span class="NLM_lpage">309</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2005&pages=299-309&author=O.+Casanovasauthor=D.+J.+Hicklinauthor=G.+Bergersauthor=D.+Hanahan&title=Drug+Resistance+by+Evasion+of+Antiangiogenic+Targeting+of+VEGF+Signaling+in+Late-Stage+Pancreatic+Islet+Tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCasanovas%26aufirst%3DO.%26aulast%3DHicklin%26aufirst%3DD.%2BJ.%26aulast%3DBergers%26aufirst%3DG.%26aulast%3DHanahan%26aufirst%3DD.%26atitle%3DDrug%2520Resistance%2520by%2520Evasion%2520of%2520Antiangiogenic%2520Targeting%2520of%2520VEGF%2520Signaling%2520in%2520Late-Stage%2520Pancreatic%2520Islet%2520Tumors%26jtitle%3DCancer%2520Cell%26date%3D2005%26volume%3D8%26spage%3D299%26epage%3D309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Sun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirazian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuda, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, J.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nematalla, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sistla, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luu, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, C.</span><span> </span><span class="NLM_article-title">Discovery of 5-[5-Fluoro-2-oxo-1,2-dihydroindol-(3<i>Z</i>)-ylidenemethyl]-2,4-dimethyl-1<i>H</i>-pyrrole-3-carboxylic Acid (2-Dimethylaminoethyl)amide, a Novel Tyrosine Kinase Inhibitor Targeting Vascular Endothelial and Platelet-Derived Growth Factor Receptor Tyrosine Kinase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1116</span><span class="NLM_x">–</span> <span class="NLM_lpage">1119</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0204183" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=1116-1119&author=L.+Sunauthor=C.+Liangauthor=S.+Shirazianauthor=Y.+Zhouauthor=T.+Millerauthor=J.+Cuiauthor=J.+Y.+Fukudaauthor=J.-Y.+Chuauthor=A.+Nematallaauthor=X.+Wangauthor=H.+Chenauthor=A.+Sistlaauthor=T.+C.+Luuauthor=F.+Tangauthor=J.+Weiauthor=C.+Tang&title=Discovery+of+5-%5B5-Fluoro-2-oxo-1%2C2-dihydroindol-%283Z%29-ylidenemethyl%5D-2%2C4-dimethyl-1H-pyrrole-3-carboxylic+Acid+%282-Dimethylaminoethyl%29amide%2C+a+Novel+Tyrosine+Kinase+Inhibitor+Targeting+Vascular+Endothelial+and+Platelet-Derived+Growth+Factor+Receptor+Tyrosine+Kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm0204183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0204183%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DL.%26aulast%3DLiang%26aufirst%3DC.%26aulast%3DShirazian%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DMiller%26aufirst%3DT.%26aulast%3DCui%26aufirst%3DJ.%26aulast%3DFukuda%26aufirst%3DJ.%2BY.%26aulast%3DChu%26aufirst%3DJ.-Y.%26aulast%3DNematalla%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DSistla%26aufirst%3DA.%26aulast%3DLuu%26aufirst%3DT.%2BC.%26aulast%3DTang%26aufirst%3DF.%26aulast%3DWei%26aufirst%3DJ.%26aulast%3DTang%26aufirst%3DC.%26atitle%3DDiscovery%2520of%25205-%255B5-Fluoro-2-oxo-1%252C2-dihydroindol-%25283Z%2529-ylidenemethyl%255D-2%252C4-dimethyl-1H-pyrrole-3-carboxylic%2520Acid%2520%25282-Dimethylaminoethyl%2529amide%252C%2520a%2520Novel%2520Tyrosine%2520Kinase%2520Inhibitor%2520Targeting%2520Vascular%2520Endothelial%2520and%2520Platelet-Derived%2520Growth%2520Factor%2520Receptor%2520Tyrosine%2520Kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D1116%26epage%3D1119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Wilhelm, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkie, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNabola, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincent, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHugh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shujath, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gawlak, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eveleigh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adnane, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auclair, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gedrich, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voznesensky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riedl, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Post, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bollag, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trail, P. A.</span><span> </span><span class="NLM_article-title">BAY 43-9006 Exhibits Broad Spectrum Oral Antitumor Activity and Targets the RAF/MEK/ERK Pathway and Receptor Tyrosine Kinases Involved in Tumor Progression and Angiogenesis</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">7099</span><span class="NLM_x">–</span> <span class="NLM_lpage">7109</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=7099-7109&author=S.+M.+Wilhelmauthor=C.+Carterauthor=L.+Tangauthor=D.+Wilkieauthor=A.+McNabolaauthor=H.+Rongauthor=C.+Chenauthor=X.+Zhangauthor=P.+Vincentauthor=M.+McHughauthor=Y.+Caoauthor=J.+Shujathauthor=S.+Gawlakauthor=D.+Eveleighauthor=B.+Rowleyauthor=L.+Liuauthor=L.+Adnaneauthor=M.+Lynchauthor=D.+Auclairauthor=I.+Taylorauthor=R.+Gedrichauthor=A.+Voznesenskyauthor=B.+Riedlauthor=L.+E.+Postauthor=G.+Bollagauthor=P.+A.+Trail&title=BAY+43-9006+Exhibits+Broad+Spectrum+Oral+Antitumor+Activity+and+Targets+the+RAF%2FMEK%2FERK+Pathway+and+Receptor+Tyrosine+Kinases+Involved+in+Tumor+Progression+and+Angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilhelm%26aufirst%3DS.%2BM.%26aulast%3DCarter%26aufirst%3DC.%26aulast%3DTang%26aufirst%3DL.%26aulast%3DWilkie%26aufirst%3DD.%26aulast%3DMcNabola%26aufirst%3DA.%26aulast%3DRong%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DVincent%26aufirst%3DP.%26aulast%3DMcHugh%26aufirst%3DM.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DShujath%26aufirst%3DJ.%26aulast%3DGawlak%26aufirst%3DS.%26aulast%3DEveleigh%26aufirst%3DD.%26aulast%3DRowley%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DAdnane%26aufirst%3DL.%26aulast%3DLynch%26aufirst%3DM.%26aulast%3DAuclair%26aufirst%3DD.%26aulast%3DTaylor%26aufirst%3DI.%26aulast%3DGedrich%26aufirst%3DR.%26aulast%3DVoznesensky%26aufirst%3DA.%26aulast%3DRiedl%26aufirst%3DB.%26aulast%3DPost%26aufirst%3DL.%2BE.%26aulast%3DBollag%26aufirst%3DG.%26aulast%3DTrail%26aufirst%3DP.%2BA.%26atitle%3DBAY%252043-9006%2520Exhibits%2520Broad%2520Spectrum%2520Oral%2520Antitumor%2520Activity%2520and%2520Targets%2520the%2520RAF%252FMEK%252FERK%2520Pathway%2520and%2520Receptor%2520Tyrosine%2520Kinases%2520Involved%2520in%2520Tumor%2520Progression%2520and%2520Angiogenesis%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D7099%26epage%3D7109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Dai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frey, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtin, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arries, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barlozzari, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauch, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouska, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bousquet, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunha, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glaser, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcotte, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moskey, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pease, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoll, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tapang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wishart, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidsen, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michaelides, M. R.</span><span> </span><span class="NLM_article-title">Thienopyrimidine Ureas as Novel and Potent Multitargeted Receptor Tyrosine Kinase Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6066</span><span class="NLM_x">–</span> <span class="NLM_lpage">6083</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050458h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm701397k&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpt1Wht7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=6066-6083&author=Y.+Daiauthor=Y.+Guoauthor=R.+R.+Freyauthor=Z.+Jiauthor=M.+L.+Curtinauthor=A.+A.+Ahmedauthor=D.+H.+Albertauthor=L.+Arnoldauthor=S.+S.+Arriesauthor=T.+Barlozzariauthor=J.+L.+Bauchauthor=J.+J.+Bouskaauthor=P.+F.+Bousquetauthor=G.+A.+Cunhaauthor=K.+B.+Glaserauthor=J.+Guoauthor=J.+Liauthor=P.+A.+Marcotteauthor=K.+C.+Marshauthor=M.+D.+Moskeyauthor=L.+J.+Peaseauthor=K.+D.+Stewartauthor=V.+S.+Stollauthor=P.+Tapangauthor=N.+Wishartauthor=S.+K.+Davidsenauthor=M.+R.+Michaelides&title=Thienopyrimidine+Ureas+as+Novel+and+Potent+Multitargeted+Receptor+Tyrosine+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Thienopyrimidine Ureas as Novel and Potent Multitargeted Receptor Tyrosine Kinase Inhibitors</span></div><div class="casAuthors">Dai, Yujia; Guo, Yan; Frey, Robin R.; Ji, Zhiqin; Curtin, Michael L.; Ahmed, Asma A.; Albert, Daniel H.; Arnold, Lee; Arries, Shannon S.; Barlozzari, Teresa; Bauch, Joy L.; Bouska, Jennifer J.; Bousquet, Peter F.; Cunha, George A.; Glaser, Keith B.; Guo, Jun; Li, Junling; Marcotte, Patrick A.; Marsh, Kennan C.; Moskey, Maria D.; Pease, Lori J.; Stewart, Kent D.; Stoll, Vincent S.; Tapang, Paul; Wishart, Neil; Davidsen, Steven K.; Michaelides, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6066-6083</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of novel thienopyrimidine-based receptor tyrosine kinase inhibitors has been discovered.  Investigation of structure-activity relationships at the 5- and 6-positions of the thienopyrimidine nucleus led to a series of N,N'-diaryl ureas that potently inhibit all of the vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF) receptor tyrosine kinases.  A kinase insert domain-contg. receptor (KDR) homol. model suggests that these compds. bind to the "inactive conformation" of the enzyme with the urea portion extending into the back hydrophobic pocket adjacent to the ATP (ATP) binding site.  A no. of compds. have been identified as displaying excellent in vivo potency.  In particular, compds. 28 and 76 possess favorable pharmacokinetic (PK) profiles and demonstrate potent antitumor efficacy against the HT1080 human fibrosarcoma xenograft tumor growth model (tumor growth inhibition (TGI) = 75% at 25 mg/kg·day, per os (po)).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYifOiC_HYHrVg90H21EOLACvtfcHk0li_3FxP03NDsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpt1Wht7Y%253D&md5=ef245a26e40d18cfaf7f98260827f274</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm050458h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050458h%26sid%3Dliteratum%253Aachs%26aulast%3DDai%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DY.%26aulast%3DFrey%26aufirst%3DR.%2BR.%26aulast%3DJi%26aufirst%3DZ.%26aulast%3DCurtin%26aufirst%3DM.%2BL.%26aulast%3DAhmed%26aufirst%3DA.%2BA.%26aulast%3DAlbert%26aufirst%3DD.%2BH.%26aulast%3DArnold%26aufirst%3DL.%26aulast%3DArries%26aufirst%3DS.%2BS.%26aulast%3DBarlozzari%26aufirst%3DT.%26aulast%3DBauch%26aufirst%3DJ.%2BL.%26aulast%3DBouska%26aufirst%3DJ.%2BJ.%26aulast%3DBousquet%26aufirst%3DP.%2BF.%26aulast%3DCunha%26aufirst%3DG.%2BA.%26aulast%3DGlaser%26aufirst%3DK.%2BB.%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DMarcotte%26aufirst%3DP.%2BA.%26aulast%3DMarsh%26aufirst%3DK.%2BC.%26aulast%3DMoskey%26aufirst%3DM.%2BD.%26aulast%3DPease%26aufirst%3DL.%2BJ.%26aulast%3DStewart%26aufirst%3DK.%2BD.%26aulast%3DStoll%26aufirst%3DV.%2BS.%26aulast%3DTapang%26aufirst%3DP.%26aulast%3DWishart%26aufirst%3DN.%26aulast%3DDavidsen%26aufirst%3DS.%2BK.%26aulast%3DMichaelides%26aufirst%3DM.%2BR.%26atitle%3DThienopyrimidine%2520Ureas%2520as%2520Novel%2520and%2520Potent%2520Multitargeted%2520Receptor%2520Tyrosine%2520Kinase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D6066%26epage%3D6083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Curtin, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frey, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heyman, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarris, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinman, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holms, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bousquet, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunha, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moskey, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pease, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glaser, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidsen, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michaelides, M. R.</span><span> </span><span class="NLM_article-title">Isoindolinone Ureas: A Novel Class of KDR Kinase Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">4505</span><span class="NLM_x">–</span> <span class="NLM_lpage">4509</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=4505-4509&author=M.+L.+Curtinauthor=R.+R.+Freyauthor=H.+R.+Heymanauthor=K.+A.+Sarrisauthor=D.+H.+Steinmanauthor=J.+H.+Holmsauthor=P.+F.+Bousquetauthor=G.+A.+Cunhaauthor=M.+D.+Moskeyauthor=A.+A.+Ahmedauthor=L.+J.+Peaseauthor=K.+B.+Glaserauthor=K.+D.+Stewartauthor=S.+K.+Davidsenauthor=M.+R.+Michaelides&title=Isoindolinone+Ureas%3A+A+Novel+Class+of+KDR+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCurtin%26aufirst%3DM.%2BL.%26aulast%3DFrey%26aufirst%3DR.%2BR.%26aulast%3DHeyman%26aufirst%3DH.%2BR.%26aulast%3DSarris%26aufirst%3DK.%2BA.%26aulast%3DSteinman%26aufirst%3DD.%2BH.%26aulast%3DHolms%26aufirst%3DJ.%2BH.%26aulast%3DBousquet%26aufirst%3DP.%2BF.%26aulast%3DCunha%26aufirst%3DG.%2BA.%26aulast%3DMoskey%26aufirst%3DM.%2BD.%26aulast%3DAhmed%26aufirst%3DA.%2BA.%26aulast%3DPease%26aufirst%3DL.%2BJ.%26aulast%3DGlaser%26aufirst%3DK.%2BB.%26aulast%3DStewart%26aufirst%3DK.%2BD.%26aulast%3DDavidsen%26aufirst%3DS.%2BK.%26aulast%3DMichaelides%26aufirst%3DM.%2BR.%26atitle%3DIsoindolinone%2520Ureas%253A%2520A%2520Novel%2520Class%2520of%2520KDR%2520Kinase%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D4505%26epage%3D4509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Albert, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tapang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magoc, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pease, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reuter, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, R.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bousquet, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghoreishi-Haack, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bukofzer, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stavropoulos, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartandi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niquette, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soni, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCall, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouska, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donawho, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcotte, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glaser, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michaelides, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidsen, S. K.</span><span> </span><span class="NLM_article-title">Preclinical activity of ABT-869, a multitargeted receptor tyrosine kinase inhibitor</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">995</span><span class="NLM_x">–</span> <span class="NLM_lpage">1006</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=16&amp;doi=10.1021%2Fjm701397k&amp;key=10.1158%2F1535-7163.MCT-05-0410" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=8&amp;doi=10.1021%2Fjm701397k&amp;key=16648571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=32&amp;doi=10.1021%2Fjm701397k&amp;key=1%3ACAS%3A528%3ADC%252BD28XjvFCkt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=995-1006&author=D.+H.+Albertauthor=P.+Tapangauthor=T.+J.+Magocauthor=L.+J.+Peaseauthor=D.+R.+Reuterauthor=R.-Q.+Weiauthor=J.+Liauthor=J.+Guoauthor=P.+F.+Bousquetauthor=N.+S.+Ghoreishi-Haackauthor=B.+Wangauthor=G.+T.+Bukofzerauthor=Y.-C.+Wangauthor=J.+A.+Stavropoulosauthor=K.+Hartandiauthor=A.+L.+Niquetteauthor=N.+Soniauthor=E.+F.+Johnsonauthor=J.+O.+McCallauthor=J.+J.+Bouskaauthor=Y.+Luoauthor=C.+K.+Donawhoauthor=Y.+Daiauthor=P.+A.+Marcotteauthor=K.+B.+Glaserauthor=M.+R.+Michaelidesauthor=S.+K.+Davidsen&title=Preclinical+activity+of+ABT-869%2C+a+multitargeted+receptor+tyrosine+kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24aR"><div class="casContent"><span class="casTitleNuber">24a</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical activity of ABT-869, a multitargeted receptor tyrosine kinase inhibitor</span></div><div class="casAuthors">Albert, Daniel H.; Tapang, Paul; Magoc, Terrance J.; Pease, Lori J.; Reuter, David R.; Wei, Ru-Qi; Li, Junling; Guo, Jun; Bousquet, Peter F.; Ghoreishi-Haack, Nayereh S.; Wang, Baole; Bukofzer, Gail T.; Wang, Yi-Chun; Stavropoulos, Jason A.; Hartandi, Kresna; Niquette, Amanda L.; Soni, Nirupama; Johnson, Eric F.; McCall, J. Owen; Bouska, Jennifer J.; Luo, Yanping; Donawho, Cherrie K.; Dai, Yujia; Marcotte, Patrick A.; Glaser, Keith B.; Michaelides, Michael R.; Davidsen, Steven K.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">995-1006</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">ABT-869 is a structurally novel, receptor tyrosine kinase (RTK) inhibitor that is a potent inhibitor of members of the vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF) receptor families (e.g., KDR IC50 = 4 nmol/L) but has much less activity (IC50s > 1 μmol/L) against unrelated RTKs, sol. tyrosine kinases, or serine/threonine kinases.  The inhibition profile of ABT-869 is evident in cellular assays of RTK phosphorylation (IC50 = 2, 4, and 7 nmol/L for PDGFR-β, KDR, and CSF-1R, resp.) and VEGF-stimulated proliferation (IC50 = 0.2 nmol/L for human endothelial cells).  ABT-869 is not a general antiproliferative agent because, in most cancer cells, >1,000-fold higher concns. of ABT-869 are required for inhibition of proliferation.  However, ABT-869 exhibits potent antiproliferative and apoptotic effects on cancer cells whose proliferation is dependent on mutant kinases, such as FLT3.  In vivo ABT-869 is effective orally in the mechanism-based murine models of VEGF-induced uterine edema (ED50 = 0.5 mg/kg) and corneal angiogenesis (>50% inhibition, 15 mg/kg).  In tumor growth studies, ABT-869 exhibits efficacy in human fibrosarcoma and breast, colon, and small cell lung carcinoma xenograft models (ED50 = 1.5-5 mg/kg, twice daily) and is also effective (>50% inhibition) in orthotopic breast and glioma models.  Redn. in tumor size and tumor regression was obsd. in epidermoid carcinoma and leukemia xenograft models, resp.  In combination, ABT-869 produced at least additive effects when given with cytotoxic therapies.  Based on pharmacokinetic anal. from tumor growth studies, efficacy correlated more strongly with time over a threshold value (cellular KDR IC50 cor. for blood plasma protein binding = 0.08 μg/mL, ≥7 h) than with plasma area under the curve or Cmax.  These results support clin. assessment of ABT-869 as a therapeutic agent for cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkn2KBvMa4wrVg90H21EOLACvtfcHk0li_3FxP03NDsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjvFCkt7g%253D&md5=a5a60b591b4da7a3c589f1618d9cffb9</span></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-05-0410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-05-0410%26sid%3Dliteratum%253Aachs%26aulast%3DAlbert%26aufirst%3DD.%2BH.%26aulast%3DTapang%26aufirst%3DP.%26aulast%3DMagoc%26aufirst%3DT.%2BJ.%26aulast%3DPease%26aufirst%3DL.%2BJ.%26aulast%3DReuter%26aufirst%3DD.%2BR.%26aulast%3DWei%26aufirst%3DR.-Q.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DBousquet%26aufirst%3DP.%2BF.%26aulast%3DGhoreishi-Haack%26aufirst%3DN.%2BS.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DBukofzer%26aufirst%3DG.%2BT.%26aulast%3DWang%26aufirst%3DY.-C.%26aulast%3DStavropoulos%26aufirst%3DJ.%2BA.%26aulast%3DHartandi%26aufirst%3DK.%26aulast%3DNiquette%26aufirst%3DA.%2BL.%26aulast%3DSoni%26aufirst%3DN.%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26aulast%3DMcCall%26aufirst%3DJ.%2BO.%26aulast%3DBouska%26aufirst%3DJ.%2BJ.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DDonawho%26aufirst%3DC.%2BK.%26aulast%3DDai%26aufirst%3DY.%26aulast%3DMarcotte%26aufirst%3DP.%2BA.%26aulast%3DGlaser%26aufirst%3DK.%2BB.%26aulast%3DMichaelides%26aufirst%3DM.%2BR.%26aulast%3DDavidsen%26aufirst%3DS.%2BK.%26atitle%3DPreclinical%2520activity%2520of%2520ABT-869%252C%2520a%2520multitargeted%2520receptor%2520tyrosine%2520kinase%2520inhibitor%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2006%26volume%3D5%26spage%3D995%26epage%3D1006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit24b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Dai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartandi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauch, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouska, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bousquet, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunha, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glaser, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcotte, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moskey, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osterling, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pease, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soni, N. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoll, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tapang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reuter, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidsen, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michaelides, M. R.</span><span> </span><span class="NLM_article-title">Discovery of <i>N</i>-(4-(3-Amino-1<i>H</i>-indazol-4-yl)phenyl)-<i>N</i>′-(2-fluoro-5-methylphenyl)urea (ABT-869), a 3-Aminoindazole-Based Orally Active Multitargeted Receptor Tyrosine Kinase Inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1584</span><span class="NLM_x">–</span> <span class="NLM_lpage">1597</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm061280h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=1584-1597&author=Y.+Daiauthor=K.+Hartandiauthor=Z.+Jiauthor=A.+A.+Ahmedauthor=D.+H.+Albertauthor=J.+L.+Bauchauthor=J.+J.+Bouskaauthor=P.+F.+Bousquetauthor=G.+A.+Cunhaauthor=K.+B.+Glaserauthor=C.+M.+Harrisauthor=D.+Hickmanauthor=J.+Guoauthor=J.+Liauthor=P.+A.+Marcotteauthor=K.+C.+Marshauthor=M.+D.+Moskeyauthor=R.+L.+Martinauthor=A.+M.+Olsonauthor=D.+J.+Osterlingauthor=L.+J.+Peaseauthor=N.+B.+Soniauthor=K.+D.+Stewartauthor=V.+S.+Stollauthor=P.+Tapangauthor=D.+R.+Reuterauthor=S.+K.+Davidsenauthor=M.+R.+Michaelides&title=Discovery+of+N-%284-%283-Amino-1H-indazol-4-yl%29phenyl%29-N%E2%80%B2-%282-fluoro-5-methylphenyl%29urea+%28ABT-869%29%2C+a+3-Aminoindazole-Based+Orally+Active+Multitargeted+Receptor+Tyrosine+Kinase+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=10.1021%2Fjm061280h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061280h%26sid%3Dliteratum%253Aachs%26aulast%3DDai%26aufirst%3DY.%26aulast%3DHartandi%26aufirst%3DK.%26aulast%3DJi%26aufirst%3DZ.%26aulast%3DAhmed%26aufirst%3DA.%2BA.%26aulast%3DAlbert%26aufirst%3DD.%2BH.%26aulast%3DBauch%26aufirst%3DJ.%2BL.%26aulast%3DBouska%26aufirst%3DJ.%2BJ.%26aulast%3DBousquet%26aufirst%3DP.%2BF.%26aulast%3DCunha%26aufirst%3DG.%2BA.%26aulast%3DGlaser%26aufirst%3DK.%2BB.%26aulast%3DHarris%26aufirst%3DC.%2BM.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DMarcotte%26aufirst%3DP.%2BA.%26aulast%3DMarsh%26aufirst%3DK.%2BC.%26aulast%3DMoskey%26aufirst%3DM.%2BD.%26aulast%3DMartin%26aufirst%3DR.%2BL.%26aulast%3DOlson%26aufirst%3DA.%2BM.%26aulast%3DOsterling%26aufirst%3DD.%2BJ.%26aulast%3DPease%26aufirst%3DL.%2BJ.%26aulast%3DSoni%26aufirst%3DN.%2BB.%26aulast%3DStewart%26aufirst%3DK.%2BD.%26aulast%3DStoll%26aufirst%3DV.%2BS.%26aulast%3DTapang%26aufirst%3DP.%26aulast%3DReuter%26aufirst%3DD.%2BR.%26aulast%3DDavidsen%26aufirst%3DS.%2BK.%26aulast%3DMichaelides%26aufirst%3DM.%2BR.%26atitle%3DDiscovery%2520of%2520N-%25284-%25283-Amino-1H-indazol-4-yl%2529phenyl%2529-N%25E2%2580%25B2-%25282-fluoro-5-methylphenyl%2529urea%2520%2528ABT-869%2529%252C%2520a%25203-Aminoindazole-Based%2520Orally%2520Active%2520Multitargeted%2520Receptor%2520Tyrosine%2520Kinase%2520Inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D1584%26epage%3D1597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="note"><p class="first last">The development of RTK inhibitors in the clinic has been extensively reviewed. For recent reviews, see the following:</p></div><div class="NLM_citation" id="rightTab-cit25a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Arora, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scholar, E. M.</span><span> </span><span class="NLM_article-title">Role of Tyrosine Kinase Inhibitors in Cancer Therapy</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">315</span><span class="NLM_x">, </span> <span class="NLM_fpage">971</span><span class="NLM_x">–</span> <span class="NLM_lpage">979</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=16&amp;doi=10.1021%2Fjm701397k&amp;key=10.1124%2Fjpet.105.084145" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=8&amp;doi=10.1021%2Fjm701397k&amp;key=16002463" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=32&amp;doi=10.1021%2Fjm701397k&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlalur3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=315&publication_year=2005&pages=971-979&author=A.+Aroraauthor=E.+M.+Scholar&title=Role+of+Tyrosine+Kinase+Inhibitors+in+Cancer+Therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25aR"><div class="casContent"><span class="casTitleNuber">25a</span><div class="casTitle"><span class="NLM_cas:atitle">Role of tyrosine kinase inhibitors in cancer therapy</span></div><div class="casAuthors">Arora, Amit; Scholar, Eric M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">315</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">971-979</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  Cancer chemotherapy has been one of the major medical advances in the last few decades.  However, the drugs used for this therapy have a narrow therapeutic index, and often the responses produced are only just palliative as well as unpredictable.  In contrast, targeted therapy that has been introduced in recent years is directed against cancer-specific mols. and signaling pathways and thus has more limited nonspecific toxicities.  Tyrosine kinases are an esp. important target because they play an important role in the modulation of growth factor signaling.  This review focuses on small mol. inhibitors of tyrosine kinase.  They compete with the ATP binding site of the catalytic domain of several oncogenic tyrosine kinases.  They are orally active, small mols. that have a favorable safety profile and can be easily combined with other forms of chemotherapy or radiation therapy.  Several tyrosine kinase inhibitors (TKIs) have been found to have effective antitumor activity and have been approved or are in clin. trials.  The inhibitors discussed in this manuscript are imatinib mesylate (STI571; Gleevec), gefitinib (Iressa), erlotinib (OSI-1774; Tarceva), lapatinib (GW-572016), canertinib (CI-1033), semaxinib (SU5416), vatalanib (PTK787/ZK222584), sorafenib (BAY 43-9006), sutent (SU11248), and leflunomide (SU101).  TKIs are thus an important new class of targeted therapy that interfere with specific cell signaling pathways and thus allow target-specific therapy for selected malignancies.  The pharmacol. properties and anticancer activities of these inhibitors are discussed in this review.  Use of these targeted therapies is not without limitations such as the development of resistance and the lack of tumor response in the general population.  The availability of newer inhibitors and improved patient selection will help overcome these problems in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMwimbtjJbArVg90H21EOLACvtfcHk0lhO6WerTQPQZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlalur3L&md5=c5671a8b1154ba8658ea0845666c7473</span></div><a href="/servlet/linkout?suffix=cit25a&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.084145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.084145%26sid%3Dliteratum%253Aachs%26aulast%3DArora%26aufirst%3DA.%26aulast%3DScholar%26aufirst%3DE.%2BM.%26atitle%3DRole%2520of%2520Tyrosine%2520Kinase%2520Inhibitors%2520in%2520Cancer%2520Therapy%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D315%26spage%3D971%26epage%3D979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit25b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Laird, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherrington, J. M.</span><span> </span><span class="NLM_article-title">Small Molecule Tyrosine Kinase Inhibitors: Clinical Development of Anticancer Agents</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">51</span><span class="NLM_x">–</span> <span class="NLM_lpage">64</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=16&amp;doi=10.1021%2Fjm701397k&amp;key=10.1517%2F13543784.12.1.51" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=8&amp;doi=10.1021%2Fjm701397k&amp;key=12517254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=32&amp;doi=10.1021%2Fjm701397k&amp;key=1%3ACAS%3A528%3ADC%252BD3sXovFKk" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2003&pages=51-64&author=A.+D.+Lairdauthor=J.+M.+Cherrington&title=Small+Molecule+Tyrosine+Kinase+Inhibitors%3A+Clinical+Development+of+Anticancer+Agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25bR"><div class="casContent"><span class="casTitleNuber">25b</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule tyrosine kinase inhibitors: clinical development of anticancer agents</span></div><div class="casAuthors">Laird, A. Douglas; Cherrington, Julie M.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">51-64</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Numerous small mol. synthetic tyrosine kinase inhibitors are in clin. development for the treatment of human cancers.  These fall into three broad categories: inhibitors of the epidermal growth factor receptor tyrosine kinase family (e.g., Iressa and Tarceva), inhibitors of the split kinase domain receptor tyrosine kinase subgroup (e.g., PTK787/ZK 222584 and SU11248) and inhibitors of tyrosine kinases from multiple subgroups (e.g., Gleevec).  In addn., agents targeting other tyrosine kinases implicated in cancer, such as Met, Tie-2 and Src, are in preclin. development.  As experience is gained in the clinic, it has become clear that unleashing the full therapeutic potential of tyrosine kinase inhibitors will require patient preselection, better assays to guide dose selection, knowledge of mechanism-based side effects and ways to predict and overcome drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpA62Xd2ANILrVg90H21EOLACvtfcHk0lhO6WerTQPQZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXovFKk&md5=3c8b0b358d79e7eea44eca260d568ad4</span></div><a href="/servlet/linkout?suffix=cit25b&amp;dbid=16384&amp;doi=10.1517%2F13543784.12.1.51&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.12.1.51%26sid%3Dliteratum%253Aachs%26aulast%3DLaird%26aufirst%3DA.%2BD.%26aulast%3DCherrington%26aufirst%3DJ.%2BM.%26atitle%3DSmall%2520Molecule%2520Tyrosine%2520Kinase%2520Inhibitors%253A%2520Clinical%2520Development%2520of%2520Anticancer%2520Agents%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2003%26volume%3D12%26spage%3D51%26epage%3D64" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit25c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Manley, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bold, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Br̈uggen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fendrich, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mestan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stolz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyhack, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stark, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strauss, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, J.</span><span> </span><span class="NLM_article-title">Advances in the Structural Biology, Design and Clinical Development of VEGF-R Kinase Inhibitors for the Treatment of Angiogenesis</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1697</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1697&publication_year=2004&pages=17-27&author=P.+W.+Manleyauthor=G.+Boldauthor=J.+Br%CC%88uggenauthor=G.+Fendrichauthor=P.+Furetauthor=J.+Mestanauthor=C.+Schnellauthor=B.+Stolzauthor=T.+Meyerauthor=B.+Meyhackauthor=W.+Starkauthor=A.+Straussauthor=J.+Wood&title=Advances+in+the+Structural+Biology%2C+Design+and+Clinical+Development+of+VEGF-R+Kinase+Inhibitors+for+the+Treatment+of+Angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManley%26aufirst%3DP.%2BW.%26aulast%3DBold%26aufirst%3DG.%26aulast%3DBr%25CC%2588uggen%26aufirst%3DJ.%26aulast%3DFendrich%26aufirst%3DG.%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DMestan%26aufirst%3DJ.%26aulast%3DSchnell%26aufirst%3DC.%26aulast%3DStolz%26aufirst%3DB.%26aulast%3DMeyer%26aufirst%3DT.%26aulast%3DMeyhack%26aufirst%3DB.%26aulast%3DStark%26aufirst%3DW.%26aulast%3DStrauss%26aufirst%3DA.%26aulast%3DWood%26aufirst%3DJ.%26atitle%3DAdvances%2520in%2520the%2520Structural%2520Biology%252C%2520Design%2520and%2520Clinical%2520Development%2520of%2520VEGF-R%2520Kinase%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Angiogenesis%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2004%26volume%3D1697%26spage%3D17%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Traxler, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furet, P.</span><span> </span><span class="NLM_article-title">Strategies toward the Design of Novel and Selective Protein Tyrosine Kinase Inhibitors</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">195</span><span class="NLM_x">–</span> <span class="NLM_lpage">206</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm701397k&amp;key=10.1016%2FS0163-7258%2898%2900044-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm701397k&amp;key=10454197" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm701397k&amp;key=1%3ACAS%3A528%3ADyaK1MXjvFOht7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1999&pages=195-206&author=P.+Traxlerauthor=P.+Furet&title=Strategies+toward+the+Design+of+Novel+and+Selective+Protein+Tyrosine+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Strategies toward the design of novel and selective protein tyrosine kinase inhibitors</span></div><div class="casAuthors">Traxler, Peter; Furet, Pascal</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">195-206</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review with 37 refs.  Protein tyrosine kinases play a fundamental role in signal transduction pathways.  Deregulated tyrosine kinase activity has been obsd. in many proliferative diseases (e.g., cancer, psoriasis, restenosis, etc.).  Tyrosine kinases are, therefore, attractive targets for the design of new therapeutic agents against cancer.  We have built up a pharmacophore model of the ATP-binding site of the epidermal growth factor receptor (EGFR) kinase and used it for the rational design of kinase inhibitors.  Several examples of the successful use of this model are presented in this review.  Amongst these, 4-substituted-pyrrolo[2,3-d]pyrimidines, a new class of highly potent and selective inhibitors of the EGFR kinase, have been identified and further optimized.  The most active derivs. inhibited the EGFR tyrosine kinase with IC50 values between 1 and 5 nM.  In EGF-dependent cellular systems, tyrosine phosphorylation, as well as c-fos mRNA expression, was inhibited with similar IC50 values.  Further successful application of this pharmacophore model led to the identification and optimization of phenylamino-pyrazolo[4,3-d]pyrimidines and substituted isoflavones and quinolones, other classes of potent, selective, and ATP competitive EGFR kinase inhibitors with IC50 values in the low nanomolar range.  Structure-activity relationships of both classes are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzTOVAYLwK77Vg90H21EOLACvtfcHk0lgcX30V6N5uIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjvFOht7Y%253D&md5=26e5ed297e37b0cb188a0676e5b27f5b</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2FS0163-7258%2898%2900044-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0163-7258%252898%252900044-8%26sid%3Dliteratum%253Aachs%26aulast%3DTraxler%26aufirst%3DP.%26aulast%3DFuret%26aufirst%3DP.%26atitle%3DStrategies%2520toward%2520the%2520Design%2520of%2520Novel%2520and%2520Selective%2520Protein%2520Tyrosine%2520Kinase%2520Inhibitors%26jtitle%3DPharmacol.%2520Ther.%26date%3D1999%26volume%3D82%26spage%3D195%26epage%3D206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><div class="note"><p class="first last">Bold, G.; Florsheimer, A.; Furet, P.; Imbach, P.; Masuya, K.; Schoepfer, R. Scientists at Novartis have independently discovered 7-amino-pyrazolo[1,5-<i>a</i>]pyrimidine ureas as kinase inhibitors: Organic compounds,</p></div> US2005/0222171 A1,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Bold%2C+G.%3B+Florsheimer%2C+A.%3B+Furet%2C+P.%3B+Imbach%2C+P.%3B+Masuya%2C+K.%3B+Schoepfer%2C+R.+Scientists+at+Novartis+have+independently+discovered+7-amino-pyrazolo%5B1%2C5-a%5Dpyrimidine+ureas+as+kinase+inhibitors%3A+Organic+compounds%2C+US2005%2F0222171+A1%2C+2005."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Alcade, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">deMendoza, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Marquina, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almera, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elguero, J.</span><span> </span><span class="NLM_article-title">Etude de la Réaction du β-Aminocrotonitrile et du α-Formyl Phénylacétonitrile avec l’Hydrazine: Synthèse d’Amino-7-pyrazolo[1,5-<i>a</i>]pyrimidines</span> <span class="citation_source-journal">J. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1974</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">423</span><span class="NLM_x">–</span> <span class="NLM_lpage">429</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1974&pages=423-429&author=E.+Alcadeauthor=J.+deMendozaauthor=J.+M.+Garcia-Marquinaauthor=C.+Almeraauthor=J.+Elguero&title=Etude+de+la+R%C3%A9action+du+%CE%B2-Aminocrotonitrile+et+du+%CE%B1-Formyl+Ph%C3%A9nylac%C3%A9tonitrile+avec+l%E2%80%99Hydrazine%3A+Synth%C3%A8se+d%E2%80%99Amino-7-pyrazolo%5B1%2C5-a%5Dpyrimidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAlcade%26aufirst%3DE.%26aulast%3DdeMendoza%26aufirst%3DJ.%26aulast%3DGarcia-Marquina%26aufirst%3DJ.%2BM.%26aulast%3DAlmera%26aufirst%3DC.%26aulast%3DElguero%26aufirst%3DJ.%26atitle%3DEtude%2520de%2520la%2520R%25C3%25A9action%2520du%2520%25CE%25B2-Aminocrotonitrile%2520et%2520du%2520%25CE%25B1-Formyl%2520Ph%25C3%25A9nylac%25C3%25A9tonitrile%2520avec%2520l%25E2%2580%2599Hydrazine%253A%2520Synth%25C3%25A8se%2520d%25E2%2580%2599Amino-7-pyrazolo%255B1%252C5-a%255Dpyrimidines%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1974%26volume%3D11%26spage%3D423%26epage%3D429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Miyaura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, A.</span><span> </span><span class="NLM_article-title">Palladium-Catalyzed Cross-Coupling Reactions of Organoboron Compounds</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">2457</span><span class="NLM_x">–</span> <span class="NLM_lpage">2483</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr00039a007" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm701397k&amp;key=1%3ACAS%3A528%3ADyaK2MXoslGiurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1995&pages=2457-2483&author=N.+Miyauraauthor=A.+Suzuki&title=Palladium-Catalyzed+Cross-Coupling+Reactions+of+Organoboron+Compounds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium-Catalyzed Cross-Coupling Reactions of Organoboron Compounds</span></div><div class="casAuthors">Miyaura, Norio; Suzuki, Akira</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2457-83</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with >250 refs. including title reactions and their mechanisms, prepn. of organoboron reagents, alkoxycarbonylation and dimerization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHwupBJT1UCbVg90H21EOLACvtfcHk0lgcX30V6N5uIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXoslGiurg%253D&md5=d127b414a75161652876eebc3ed0c486</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fcr00039a007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr00039a007%26sid%3Dliteratum%253Aachs%26aulast%3DMiyaura%26aufirst%3DN.%26aulast%3DSuzuki%26aufirst%3DA.%26atitle%3DPalladium-Catalyzed%2520Cross-Coupling%2520Reactions%2520of%2520Organoboron%2520Compounds%26jtitle%3DChem.%2520Rev.%26date%3D1995%26volume%3D95%26spage%3D2457%26epage%3D2483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Fraley, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubino, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hungate, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tebben, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rutledge, R. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McFall, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huckle, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kendall, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coll, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, K. A.</span><span> </span><span class="NLM_article-title">Synthesis and Initial SAR Studies of 3,6-Disubstituted Pyrazolo[1,5-<i>a</i>]pyrimidines: A New Class of KDR Kinase Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">2767</span><span class="NLM_x">–</span> <span class="NLM_lpage">2770</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=2767-2770&author=M.+E.+Fraleyauthor=W.+F.+Hoffmanauthor=R.+S.+Rubinoauthor=R.+W.+Hungateauthor=A.+J.+Tebbenauthor=R.+Z.+Rutledgeauthor=R.+C.+McFallauthor=W.+R.+Huckleauthor=R.+L.+Kendallauthor=K.+E.+Collauthor=K.+A.+Thomas&title=Synthesis+and+Initial+SAR+Studies+of+3%2C6-Disubstituted+Pyrazolo%5B1%2C5-a%5Dpyrimidines%3A+A+New+Class+of+KDR+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFraley%26aufirst%3DM.%2BE.%26aulast%3DHoffman%26aufirst%3DW.%2BF.%26aulast%3DRubino%26aufirst%3DR.%2BS.%26aulast%3DHungate%26aufirst%3DR.%2BW.%26aulast%3DTebben%26aufirst%3DA.%2BJ.%26aulast%3DRutledge%26aufirst%3DR.%2BZ.%26aulast%3DMcFall%26aufirst%3DR.%2BC.%26aulast%3DHuckle%26aufirst%3DW.%2BR.%26aulast%3DKendall%26aufirst%3DR.%2BL.%26aulast%3DColl%26aufirst%3DK.%2BE.%26aulast%3DThomas%26aufirst%3DK.%2BA.%26atitle%3DSynthesis%2520and%2520Initial%2520SAR%2520Studies%2520of%25203%252C6-Disubstituted%2520Pyrazolo%255B1%252C5-a%255Dpyrimidines%253A%2520A%2520New%2520Class%2520of%2520KDR%2520Kinase%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D2767%26epage%3D2770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Nam, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grandberg, I. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorokin, V. I.</span><span> </span><span class="NLM_article-title">Pyrazolopyrimidines Based on 5-Aminopyrazoles Unsubstituted at the Position 1</span> <span class="citation_source-journal">Chem. Heterocycl. Compd.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">1371</span><span class="NLM_x">–</span> <span class="NLM_lpage">1374</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm701397k&amp;key=10.1023%2FA%3A1022186627777" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm701397k&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjt1SltbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2002&pages=1371-1374&author=N.+L.+Namauthor=I.+I.+Grandbergauthor=V.+I.+Sorokin&title=Pyrazolopyrimidines+Based+on+5-Aminopyrazoles+Unsubstituted+at+the+Position+1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrazolopyrimidines based on 5-aminopyrazoles unsubstituted at the position 1</span></div><div class="casAuthors">Nam, N. L.; Grandberg, I. I.; Sorokin, V. I.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry of Heterocyclic Compounds (New York, NY, United States)(Translation of Khimiya Geterotsiklicheskikh Soedinenii)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1371-1374</span>CODEN:
                <span class="NLM_cas:coden">CHCCAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-3122</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic/Consultants Bureau</span>)
        </div><div class="casAbstract">By condensation of various sym. β-diketones with a series of 5-aminopyrazoles that are unsubstituted at the position 1, we have obtained a series of pyrazolo[1,5-a]pyrimidines that are of interest as physiol. active compds.  Hexafluoroacetylacetone reacts in another direction, forming pyrazolo[4,5-b]pyridine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYuJ4oIruamrVg90H21EOLACvtfcHk0lgcX30V6N5uIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjt1SltbY%253D&md5=6c0919c181b38eeafcbebcef029640d3</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1023%2FA%3A1022186627777&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1022186627777%26sid%3Dliteratum%253Aachs%26aulast%3DNam%26aufirst%3DN.%2BL.%26aulast%3DGrandberg%26aufirst%3DI.%2BI.%26aulast%3DSorokin%26aufirst%3DV.%2BI.%26atitle%3DPyrazolopyrimidines%2520Based%2520on%25205-Aminopyrazoles%2520Unsubstituted%2520at%2520the%2520Position%25201%26jtitle%3DChem.%2520Heterocycl.%2520Compd.%26date%3D2002%26volume%3D38%26spage%3D1371%26epage%3D1374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Gribble, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loussouarn, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tucker, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashcroft, F. M.</span><span> </span><span class="NLM_article-title">A Novel Method for Measurement of Submembrane ATP Concentration</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">30046</span><span class="NLM_x">–</span> <span class="NLM_lpage">30049</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm701397k&amp;key=10.1074%2Fjbc.M001010200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm701397k&amp;key=10866996" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm701397k&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnt1ahuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=30046-30049&author=F.+M.+Gribbleauthor=G.+Loussouarnauthor=S.+J.+Tuckerauthor=C.+Zhaoauthor=C.+G.+Nicholsauthor=F.+M.+Ashcroft&title=A+Novel+Method+for+Measurement+of+Submembrane+ATP+Concentration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">A novel method for measurement of submembrane ATP concentration</span></div><div class="casAuthors">Gribble, Fiona M.; Loussouarn, Gildas; Tucker, Stephen J.; Zhao, Chao; Nichols, Colin G.; Ashcroft, Frances M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">30046-30049</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">There has been considerable debate as to whether ATP (ATP) is compartmentalized within cells and, in particular, whether the ATP concn. directly beneath the plasma membrane, experienced by membrane proteins, is the same as that of the bulk cytoplasm.  This issue has been difficult to address because there is no indicator of cytosolic ATP, such as those available for Ca2+, capable of resolving the submembrane ATP concn. ([ATP]sm) in real time within a single cell.  We show here that mutant ATP-sensitive K+ channels can be used to measure [ATP]sm by comparing the increase in current amplitude on patch excision with the ATP dose-response curve.  In Xenopus oocytes, [ATP]sm was 4.6±0.3 mM (n = 29) under resting conditions, slightly higher than that measured for the bulk cytoplasm (2.3 mM).  In mammalian (COSm6) cells, [ATP]sm was slightly lower and averaged 1.4±0.1 mM (n = 66).  Metabolic poisoning (10 min of 3 mM azide) produced a significant fall in [ATP]sm in both types of cells: to 1.2±0.1 mM (n = 24) in oocytes and 0.8±0.11 mM for COSm6 cells.  We conclude that [ATP]sm lies in the low millimolar range and that there is no gradient between bulk cytosolic and submembrane [ATP].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-yulyqd3I6LVg90H21EOLACvtfcHk0lhDAaW2RIdYTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnt1ahuro%253D&md5=a3b5602e5c3ba8f1bda318adf5108d6b</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M001010200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M001010200%26sid%3Dliteratum%253Aachs%26aulast%3DGribble%26aufirst%3DF.%2BM.%26aulast%3DLoussouarn%26aufirst%3DG.%26aulast%3DTucker%26aufirst%3DS.%2BJ.%26aulast%3DZhao%26aufirst%3DC.%26aulast%3DNichols%26aufirst%3DC.%2BG.%26aulast%3DAshcroft%26aufirst%3DF.%2BM.%26atitle%3DA%2520Novel%2520Method%2520for%2520Measurement%2520of%2520Submembrane%2520ATP%2520Concentration%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D30046%26epage%3D30049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Miyazaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsunaga, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philippe, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibahara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolte, R. T.</span><span> </span><span class="NLM_article-title">Novel 4-Amino-furo[2,3-<i>d</i>]pyrimidines as Tie-2 and VEGFR2 Dual Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2203</span><span class="NLM_x">–</span> <span class="NLM_lpage">2207</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=2203-2207&author=Y.+Miyazakiauthor=S.+Matsunagaauthor=J.+Tangauthor=Y.+Maedaauthor=M.+Nakanoauthor=R.+J.+Philippeauthor=M.+Shibaharaauthor=W.+Liuauthor=H.+Satoauthor=L.+Wangauthor=R.+T.+Nolte&title=Novel+4-Amino-furo%5B2%2C3-d%5Dpyrimidines+as+Tie-2+and+VEGFR2+Dual+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMiyazaki%26aufirst%3DY.%26aulast%3DMatsunaga%26aufirst%3DS.%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DMaeda%26aufirst%3DY.%26aulast%3DNakano%26aufirst%3DM.%26aulast%3DPhilippe%26aufirst%3DR.%2BJ.%26aulast%3DShibahara%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DSato%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DNolte%26aufirst%3DR.%2BT.%26atitle%3DNovel%25204-Amino-furo%255B2%252C3-d%255Dpyrimidines%2520as%2520Tie-2%2520and%2520VEGFR2%2520Dual%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D2203%26epage%3D2207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Fraley, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubino, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hambaugh, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrington, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hungate, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilodeau, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tebben, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rutledge, R. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kendall, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McFall, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huckle, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coll, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, K. A.</span><span> </span><span class="NLM_article-title">Optimization of a Pyrazolo[1,5-<i>a</i>]pyrimidine Class of KDR Kinase Inhibitors: Improvements in Physical Properties Enhance Cellular Activity and Pharmacokinetics</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">3537</span><span class="NLM_x">–</span> <span class="NLM_lpage">3541</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=3537-3541&author=M.+E.+Fraleyauthor=R.+S.+Rubinoauthor=W.+F.+Hoffmanauthor=S.+R.+Hambaughauthor=K.+L.+Arringtonauthor=R.+W.+Hungateauthor=M.+T.+Bilodeauauthor=A.+J.+Tebbenauthor=R.+Z.+Rutledgeauthor=R.+L.+Kendallauthor=R.+C.+McFallauthor=W.+R.+Huckleauthor=K.+E.+Collauthor=K.+A.+Thomas&title=Optimization+of+a+Pyrazolo%5B1%2C5-a%5Dpyrimidine+Class+of+KDR+Kinase+Inhibitors%3A+Improvements+in+Physical+Properties+Enhance+Cellular+Activity+and+Pharmacokinetics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFraley%26aufirst%3DM.%2BE.%26aulast%3DRubino%26aufirst%3DR.%2BS.%26aulast%3DHoffman%26aufirst%3DW.%2BF.%26aulast%3DHambaugh%26aufirst%3DS.%2BR.%26aulast%3DArrington%26aufirst%3DK.%2BL.%26aulast%3DHungate%26aufirst%3DR.%2BW.%26aulast%3DBilodeau%26aufirst%3DM.%2BT.%26aulast%3DTebben%26aufirst%3DA.%2BJ.%26aulast%3DRutledge%26aufirst%3DR.%2BZ.%26aulast%3DKendall%26aufirst%3DR.%2BL.%26aulast%3DMcFall%26aufirst%3DR.%2BC.%26aulast%3DHuckle%26aufirst%3DW.%2BR.%26aulast%3DColl%26aufirst%3DK.%2BE.%26aulast%3DThomas%26aufirst%3DK.%2BA.%26atitle%3DOptimization%2520of%2520a%2520Pyrazolo%255B1%252C5-a%255Dpyrimidine%2520Class%2520of%2520KDR%2520Kinase%2520Inhibitors%253A%2520Improvements%2520in%2520Physical%2520Properties%2520Enhance%2520Cellular%2520Activity%2520and%2520Pharmacokinetics%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D3537%26epage%3D3541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Aronov, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bemis, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Germann, U. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobs, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janetka, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maltais, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez-Botella, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Namchuk, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Straub, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, X.</span><span> </span><span class="NLM_article-title">Flipped Out: Structure-Guided Design of Selective Pyrazolylpyrrole ERK Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1280</span><span class="NLM_x">–</span> <span class="NLM_lpage">1287</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm061381f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=1280-1287&author=A.+M.+Aronovauthor=C.+Bakerauthor=G.+W.+Bemisauthor=J.+Caoauthor=G.+Chenauthor=P.+J.+Fordauthor=U.+A.+Germannauthor=J.+Greenauthor=M.+R.+Haleauthor=M.+Jacobsauthor=J.+W.+Janetkaauthor=F.+Maltaisauthor=G.+Martinez-Botellaauthor=M.+N.+Namchukauthor=J.+Straubauthor=Q.+Tangauthor=X.+Xie&title=Flipped+Out%3A+Structure-Guided+Design+of+Selective+Pyrazolylpyrrole+ERK+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm061381f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061381f%26sid%3Dliteratum%253Aachs%26aulast%3DAronov%26aufirst%3DA.%2BM.%26aulast%3DBaker%26aufirst%3DC.%26aulast%3DBemis%26aufirst%3DG.%2BW.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DFord%26aufirst%3DP.%2BJ.%26aulast%3DGermann%26aufirst%3DU.%2BA.%26aulast%3DGreen%26aufirst%3DJ.%26aulast%3DHale%26aufirst%3DM.%2BR.%26aulast%3DJacobs%26aufirst%3DM.%26aulast%3DJanetka%26aufirst%3DJ.%2BW.%26aulast%3DMaltais%26aufirst%3DF.%26aulast%3DMartinez-Botella%26aufirst%3DG.%26aulast%3DNamchuk%26aufirst%3DM.%2BN.%26aulast%3DStraub%26aufirst%3DJ.%26aulast%3DTang%26aufirst%3DQ.%26aulast%3DXie%26aufirst%3DX.%26atitle%3DFlipped%2520Out%253A%2520Structure-Guided%2520Design%2520of%2520Selective%2520Pyrazolylpyrrole%2520ERK%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D1280%26epage%3D1287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Ma, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robert, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrahamson, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dey, S. K.</span><span> </span><span class="NLM_article-title">Adult Tissue Angiogenesis: Evidence for Negative Regulation by Estrogen in the Uterus</span> <span class="citation_source-journal">Mol. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1983</span><span class="NLM_x">–</span> <span class="NLM_lpage">1992</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm701397k&amp;key=10.1210%2Fme.15.11.1983" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm701397k&amp;key=11682628" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm701397k&amp;key=1%3ACAS%3A528%3ADC%252BD3MXotFKjtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2001&pages=1983-1992&author=W.+Maauthor=J.+Tanauthor=H.+Matsumotoauthor=B.+Robertauthor=D.+R.+Abrahamsonauthor=S.+K.+Dasauthor=S.+K.+Dey&title=Adult+Tissue+Angiogenesis%3A+Evidence+for+Negative+Regulation+by+Estrogen+in+the+Uterus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Adult tissue angiogenesis: evidence for negative regulation by estrogen in the uterus</span></div><div class="casAuthors">Ma, W.; Tan, J.; Matsumoto, H.; Robert, B.; Abrahamson, D. R.; Das, S. K.; Dey, S. K.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1983-1992</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">Increased uterine vascular permeability and angiogenesis are two major events of embryo implantation and placentation during pregnancy.  These latter processes require coordinated, uterine-specific interactions between progesterone (P4) and estrogen (E) signaling.  Although roles of these steroids have long been suspected, definitive functions of E and/or P4 in uterine angiogenesis still remain elusive.  The authors have therefore exploited the availability of reporter and mutant mice to explore the regulation of angiogenesis in response to steroid hormonal changes in vivo.  The authors present here mol., genetic, physiol., and pharmacol. evidence that E and P4 have different effects in vivo: E promotes uterine vascular permeability but profoundly inhibits angiogenesis, whereas P4 stimulates angiogenesis with little effect on vascular permeability.  These effects of E and P4 are mediated by differential spatiotemporal expression of proangiogenic factors in the uterus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2L9CNTcN1OLVg90H21EOLACvtfcHk0lg8p84bKzmBHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXotFKjtrw%253D&md5=c1b547382095f74aed4501ed55f622b9</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1210%2Fme.15.11.1983&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.15.11.1983%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DW.%26aulast%3DTan%26aufirst%3DJ.%26aulast%3DMatsumoto%26aufirst%3DH.%26aulast%3DRobert%26aufirst%3DB.%26aulast%3DAbrahamson%26aufirst%3DD.%2BR.%26aulast%3DDas%26aufirst%3DS.%2BK.%26aulast%3DDey%26aufirst%3DS.%2BK.%26atitle%3DAdult%2520Tissue%2520Angiogenesis%253A%2520Evidence%2520for%2520Negative%2520Regulation%2520by%2520Estrogen%2520in%2520the%2520Uterus%26jtitle%3DMol.%2520Endocrinol.%26date%3D2001%26volume%3D15%26spage%3D1983%26epage%3D1992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><div class="note"><p class="first last">Inhibition values exceeding 30% were significantly different (<i>p</i> < 0.05) from vehicle-treated controls.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Inhibition+values+exceeding+30%25+were+significantly+different+%28p+%3C+0.05%29+from+vehicle-treated+controls."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><div class="note"><p class="first last">Compound <b>34a</b> was screened against a wider panel of 150 kinases. At 1 mM ATP concentration, IC<sub>50</sub> values of <1000 nM were noted for TrkA (99 nM) and TrkB (52 nM). Kinases showing IC<sub>50</sub> < 1000 nM at lower ATP concentration included Src, Lck, JAK2, Abl, and Fyn. Without inhibition data at 1 mM ATP, however, it is not possible to make a direct comparison of these screening data with the data reported in Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Compound+34a+was+screened+against+a+wider+panel+of+150+kinases.+At+1+mM+ATP+concentration%2C+IC50+values+of+%3C1000+nM+were+noted+for+TrkA+%2899+nM%29+and+TrkB+%2852+nM%29.+Kinases+showing+IC50+%3C+1000+nM+at+lower+ATP+concentration+included+Src%2C+Lck%2C+JAK2%2C+Abl%2C+and+Fyn.+Without+inhibition+data+at+1+mM+ATP%2C+however%2C+it+is+not+possible+to+make+a+direct+comparison+of+these+screening+data+with+the+data+reported+in+Table+7."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Kolb, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplita, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, Y.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pernell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Major, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathis, G.</span><span> </span><span class="NLM_article-title">Tyrosine Kinase Assays Adapted to Homogeneous Time-Resolved Fluorescence</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">333</span><span class="NLM_x">–</span> <span class="NLM_lpage">342</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1998&pages=333-342&author=A.+J.+Kolbauthor=P.+V.+Kaplitaauthor=D.+J.+Hayesauthor=Y.-W.+Parkauthor=C.+Pernellauthor=J.+S.+Majorauthor=G.+Mathis&title=Tyrosine+Kinase+Assays+Adapted+to+Homogeneous+Time-Resolved+Fluorescence"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKolb%26aufirst%3DA.%2BJ.%26aulast%3DKaplita%26aufirst%3DP.%2BV.%26aulast%3DHayes%26aufirst%3DD.%2BJ.%26aulast%3DPark%26aufirst%3DY.-W.%26aulast%3DPernell%26aufirst%3DC.%26aulast%3DMajor%26aufirst%3DJ.%2BS.%26aulast%3DMathis%26aufirst%3DG.%26atitle%3DTyrosine%2520Kinase%2520Assays%2520Adapted%2520to%2520Homogeneous%2520Time-Resolved%2520Fluorescence%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D1998%26volume%3D3%26spage%3D333%26epage%3D342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i63"><a href="/doi/suppl/10.1021/jm701397k">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_06126"></div></div></div></div></div><hr /></hr><p class="last">Synthesis and spectral data for compounds <b>2</b>, <b>4</b>, <b>23</b>−<b>27</b>, <b>29</b>−<b>33</b>, <b>35</b>, <b>39</b>, <b>40</b>, and <b>42</b>. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm701397k/suppl_file/jm701397k-file003.pdf">jm701397k-file003.pdf (49.28 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm701397k&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2008.51.issue-13%3Barticle%3Aarticle%3A10.1021%2Fjm701397k%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm701397k" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                409KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677aef387f803d06","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
